Sentence,class,file
Curr Opin Immunol 2009; 21:346-51; PMID:19500964; http://dx.doi.org/10.1016/j.coi.2009.05.016 93.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
J Virol 2003; 77:8729-35; PMID:12885892; http://dx.doi.org/10.1128/JVI.77.16.8729-8735.2003 95.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
Vaccine 2003; 21:4555-64; PMID:14575768; http://dx.doi.org/ 10.1016/S0264-410X(03)00499-7 9 6 .,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
J Immunol 2003;171:6774-9; PMID:14662882; http://dx.doi.org/10.4049/ jimmunol.171.12.677497.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
J Virol 2003; 77:799-803; PMID:12477888; http://dx.doi.org/10.1128/JVI.77.1.799-803.2003 98.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
J Infect Dis 2010; 201:600-7; PMID:20078213; http://dx.doi.org/10.1086/650299 99.,OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
J Virol 2007; 81:6594-604; PMID:17428852; http://dx.doi.org/ 10.1128/JVI.02497-06 100.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
Appl Microbiol Biotechnol 2007; 76:1131-6; PMID:17581748; http://dx.doi.org/10.1007/s00253-007-1073-y 101.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
Expert Rev Vaccines 2013; 12:379-93; PMID:23560919; http://dx.doi.org/10.1586/erv.13.15 102.,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
Vaccine 2009; 27:4468- 74; PMID:19450644; http://dx.doi.org/10.1016/j.vaccine.2009.05.018 2884 Volume 10 Issue 10 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/e0/06/khvi-10-10-972880.PMC5443060.pdf
"Treat-ing multiple sites simultaneously would not only increase the © Jay R McCoy, Janess M Mendoza, Kristin W Spik, Catherine Badger, Alan F Gomez, Connie S Schmaljohn, Niranjan Y Sardesai, and Kate E Broderick *Correspondence to: Kate Broderick; Email: kbroderick@inovio.comSubmitted: 04/16/2014; Revised: 06/09/2014; Accepted: 06/20/2014 http://dx.doi.org/10.4161/hv.29671 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2008; 26:5073-4; PMID:18652867; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
J Virol 2001; 75:10991-1001; PMID:11602739; http://dx.doi.org/10.1128/JVI.75.22.10991-11001.2001 5.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Virology 2003; 314:134-46; PMID:14517067; http://dx.doi.org/10.1016/S0042-6822(03)00459-86.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
J Infect Dis 2001; 184:809-16; PMID:11550123; http://dx.doi.org/10.1086/323395 7.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
J Infect Dis 2013; 208:818-29; PMID:23840043; http://dx.doi.org/10.1093/infdis/jit236 8.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
J Infect Dis 2011; 203:95-102; PMID:21148501; http://dx.doi.org/10.1093/infdis/jiq017 9.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2006; 24:2200-7; PMID:16316713; http://dx.doi.org/ 10.1016/j.vaccine.2005.11.00210.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
PLoS One 2008; 3:e2517; PMID:18575608; http://dx.doi.org/10.1371/journal.pone.0002517 11.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Biochem Biophys Res Commun2001; 282:442-6; PMID:11401479; http://dx.doi.org/ 10.1006/bbrc.2001.4580 12.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Sci Transl Med 2012; 4:ra138; PMID: 23052295; http://dx.doi.org/10.1126/scitranslmed.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Virology 2006; 347:208-16; PMID:16378630; http://dx.doi.org/10.1016/j.virol.2005.11.035 14.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2008; 26:5177-81; PMID:18482782; http://dx.doi.org/ 10.1016/j.vaccine.2008.03.097 15.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Virology 2000; 266:329-39; PMID: 10639319; http://dx.doi.org/10.1006/viro.1999.0096 16.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2007; 25:4540-53;PMID:17485151; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Virology 2001; 284:46-61; PMID:11352667; http://dx.doi.org/10.1006/ viro.2001.0905 18.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
PLoS One 2012; 7:e45146; PMID:23024803; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
PLoS One 2012; 7:e34723; PMID:22509350; http://dx.doi.org/10.1371/journal.pone.0034723 20.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Biophys Chem 1987; 26:321-35; PMID:3607233; http://dx.doi.org/10.1016/0301-4622(87)80033-9 21.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Mol Ther 2005; 12:1197-205; PMID:16112909; http://dx.doi.org/10.1016/j.ymthe.2005.06.473 23.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2004; 22:2489-93; PMID:15193413; http://dx.doi.org/ 10.1016/j.vaccine.2003.11.07324.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Gene Ther 2007; 14:553-64; PMID:17215847; http://dx.doi.org/ 10.1038/sj.gt.3302907 25.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
J Immunol 2000; 164:4635-40; PMID:10779767; http://dx.doi.org/10.4049/jimmunol.164.9.4635 26.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Gene Ther 1999;6:508-14; PMID:10476210; http://dx.doi.org/ 10.1038/sj.gt.3300847 27.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2006; 24:4503-9; PMID:16181711; http://dx.doi.org/ 10.1016/j.vaccine.2005.08.017 28.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Gene Ther 2011; 18:258-65; PMID:20962869; http://dx.doi.org/10.1038/gt.2010.137 30.,OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Mol Ther Nucleic Acids 2012; 1:e11; PMID: 23344722; http://dx.doi.org/10.1038/mtna.2012.1 31.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2012; 30:6946-54; PMID:22406460; http://dx.doi.org/10.1016/j.vaccine.2012.02.071 32.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccines 2013; 1:384-97; http://dx.doi.org/10.3390/vaccines1030384 34.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2010; 28:8203-9; PMID:20951666; http://dx.doi.org/10.1016/j.vaccine.2010.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
PLoS One 2011; 6:e19181; PMID:21559474; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2013;31:3843-8; PMID:23831327; http://dx.doi.org/ 10.1016/j.vaccine.2013.06.063 37.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Hum Vac- cin Immunother 2012; 8:1694-702; PMID:23111168; http://dx.doi.org/10.4161/hv.22062 38.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Genet Vac- cines Ther 2012; 10:5; PMID:22873174; http://dx.doi.org/10.1186/1479-0556-10-5 39.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccines 2013; 1:367-83; http://dx.doi.org/10.3390/vaccines1030367 41.,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
Vaccine 2010; 28:2046-52; PMID:19896448; http://dx.doi.org/10.1016/j.vaccine.2009.10.057 www.landesbioscience.com 3047 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/81/3c/khvi-10-10-980635.PMC5443063.pdf
"2In Europe lyssavi- russpecies responsible for bat rabies are European bat lyssavi- rus1a n d2( E B L V - 1a n d- 2 ) .7In 2010, a novel lyssavirus species has been identiﬁed, which after the place of its ﬁrst © Claudius Malerczyk, Conrad Freuling, Dieter Gniel, Alexandra Giesen, Thomas Selhorst, and Thomas M €uller *Correspondence to: Claudius Malerczyk; Email: claudius.malerczyk@novartis.comSubmitted: 04/08/2014; Revised: 07/09/2014; Accepted: 07/27/2014 http://dx.doi.org/10.4161/21645515.2014.972741 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Philos Trans R Soc Lond B Biol Sci 2013; 368 (1623):20120142; PMID:23798690; http://dx.doi.org/10.1098/rstb.2012.0142 4.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Virus Genes 2013; 47(2):305-10; PMID:23839669; http://dx.doi.org/ 10.1007/s11262-013-0952-9 6.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Zoonoses Public Health 2013; 60(1):22-34; PMID:22963584; http://dx.doi.org/10.1111/zph.120028.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Virus Res 2013; 177(2):201-4; PMID:23932899; http://dx.doi.org/ 10.1016/j.virusres.2013.07.021 10.,OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Arch Virol 2013; 158 (11):2333-40; PMID:23760600; http://dx.doi.org/10.1007/s00705-013-1747-y www.landesbioscience.com 2803 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Emerg InfectDis 2012; 18(4):664-7; PMID:22469151; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Emerg Infect Dis 2013; 19(5):793-5; http://dx.doi.org/10.3201/eid1905.121071 13.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Epidemiol Infect 2003; 131(3):1029-39;PMID:14959767; http://dx.doi.org/10.1017/S0950 268803001481 16.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Vet Microbiol 2010; 142:151-159; PMID:20188498; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
J Virol 2010;84 (22):11841-8; PMID:20826698; http://dx.doi.org/10.1128/JVI.01153-10 22.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Epidemiol Infect 2008;136 (5):670-8; PMID:17588277; http://dx.doi.org/ 10.1017/S0950268807008965 23.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Vaccine 2005; 23(32):4101-9; PMID:15964478; http://dx.doi.org/10.1016/j.vaccine.2005.03.037 24.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Vaccine 2009; 27:5320-5; PMID:19615958; http://dx.doi.org/ 10.1016/j.vaccine.2009.06.095 26.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Virus Res 2005; 111(1):44-54; PMID:15896401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
J Virol 2001; 75(7):3268-76;PMID:11238853; http://dx.doi.org/10.1128/JVI.75.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
J Infect Dis 1992; 166(5):972-7; PMID:1402044; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
2006; 24(19):4116-21; PMID:16545510; http://dx.doi.org/10.1016/j.vaccine.2006.02.036 32.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
J Vet Med Ser B2004; 51(7):327-32; http://dx.doi.org/10.1111/j.1439- 0450.2004.00793.x 33.,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
"R Foundation for StatisticalComputing, Vienna, Austria; 2011; ISBN 3-900051- 07-0, URL: http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
Mol Biol Evol 2011; 28(10):2731-9; PMID:21546353; http://dx.doi.org/10.1093/molbev/msr121 2804 Volume 10 Issue 10 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/df/2f/khvi-10-10-972741.PMC5443070.pdf
"To make up impairment, avoid thesecondary damage and enable the victimsKeywords: adverse events following immunization, hepatitis B vaccine, post- baccination, regulatory science, vaccinesafety © Li Meina, Liu Xiaodong, and Zhang Lulu *Correspondence to: Li Meina; Email: lijinhan53@126.com; Zhang Lulu; Email: zllrmit@aliyun.com Submitted: 06/30/2014Revised: 07/13/2014 Accepted: 07/13/2014 http://dx.doi.org/10.4161/21645515.2014.971643 This is an Open Access article distributed under theterms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Vaccine 2014; 32:3362 -6; PMID:24793939; http://dx.doi.org/ 10.1016/j.vaccine.2014.04.045 2.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Vaccine 2014; 32:2127-33; PMID:24560676; http://dx.doi.org/10.1016/j.vaccine.2014.01.099 3.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Hum Vaccin Immunother 2013; 9:1661-72; PMID:23732907; http://dx.doi.org/ 10.4161/hv.247154.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Autoimmun Rev 2012; 12:144-9; PMID:22498789; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
J Neurol 2013; 260:1951-9; PMID:23086181; http://dx.doi.org/10.1007/s00415-012-6716-y 6.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
J Clin Virol 2009; 46:202-5; PMID:19716764; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Vaccine 2014; 32:1778-80; PMID:24530935; http://dx.doi.org/10.1016/j.vaccine.2014.01.080 8.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Vaccine 2014; 32:3175-8; PMID:24731808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
Med Mal Infecti 2009; 39:809-14;PMID:19819656; http://dx.doi.org/10.1016/j.medmal.,OADS,/arxiv_data1/oa_pdf/c2/fb/khvi-10-10-971643.PMC5443087.pdf
"28, 1303265 http://dx.doi.org/10.1080/16512235.2017.1303265 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/53/4d/zmeh-28-1303265.PMC5443090.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/4d/zmeh-28-1303265.PMC5443090.pdf
Acknowledgments The authors wish to thank additional members of the SAMSI working group Discovering Complex Human Health Patterns in Microbiome Data and members of the Vaginal Microbiome Consortium ( http://vmc.vcu.edu ) for initial thoughts and suggestions as well as Omer Weissbrod and Tal El-Hay for SCUP support and advice.,Non-OADS,/arxiv_data1/oa_pdf/53/4d/zmeh-28-1303265.PMC5443090.pdf
"ORCID Guanhua Chen http://orcid.org/0000-0002-9314-2037 References [1] Huang B, Fettweis JM, Brooks JP, et al.",OADS,/arxiv_data1/oa_pdf/53/4d/zmeh-28-1303265.PMC5443090.pdf
Available from: https://cran.rstu dio.com/web/packages/markovchain/index.html [38] Zhou YH.,Non-OADS,/arxiv_data1/oa_pdf/53/4d/zmeh-28-1303265.PMC5443090.pdf
Available from: https://github.com/pkimes/sigclust2 [47] Ward JH Jr. Hierarchical grouping to optimize an objective function.,OADS,/arxiv_data1/oa_pdf/53/4d/zmeh-28-1303265.PMC5443090.pdf
"In addition, the presence of LY6K 172– 191LP-speciﬁc Th cells in head and neck cancer patients vacci- n a t e dw i t ht h eL Y 6 K 177–186 short peptide (SP) suggests that tumor lysis induced by SP vaccination-activated CTLs accelerates uptakeand processing of LY6K protein by APCs which in turn present© Mustafa Diken, Sebastian Boegel, Christian Grunwitz, Lena M. Kranz, Kerstin Reuter, Niels van de Roemer, Fulvia Vascotto, Mathias Vormehr, and SebastianKreiter *Correspondence to: Mustafa Diken; Email: Mustafa.Diken@TrOn-Mainz.DE Submitted: 06/15/2014; Revised: 06/15/2014; Accepted: 07/28/2014http://dx.doi.org/10.4161/hv.29767 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Med 2013; 19:465-72; PMID:23455713; http://dx.doi.org/ 10.1038/nm.3105 2.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Clin Cancer Res 2006; 12:2342s-5s; PMID:16609056; http://dx.doi.org/ 10.1158/1078-0432.CCR-05-2541 3.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Int J Cancer 2014; 134:352-66; PMID: 24734272; http://dx.doi.org/10.1002/ijc.28376 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Clin Cancer Res 2013; 19:4508-20; PMID:23714729; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Oncoimmunology 2013; 2:e25801; PMID:24327937; http://dx.doi.org/10.4161/onci.25801 6.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Blood 2006; 108:4009-17; PMID:16940422; http://dx.doi.org/10.1182/blood- 2006-04-015024 7.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Immunol 2008; 180:309-18; PMID:18097032; http://dx.doi.org/10.4049/jimmunol.180.1.309 8.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Gene Ther 2010; 17:961-71; PMID:20410931; http://dx.doi.org/10.1038/ gt.2010.52 9.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cancer Res 2010; 70:9031-40;PMID:21045153; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0699 10.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cancer Res 2012; 72:1081-91; PMID:22237626; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3722 11. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInf ormation/Guidances/ UCM236669.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;http://dx.doi.org/10.1056/NEJMoa1003466 13.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
NEngl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690 14.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2011; 480:480-9; PMID:22193102; http://dx.doi.org/10.1038/ nature10673 15.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
N Engl J Med 2013; 369:122-33; PMID:23724867; http://dx.doi.org/ 10.1056/NEJMoa1302369 17.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Rev Clin Oncol 2014; 11:91-9; PMID:24445516; http://dx.doi.org/10.1038/nrclinonc.2013.245 19.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
PLoS One 2011; 6:e19499; PMID:21559358; http://dx.doi.org/10.1371/journal.pone.0019499 20.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cancer Res 2006; 66:7276-84; PMID:16849577; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Exp Med 2013; 210:743-55; PMID:23547098; http://dx.doi.org/10.1084/jem.20121190 22.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Immunol 2014; 15:431-8; PMID:24658051; http://dx.doi.org/ 10.1038/ni.2850 23.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Immunol 2004; 172:3994-8; PMID:15034010; http://dx.doi.org/10.4049/ jimmunol.172.7.3994 24.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Exp Med 2006; 203:1651-6; PMID:16801397; http://dx.doi.org/10.1084/jem.20051848 25.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Med 2008; 14:28- 36; PMID:18157142; http://dx.doi.org/10.1038/ nm1699 26.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Med 2014; 20:607-15; PMID:24793239; http://dx.doi.org/10.1038/nm.3541 27.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Exp Med 2013; 210:1695-710; PMID:23897981; http://dx.doi.org/10.1084/jem.20130579 28.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Br J Cancer 2013; 108:1560-5;PMID:23511566; http://dx.doi.org/10.1038/ bjc.2013.117 29.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Transl Med 2011; 9:108; PMID:21745365; http://dx.doi.org/10.1186/1479-5876-9-108 30.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunity 2012; 37:1-2; PMID:22840835; http://dx.doi.org/10.1016/j.immuni.2012.07.010 31.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cancer Immunol Immunother 2013; 62:615-27; PMID:23138872; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Transl Med 2011; 9:44; PMID:21507256; http://dx.doi.org/10.1186/ 1479-5876-9-44 33.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunity 2013; 38:742-53; PMID:23601686;http://dx.doi.org/10.1016/j.immuni.2012.12.006 34.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Rev Immunol 2013; 13:145-9; PMID:23348417; http://dx.doi.org/ 10.1038/nri3365 35.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Clin Invest 2012; 122:821-32; PMID:22354167; http://dx.doi.org/ 10.1172/JCI61014 36.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Rev Immunol 2012; 12:239-52; PMID:22437937; http://dx.doi.org/10.1038/nri3174 37.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Blood 2014; 123:678-86; PMID:24326534; http://dx.doi.org/10.1182/blood- 2013-08-519199 38.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Bioinformatics 2013; 29:1233-4; PMID:23479349; http://dx.doi.org/ 10.1093/bioinformatics/btt115 42.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Genome Med 2013; 4:102; PMID:23259685; http://dx.doi.org/10.1186/gm403 43.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Sci Rep 2014;4:4743; PMID:24752137; http://dx.doi.org/ 10.1038/srep04743 45.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nucleic Acids Res 2008; 36(Web Server issue):W509- 12; PMID:18463140; http://dx.doi.org/10.1093/nar/gkn202 46.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
PLoS One 2011;6:e26781; PMID:22073191; http://dx.doi.org/ 10.1371/journal.pone.0026781 47.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
BMC Bioinformatics 2009; 10:296; PMID:19765293; http://dx.doi.org/10.1186/1471-2105-10-296 48.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
PLoS One 2007; 2:e796; PMID:17726526; http://dx.doi.org/10.1371/ journal.pone.0000796 49.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunogenetics 2013; 65:711-24; PMID:23900783; http://dx.doi.org/10.1007/ s00251-013-0720-y 50.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunogenetics 2010; 62:357-68; PMID:20379710; http://dx.doi.org/10.1007/s00251- 010-0441-4 51.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunogenetics 2005;57:33-41; PMID:15744535; http://dx.doi.org/ 10.1007/s00251-005-0781-7 52.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Immunol 2013; 191:5831-9; PMID:24190657; http://dx.doi.org/10.4049/ jimmunol.1302101 53.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Eur J Immunol 2012; 42:1405-16; PMID:22678897; http://dx.doi.org/10.1002/eji.201141774 54.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunology 2014; 141:18-26; PMID:23927693; http://dx.doi.org/10.1111/ imm.12160 55.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
PLoS Comput Biol 2013; 9:e1003266; PMID:24204222; http://dx.doi.org/ 10.1371/journal.pcbi.1003266 56.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunogenetics 2014; 66:449-56; PMID:24863339; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Sci Transl Med2011; 3:96ra77; PMID:21849665; http://dx.doi.org/ 10.1126/scitranslmed.3001318 59.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cancer Discov 2013; 3:1364-77; PMID:24078773; http://dx.doi.org/10.1158/2159-8290.CD-13-0183 60.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Unifying immunology with informatics and multiscale biology.Nat Immunol 2014; 15:118-27; PMID:24448569; http://dx.doi.org/10.1038/ni.2787 61.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Rev Immunol 2012; 12:269-81; PMID:22437939; http://dx.doi.org/10.1038/nri3191 62.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Blood 2011; 118:50-9; PMID:21566093; http://dx.doi.org/10.1182/blood-2010-12-325993 63.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cancer Immunol Immunother 2012; 61:953-62;PMID:22527245; http://dx.doi.org/10.1007/s00262- 012-1254-0 64.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Sci Transl Med 2012; 4:32ra53; PMID:22553251;http://dx.doi.org/10.1126/scitranslmed.300376166.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Immunol 2004; 172:104-13; PMID:14688315; http://dx.doi.org/10.4049/ jimmunol.172.1.104 67.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Mol Ther 2009; 17:1453-64; PMID:19384291; http://dx.doi.org/10.1038/ mt.2009.83 68.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Sci Transl Med 2011; 3:95ra73; PMID:21832238;http://dx.doi.org/10.1126/scitranslmed.3002842 69.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849 70.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
N Engl J Med 2013; 368:1509-18; PMID:23527958; http://dx.doi.org/10.1056/NEJMoa1215134 71.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Leukemia 2013; 27:1328-38; PMID: 23277330; http://dx.doi.org/10.1038/leu.2012.374 73.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Immunol 2013; 14:908-16; PMID:23872678; http://dx.doi.org/10.1038/ni.2665 74.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunity 2009; 31:25-34; PMID:19576794; http://dx.doi.org/10.1016/j.immuni.2009.05.008 76.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Adv Drug Deliv Rev 2013; 65:331-5;PMID:22750807; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Curr Opin Immunol 2011; 23:399-406; PMID:21497074; http://dx.doi.org/ 10.1016/j.coi.2011.03.007 80.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Eur J Immunol 2000; 30:1-7; PMID:10602021; http://dx.doi.org/ 10.1002/1521-4141(200001)30:1 /C201::AID- IMMU1 /C213.0.CO;2-# 81.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Immunother 2011; 34:1-15; PMID:21150709; http://dx.doi.org/ 10.1097/CJI.0b013e3181f7dbe8 83.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Gene Med 2012;14:428-39; PMID:22262664; http://dx.doi.org/ 10.1002/jgm.2605 84.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Clin Invest 2012;122:4160-71; PMID:23064366; http://dx.doi.org/ 10.1172/JCI65459 85.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Oncoimmunology 2013; 2:e23084; PMID:23802062; http://dx.doi.org/ 10.4161/onci.23084 87.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 1999; 397:315-23; PMID:9950424; http://dx.doi.org/10.1038/16852 89.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 1997; 390:175-9; PMID:9367155; http://dx.doi.org/ 10.1038/36593 90.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Genes Dev 1999; 13:2412-24; PMID:10500098; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2009; 462:505-9; PMID:19940926; http://dx.doi.org/10.1038/nature08596 92.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Cell 2000; 103:41-50; PMID:11051546; http://dx.doi.org/10.1016/S0092-8674(00)00103-3 93.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Exp Gerontol 2000; 35:947-56; PMID:11121682; http://dx.doi.org/ 10.1016/S0531-5565(00)00178-9 95.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Ann N Y Acad Sci 2012; 1263:29-40; PMID:22831177;http://dx.doi.org/10.1111/j.1749-6632.2012.06674.x 96.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nat Rev Drug Discov 2012; 11:401-19; PMID:22543469; http://dx.doi.org/10.1038/ nrd3705 97.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2010; 468:98-102; PMID:20881962; http://dx.doi.org/10.1038/ nature09387 100.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2010; 468:103-7; PMID: 20881963; http://dx.doi.org/10.1038/nature09495 102.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2006; 440:692-6; PMID:16572175; http://dx.doi.org/10.1038/nature04524 103.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2000; 403:211- 6; PMID:10646608; http://dx.doi.org/10.1038/ 35003228 104.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Immunity 2004; 21:167-77; PMID:15308098; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
J Exp Med 2007; 204:879-91; PMID:17403934; http://dx.doi.org/10.1084/jem.20061699 106.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Nature 2014; 507:508-12; PMID:24553136; http://dx.doi.org/10.1038/nature12998 107.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
Science 2013; 342:1432-3; PMID:24357284; http://dx.doi.org/10.1126/ science.342.6165.1432 3100 Volume 10 Issue 10 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/aa/92/khvi-10-10-978233.PMC5443098.pdf
"6This vaccine comprises 4 mono- valent viruses, one per serotype (CYD-1–4), each of which was © Gustavo H Dayan, Juan-Francisco Galan-Herrera, Remi Forrat, Betzana Zambrano, Alain Bouckenooghe, Anke Harenberg, Bruno Guy, and Jean Lang *Correspondence to: Gustavo H Dayan; Email: Gustavo.Dayan@sano ﬁpasteur.com Submitted: 04/23/2014; Revised: 06/28/2014; Accepted: 07/20/2014 http://dx.doi.org/10.4161/21645515.2014.972131 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Nature 2013; 496:504-7; PMID:23563266; http://dx.doi.org/10.1038/nature12060 2.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Am J Trop Med Hyg2012; 87:584-93; PMID:23042846; http://dx.doi.org/ 10.4269/ajtmh.2012.11-0770 3.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
N Engl J Med 2012; 366:1423-32; PMID:22494122; http://dx.doi.org/10.1056/NEJMra1110265 4.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Comp Immunol Microbiol Infect Dis 2007; 30:329-40; PMID:17645944; http://dx.doi.org/10.1016/j.cimid.2007.05.010 5.,OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Biotechnol Adv2011; 29:239-47; PMID:21146601; http://dx.doi.org/ 10.1016/j.biotechadv.2010.11.008 6.,OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Lancet 2013;381:1094-5; PMID:23540847; http://dx.doi.org/ 10.1016/S0140-6736(13)60755-2 7.,OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
J Virol 2001; 75:7290-304; PMID:11462001; http://dx.doi.org/10.1128/JVI.75.16.7290-7304.2001 8.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
J Infect Dis 2011; 204:442-50; PMID:21742844; http://dx.doi.org/10.1093/infdis/jir279 9.,OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Pediatr Infect Dis J 2011; 30:e9-17; http://dx.doi.org/10.1097/INF.0b013e3181f e05af11.,OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
J Infect Dis 2010; 201:370-7; PMID:20059357; http://dx.doi.org/10.1086/649916 12.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Vaccine 2011;29:3863-72; PMID:21477675; http://dx.doi.org/ 10.1016/j.vaccine.2011.03.057 13.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Lancet 2007; 370:1644-52; PMID:17993365; http://dx.doi.org/10.1016/S0140- 6736(07)61687-0 14.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Lancet 2012;380:1559-67; PMID:22975340; http://dx.doi.org/ 10.1016/S0140-6736(12)61428-7 15.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
J Infect Dis 2011; 203:327-34;PMID:21208923; http://dx.doi.org/10.1093/infdis/ jiq059 16.,OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Virology 2010; 396:280-8; PMID:19913867; http://dx.doi.org/10.1016/j.virol.2009.10.023 17.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Vaccine 2008; 26:5712-21; PMID:18762226; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Nature 2009;458:211-4; PMID:19182777; http://dx.doi.org/ 10.1038/nature07657 20.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Hum Vaccin Immunother 2012; 8:1259-71; PMID:22894958; http://dx.doi.org/ 10.4161/hv.21224 22.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
PLoS Negl Trop Dis 2012; 6:e1732; PMID:22860141; http://dx.doi.org/ 10.1371/journal.pntd.0001732 23.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Vaccine 2006; 24:4914-26; PMID:16632108; http://dx.doi.org/10.1016/j.vaccine.2006.03.066 25.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Am J Trop Med Hyg 2013; 88:962-70; PMID:23458954; http://dx.doi.org/10.4269/ajtmh.12-0461 26.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
Vaccine 2013; 31:5047-54; PMID:24021313; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/khvi-10-10-972131.PMC5443102.pdf
"Partially in response to this prob-lem, GlaxoSmithKline (GSK) Vaccines developed the AdjuvantSystem AS03, an oil-in-water emulsion containing a-tocopherol, © David W Vaughn, Harry Seifert, Anne Hepburn, Walthere Dewe, Ping Li, Mamadou Drame, Catherine Cohet, Bruce L Innis, and Louis F Fries *Correspondence to: David W Vaughn; Email: david.w.vaughn@gsk.comSubmitted: 05/12/2014; Revised: 07/15/2014; Accepted: 07/25/2014 http://dx.doi.org/10.4161/21645515.2014.972149 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Nature 2006; 442:448-52; PMID:16642006; http://dx.doi.org/10.1038/ nature04795 2.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Proc Natl Acad Sci USA 2006;103:5935-40; PMID:16585506; http://dx.doi.org/ 10.1073/pnas.0601266103 3.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Lancet 2007; 370:580-9; PMID:17707753; http://dx.doi.org/10.1016/S0140-6736(07)61297-5 4.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2010; 28:1740-5; PMID:20034605; http://dx.doi.org/ 10.1016/j.vaccine.2009.12.014 5.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
PLoS One 2008; 3:e1665; PMID:18301743; http://dx.doi.org/10.1371/journal.pone.0001665 6.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Clin Vaccine Immunol 2011; 18:835-43; PMID:21450978; http://dx.doi.org/ 10.1128/CVI.00480-10 7.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2013;31:4389-97; PMID:23856331; http://dx.doi.org/ 10.1016/j.vaccine.2013.07.007 8.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2014; 32:1121-9; PMID:24252703; http://dx.doi.org/10.1016/j.vaccine.2013.11.031 9.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Infect Dis 2012; 205:733-44; PMID: 22315336; http://dx.doi.org/10.1093/infdis/jir641 10.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Public Health Policy 2005; 26:4-29; PMID:15906873;http://dx.doi.org/10.1057/palgrave.jphp.320000811.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2008; 26:2378-88; PMID:18407382; http://dx.doi.org/ 10.1016/j.vaccine.2008.02.068 12.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Infect Dis 2010; 201:1644-53; PMID:20423222; http://dx.doi.org/10.1086/652701 13.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
BMJ 2011; 342:c7297; PMID:21292718; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Inﬂuenza Other Respir Viruses 2010; 4:171-178; PMID:20629771; http://dx.doi.org/10.1111/j.1750-2659.2010.00146.x 15.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
"Assessment report for Pandemic inﬂuenza vaccine (H5N1) (split virion, inac- tivated, adjuvanted) GlaxoSmithKline Biologicals.Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/ human/001206/WC500049547.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Available at: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/ pdf/prodpharma/legislation/interimorders-arretesurgence/prodinfo-vaccin-eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Lancet 2007; 369:1961-71; PMID:17560449; http://dx.doi.org/ 10.1016/S0140-6736(07)60917-9 21.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Infect Dis 2001; 183(Suppl 1):S1-4; PMID:11171002; http://dx.doi.org/ 10.1086/318850 22.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ ApprovedProducts/UCM379021.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2011;29:2461-73; PMID:21256188; http://dx.doi.org/ 10.1016/j.vaccine.2011.01.011 25.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Lancet 2009; 374:2115-22; PMID:19880172; http://dx.doi.org/10.1016/S0140-6736(09)61877-8 26.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Neu-roepidemiology 1993; 12:313-25; PMID:8309506; http://dx.doi.org/10.1159/000110333 27.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Otolaryngol Head Neck Surg 1999; 120:269-71; PMID:9949364; http://dx.doi.org/10.1016/S0194- 5998(99)70418-3 29.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Ann Neurol 1986; 20:622-7; PMID:3789675; http://dx.doi.org/10.1002/ana.410200511 30.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2011; 29:4378-87; PMID:21501644; http://dx.doi.org/10.1016/j.vaccine.2011.04.005 31.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Neuroepidemiology 2002; 21:255-61;PMID:12207155; http://dx.doi.org/10.1159/ 000065645 32.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Ann Rheum Dis 2006; 65:1093-8; PMID:16414971; http://dx.doi.org/ 10.1136/ard.2005.046912 35.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Am Acad Dermatol 2009; 60:394-401; PMID:19231638; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Eur J Endocrinol2008; 158:823-7; PMID:18505903; http://dx.doi.org/ 10.1530/EJE-07-0877 38.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Clin Endocrinol (Oxf) 1990; 33:249-59; PMID:2225482;http://dx.doi.org/10.1111/j.1365-2265.1990.tb00489.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2010; 28:1062-8; PMID:19896453; http://dx.doi.org/ 10.1016/j.vaccine.2009.10.115 42.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Neurol Sci 2003; 216:89-93; PMID:14607307; http://dx.doi.org/10.1016/j.jns.2003.07.007 43.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Brain 1994; 117:325-35; PMID:8186959; http://dx.doi.org/10.1093/brain/117.2.325 46.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Gastroenterology 2011; 140:1785-94;PMID:21530745; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Gastroenterol Clin North Am 2002; 31:1-20; PMID:12122726; http://dx.doi.org/10.1016/S0889-8553(01)00002-4 48.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Rheumatology (Oxford) 2008; 47:1088- 92; PMID:18511475; http://dx.doi.org/10.1093/rheumatology/ken20549.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Rheumatol Int 2009; 29:411-5; PMID:18853167;http://dx.doi.org/10.1007/s00296-008-0713-6 50.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Ophthalmology 2004; 111:491-500; PMID:15019324; http://dx.doi.org/10.1016/j.ophtha.2003.06.014 51.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Pharmacoepide- miol Drug Saf 2004; 13:505-10; PMID:15317028; http://dx.doi.org/10.1002/pds.998 52.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
BMJ 2011; 343:d5956; PMID:21994316; http://dx.doi.org/ 10.1136/bmj.d5956 55.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
PLoS One 2012; 7: e33536; PMID:22470453; http://dx.doi.org/10.1371/ journal.pone.0033536 57.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Available at: http://www.julkari.ﬁ/bitstream/handle/10024/104482/URN_ISBN_978-952-245-921-3.pdf?,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Available at: http://www.lakemedelsverket.se/upload/nyheter/2011/Fallinventer ingsrapport_pandermrix_110630.pdf.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Neurology 2013;80:1315-21; PMID:23486871; http://dx.doi.org/10.1212/WNL.0b013e31828ab26f61.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Avail-able at: http://www.dohc.ie/publications/pdf/ Final_Report_of_National_Narcolepsy_Study_Stee ring_Committee.pdf?direct=1.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Brain 2013; 136:2486-96; PMID:23884811; http://dx.doi.org/10.1093/brain/awt187 63.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Available at: http://ecdc.europa.eu/en/ publications/Publications/Vaesco%20report%20FINAL %20with%20cover.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Sleep Med 2013; 14:867-71; PMID:23773727; http://dx.doi.org/ 10.1016/j.sleep.2013.03.020 66.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Infect Dis 2011; 203:1729-38; PMID: 21606531; http://dx.doi.org/10.1093/infdis/jir172 67.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Med Care 2007; 45:S89-95;PMID:17909389; http://dx.doi.org/10.1097/ MLR.0b013e3180616c0a 68.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2011; 29:6408-18; PMID:21554915; http://dx.doi.org/10.1016/j.vaccine.2011.04.072 71.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Infect Dis 2011; 203:1054-62; PMID: 21450995; http://dx.doi.org/10.1093/infdis/jiq174 73.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
BMC Infect Dis.2012; 12:279; PMID:23110320; http://dx.doi.org/ 10.1186/1471-2334-12-279 74.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Infect Dis 2011; 204:574-81; PMID:21791660; http://dx.doi.org/10.1093/infdis/jir328 75.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
BMC Infect Dis 2010; 10:338; PMID:21108818; http://dx.doi.org/10.1186/1471-2334-10-338 76.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2009; 27:6284-90; PMID:19856521; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2010; 28:849-57; PMID:19835828; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
BMC Infect Dis 2014; 14:142; PMID:24628789; http://dx.doi.org/ 10.1186/1471-2334-14-142 79.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
J Formos Med Assoc 2012; 111:333-9;PMID:22748624; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Hum Vaccin 2010; 6:888-93; PMID:20980795; http://dx.doi.org/10.4161/hv.6.11.12851 81.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Clin Infect Dis2010; 51:668-77; PMID:20687838; http://dx.doi.org/ 10.1086/655830 82.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
BMC Infect Dis 2013;13:1-11; PMID:23280237; http://dx.doi.org/10.1186/ 1471-2334-13-435 83.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Vaccine 2012; 30:6483-91;PMID:22885014; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
Br J Haematol 2010; 149:855-64; PMID:20377590; http://dx.doi.org/10.1111/j.1365-2141.2010.08176.x www.landesbioscience.com 2957 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/c1/ce/khvi-10-10-972149.PMC5443104.pdf
2014;4(4):1-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/autopsy-04-04001.PMC5443126.pdf
Available from: http://brasilemsintese.ibge.gov.br/populacao/ taxas-de-mortalidade-infantil.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/autopsy-04-04001.PMC5443126.pdf
2014;4(4):5-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1995; 22(3):983- 93. http://dx.doi.org/10.1002/ hep.1840220341.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1999; 23(12):1441- 54.  http://dx.doi.org/10.1097/00000478-199912000-00001.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1997; 26(4):891- 5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1985; 5(6):1194- 200. http://dx.doi.org/10.1002/ hep.1840050622.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1998; 194(7):487- 95. http://dx.doi.org/10.1016/ S0344-0338(98)80117-9.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
Autopsy and Case Reports 2014; 4(4): 5-8Focal nodular hyperplasia of the liver 82005; 100(7):1616- 9. http://dx.doi.org/10.1111/j.1572- 0241.2005.41898.x.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2013; 144( 5):888- 902. http://dx.doi.org/10.1053/j.gastro.2013.02.032.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2012; 36(11):1691- 9.  http://dx.doi.org/10.1097/PAS.0b013e3182653ece.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2008; 48(1):163- 70. http://dx.doi.org/10.1016/j.jhep.2007.10.003.,OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1984; 251(11):1461- 3.  http://dx.doi.org/10.1001/jama.1984.03340350051028.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1995; 22(6):1674- 81. http://dx.doi.org/10.1002/ hep.1840220610.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1996; 24(7):345- 50. http://dx.doi.org/10.1002/(SICI)1097- 0096(199609)24:7<345::AID-JCU3>3.0.CO;2-B .,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2004; 24(1):3-17. http://dx.doi.org/10.1148/ rg.241035050.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
1996; 198(3):889- 92. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2010; 90(4):719- 35. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2005 ;39( 5):401- 12. http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2006; 24(4):864- 72. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
2005; 236(1):166- 77. http://dx.doi.org/10.1148/radiol.2361040338.,OADS,/arxiv_data1/oa_pdf/4a/3e/autopsy-04-04005.PMC5443127.pdf
"2014;4(4):9-17. http://dx.doi.org/10.4322/acr.2014.034 ABSTRACT Cardiovascular involvement of amyloidosis is present in 90% of cases, which is frequently associated with the primary form  of the disease (AL amyloidosis).",Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2012; 7(1):54. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2012; 126( 12):e178- 82. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2006; 1(1):38. http://dx.doi.org/10.1186/1749-8090-1- 38.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2010; 52(4):347 -61. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2007; 38(12):1798- 809. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2013; 34(10):711- 4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
1979; 24(2):129- 35. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2000; 109(2):109- 13. http://dx.doi.org/10.1016/S0002- 9343(00)00461-7.,OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2013; 2(2):99- 108. http://dx.doi.org/10.1177/2048872612474906.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
2011; 20(3):135- 42. http://dx.doi.org/10.1055/s-0031-1284434.,Non-OADS,/arxiv_data1/oa_pdf/c2/0e/autopsy-04-04009.PMC5443128.pdf
"2014;4(4):19-24. http://dx.doi.org/10.4322/acr.2014.035 ABSTRACT Hepatosplenic T-cell lymphoma (HSTCL) is a rare non-Hodgkin lymphoma, marked by liver, spleen, and bone marrow  sinusoidal infiltration, with an aggressive clinical course, which represents a difficult diagnostic task for clinicians and pathologists.",Non-OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2012; 83(2):283- 92. http://dx.doi.org/10.1016/j.critrevonc.2011.10.001.,OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2012; 61(1):131- 2.  http://dx.doi.org/10.1111/j.1365-2559.2012.04231.x.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2013; 163(5):1253- 9. http://dx.doi.org/10.1016/j.jpeds.2013.06.053.,OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2004 ;3(2):69-75.  http://dx.doi.org/10.1016/S1568-9972(03)00091-0.,OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
1999; 60(1):61-5. http://dx.doi.org/10.1002/(SICI)1096- 8652(199901)60:1<61::AID-AJH10>3.0.CO;2-L.  PMid:9883807 8.,OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2007; 21(5):245- 53. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2012; 2(2):11- 20.  http://dx.doi.org/10.4322/acr.2012.011.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/autopsy-04-04019.PMC5443129.pdf
2014;4(4):25-34. http://dx.doi.org/10.4322/acr.2014.036 ABSTRACT The authors describe a peculiar form of Epstein-Barr virus (EBV)-associated T-cell lymphoma in an HIV-positive patient  presenting an aggressive clinical course.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2014; 19(1-2):21- 45.  http://dx.doi.org/10.1615/CritRevOncog.2014010804.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
1975; 5(2):112- 7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
1975; 5(2):117- 21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
1975; 16(2):216- 29. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2000; 21(11):573- 83. http://dx.doi.org/10.1016/ S0167-5699(00)01735-7.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2011; 11(2):131- 42. http://dx.doi.org/10.1038/nri2904.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2014; 5:486. http://dx.doi.org/10.3389/ fimmu.2014.00486.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2003; 3(5):413- 25. http://dx.doi.org/10.1038/nri1088.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2001; 2001( 1):259- 81.  http://dx.doi.org/10.1182/asheducation-2001.1.259.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2003; 40(3):175- 84. http://dx.doi.org/10.1016/S0037- 1963(03)00132-X.,OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2014; 38(10):e60- 71.  http://dx.doi.org/10.1097/PAS.0000000000000295.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2013; 26(1):23-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
1996; 20(1):103- 11.  http://dx.doi.org/10.1097/00000478-199601000-00012.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
1997; 15(2):71- 9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2013; 8(1):95-104. http://dx.doi.org/10.1186/1750-1172- 8-95.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2011; 35(8):1195- 203.  http://dx.doi.org/10.1097/PAS.0b013e31821ec4b5.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2013; 37(1):14-23. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2009; 113(17):3931- 7. http://dx.doi.org/10.1182/blood- 2008-10-185256.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2008; 52(5):585- 96.  http://dx.doi.org/10.1111/j.1365-2559.2008.02997.x.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2010; 206(7):463-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2004; 18(4):763- 70. http://dx.doi.org/10.1038/ sj.leu.2403262.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2004; 45(12):2427- 38. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2013; 346(1):56- 63. http://dx.doi.org/10.1097/MAJ.0b013e3182764b59.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2014; 64(2):171- 99. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2004; 79(5):480- 3. http://dx.doi.org/10.1532/ IJH97.A10316.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2010; 3(1):35- 40.  http://dx.doi.org/10.1007/s12308-010-0057-5.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
2014; 100(4):402- 6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/86/autopsy-04-04025.PMC5443130.pdf
"2014;4(4):35-41.  http://dx.doi.org/10.4322/acr.2014.037 ABSTRACT Prune-belly syndrome (PBS) is a rare congenital anomaly characterized by a spectrum of mild-to-severe presentations  of urinary tract malformations, deficient abdominal wall musculature, and cryptorchidism in male newborns or genital abnormalities in the female newborns.",Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2012; 28(3):219- 28. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2013; 31(1):13- 24. http://dx.doi.org/10.3109/15513815 .2012.659411.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
"2007; 7(3):132- 43, quiz 144-5. http://dx.doi.org/10.1097/01.",Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2014; 17(4):425- 30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1997; 72(1):31-3. http://dx.doi.org/10.1016/ S0301-2115(96)02664-4.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2012; 187(1):272- 8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2001; 43(2):172- 5.  http://dx.doi.org/10.1046/j.1442-200x.2001.01347.x .,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1995; 9(6):770- 8. http://dx.doi.org/10.1007/BF00868740.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2008; 23(7):2412- 5.  http://dx.doi.org/10.1093/ndt/gfn169.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1997; 70(1):32- 6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1984; 19(3):603- 4. http://dx.doi.org/10.1002/ ajmg.1320190326.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1987; 26(3):747- 8. http://dx.doi.org/10.1002/ajmg.1320260332.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1990; 25(3):342- 5. http://dx.doi.org/10.1016/0022- 3468(90)90083-L.  PMid:2138219 19.,OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2000; 7(5):161- 6. http://dx.doi.org/10.1046/j.1442- 2042.2000.00159.x.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1977 ;5(4):268-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1995; 346(8974):537- 40. http://dx.doi.org/10.1016/S0140-6736(95)91381-5.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
1995; 172(1):206- 9. http://dx.doi.org/10.1016/0002-9378(95)90115-9.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2013; 56(4):265- 8. http://dx.doi.org/10.5468/ ogs.2013.56.4.265.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2011; 37(6):696- 701. http://dx.doi.org/10.1002/ uog.8963.,Non-OADS,/arxiv_data1/oa_pdf/6d/c5/autopsy-04-04035.PMC5443131.pdf
2014;4(4):43-9. http://dx.doi.org/10.4322/acr.2014.038 ABSTRACT The calcifying odontogenic cystic tumor (CCOT) is a benign lesion of odontogenic origin characterized by an ameloblastoma- like epithelium with ghost cells that may calcify.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
1962; 15(10):1235- 43. http://dx.doi.org/10.1016/0030- 4220(62)90159-7.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
1991; 72(1):56- 64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
2008; 37(5):302- 8. http://dx.doi.org/10.1111/ j.1600-0714.2007.00623.x.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
2003; 27(3):372- 84.  http://dx.doi.org/10.1097/00000478-200303000-00011.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
2003; 32(3):163- 70.  http://dx.doi.org/10.1034/j.1600-0714.2003.00070.x.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
1991; 49(4):330- 9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
1998; 27(2):49- 52.  http://dx.doi.org/10.1111/j.1600-0714.1998.tb02092.x.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
1981; 39(4):227- 40. http://dx.doi.org/10.3109/00016358109162284.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
2001; 42(1):51- 5. http://dx.doi.org/10.2209/tdcpublication.42.51.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
2013; 25(4):328- 32.  http://dx.doi.org/10.1016/j.ajoms.2013.01.007.,OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
1995; 53(7):748- 54; discussion 755-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
2012; 85(1013):548- 54. http://dx.doi.org/10.1259/ bjr/19841479.,Non-OADS,/arxiv_data1/oa_pdf/10/b0/autopsy-04-04043.PMC5443132.pdf
"2014;4(4):51-6. http://dx.doi.org/10.4322/acr.2014.039 ABSTRACT Placental mesenchymal dysplasia (PMD) is a rare placental disorder characterized by placental enlargement and areas of  abnormal, enlarged, grape-like villi.",Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2004; 25(7):671- 2. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
1997; 18(8):701- 6. http://dx.doi.org/10.1016/ S0143-4004(97)90012-6.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2000; 50(9):759- 64. http://dx.doi.org/10.1046/j.1440- 1827.2000.01100.x.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2006; 126(1):67- 78. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2014; 384(9946):857- 68. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2007; 114(6):715- 20. http://dx.doi.org/10.1111/ j.1471-0528.2007.01327.x.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
1991; 187(2-3):324- 8. http://dx.doi.org/10.1016/ S0344-0338(11)80791-0.,OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2013; 75(4):217- 23. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2001; 39(5):447- 54.  http://dx.doi.org/10.1046/j.1365-2559.2001.01256.x.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2003; 53(11):810- 3. http://dx.doi.org/10.1046/ j.1440-1827.2003.01550.x.,Non-OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
1991; 22(6):591- 7.  http://dx.doi.org/10.1016/0046-8177(91)90237-J.,OADS,/arxiv_data1/oa_pdf/3c/82/autopsy-04-04051.PMC5443133.pdf
2014;4(4): 57-61. http://dx.doi.org/10.4322/acr.2014.040 ABSTRACT Plasmocytoid variant urothelial carcinoma (PVUC) of the urinary bladder is a rare histological variant of transitional  cell carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2011; 129(2):346- 54.  http://dx.doi.org/10.1002/ijc.25700.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2013; 189( 5):1656- 61. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2006; 50(5):1111- 4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2009; 40(7):1023- 8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2011; 42(8):1149- 58. http://dx.doi.org/10.1016/j.humpath.2010.11.011.,OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2007; 39(4):1031- 7. http://dx.doi.org/10.1007/ s11255-006-9159-5.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2014; 45(7):1473- 82. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2014; 83(5):1112- 6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2014; 24(5):517 -23.  http://dx.doi.org/10.1097/MOU.0000000000000089.,Non-OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2014; 32(6):833- 8. http://dx.doi.org/10.1016/j.urolonc.2014.03.008.,OADS,/arxiv_data1/oa_pdf/24/a9/autopsy-04-04057.PMC5443134.pdf
2014;4(4): 63-9. http://dx.doi.org/10.4322/acr.2014.041 ABSTRACT Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ or system.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2013; 25(5):577- 83. http://dx.doi.org/10.1097/ BOR.0b013e328363eaf1.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2014; 35(2):249- 54. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2010; 6(6):358- 67. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
1993; 32(6):458- 62. http://dx.doi.org/10.1093/rheumatology/32.6.458.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2008 ;58(11):3286 - 98. http://dx.doi.org/10.1002/art.23991.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2013; 40(3):273- 81. http://dx.doi.org/10.3899/ jrheum.121048.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2012; 21(12):1316- 25. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2007 ;57(8):1461 -72. http://dx.doi.org/10.1002/ art.23098.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2013 ;33(8):1923- 32. http://dx.doi.org/10.1007/s00296- 013-2750-z.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
1994; 37 (9):1311- 20. http://dx.doi.org/10.1002/ art.1780370907.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
1965; 1(5445):1273- 7. http://dx.doi.org/10.1136/ bmj.1.5445.1273.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2007; 16(6):410- 7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
"Autopsy and Case Reports 2014; 4(4):  63-69Barbosa BJAP , Cardozo FAM, Ferraz JFFM, Rays J, Kanegae MY, Takayasu V. 693. http://dx.doi.org/10.1177/0961203314536248.",Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2000; 75(5):467- 72. http://dx.doi.org/10.1016/ S0025-6196(11)64215-8.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2004; 30(3):261- 3. http://dx.doi.org/10.1590/ S1806-37132004000300012.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2012; 62(2):274- 80. http://dx.doi.org/10.1016/S0034- 7094(12)70126-5.,OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2012; 32(5):1391- 6. http://dx.doi.org/10.1007/s00296-011-1863-5.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
2009;39(1 ):30- 7. http://dx.doi.org/10.1016/j.semarthrit.2008.04.003.,OADS,/arxiv_data1/oa_pdf/9a/30/autopsy-04-04063.PMC5443135.pdf
"National Center for Chronic Disease  Prevention and Health Promotion, Division of Population Health,  Atlanta, GA, 2014. http://apps.nccd.cdc.gov/brfss/index.asp.",OADS,/arxiv_data1/oa_pdf/1a/f8/etm-13-05-2375.PMC5443168.pdf
The raw expression data was prepro - cessed using the robust multiarray average ( 11) algorithm by  applying an oligo  (12) in the R statistical software program  in Bioconductor (http://www.bioconductor.org/).,OADS,/arxiv_data1/oa_pdf/b1/af/etm-13-05-1832.PMC5443169.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.NEUROGENESIS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"1, e1313647 (11 pages)https://doi.org/10.1080/23262133.2017.1313647",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Neuron2011; 69:840-55; PMID:21382546; https://doi.org/ 10.1016/j.neuron.2011.02.031 [2] Andersson ER, Sandberg R, Lendahl U.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Development2011; 138:3593-612; PMID:21828089; https://doi.org/10.1242/dev.063610 [3] Louvi A, Artavanis-Tsakonas S. Notch signalling in vertebrate neural development.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Rev Neurosci2006; 7:93-102; PMID:16429119; https://doi.org/ 10.1038/nrn1847 [4] Shimojo H, Ohtsuka T, Kageyama R. Dynamic expres- sion of Notch signaling genes in neural stem/progenitorcells.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
Front Neurosci 2011; 5:78; PMID:21716644;https://doi.org/10.3389/fnins.2011.00078 [5] Schwanbeck R. The role of epigenetic mechanisms in Notch signaling during development.,OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"J Cell Physiol 2015;230:969-81; PMID:25336183; https://doi.org/10.1002/ jcp.24851[6] Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Front Cell Neurosci 2013; 7:220;PMID:24312010; https://doi.org/10.3389/fncel.2013.00220 [7] Li Y, Wang F, Lee JA, Gao FB.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Genes & Development 2006; 20:2793-805;https://doi.org/10.1101/gad.1466306 [8] Bonev B, Pisco A, Papalopulu N. MicroRNA-9 reveals regional diversity of neural progenitors along the anterior-posterior axis.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Dev Cell 2011; 20:19-32; PMID:21238922;https://doi.org/10.1016/j.devcel.2010.11.018 [9] Leucht C, Stigloher C, Wizenmann A, Klafke R, Folchert A, Bally-Cuif L. MicroRNA-9 directs late organizer activ-ity of the midbrain-hindbrain boundary.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Neurosci2008; 11:641-8; PMID:18454145; https://doi.org/10.1038/ nn.2115 [10] Bonev B, Stanley P, Papalopulu N. MicroRNA-9 modulates Hes1 ultradian oscillations by forming a double-negativefeedback loop.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell Rep 2012; 2:10-18; PMID:22840391;https://doi.org/10.1016/j.celrep.2012.05.017 [11] Koch P, Opitz T, Steinbeck JA, Ladewig J, Br €ustle O.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"PLoS One 2012; 7:e29597; PMID:22272239; https://doi.org/ 10.1371/journal.pone.0029597 [13] Roese-Koerner B, Stappert L, Berger T, Braun NC, Veltel M, Jungverdorben J, Evert BO, Peitz M, Borghese L,Br€ustle O.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"PLoS One 2013; 8: e59011; PMID:23527072; https://doi.org/10.1371/journal.pone.0059011 [15] Roese-Koerner B, Stappert L, Koch P, Br €ustle O, Borgh- ese L. Pluripotent stem cell-derived somatic stem cells as tool to study the role of microRNAs in early human neu-ral development.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
Curr Mol Med 2013; 13:707-22; https://doi.org/10.2174/1566524011313050003 [16] Bartel DP.,Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell 2004; 116:281-97; https://doi.org/10.1016/S0092-8674(04)00045-5 [17] Coolen M, Thieffry D, Drivenes Ø, Becker TS, Bally-Cuif L. miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
22:1052-64; PMID:22595676; https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"J Neurosci 2010; 30:4048-61; PMID:20237275;https://doi.org/10.1523/JNEUROSCI.4982-09.2010 [19] Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"RNA 2003;9:1274-81; PMID:13130141; https://doi.org/10.1261/rna.5980303 [20] Shimojo H, Ohtsuka T, Kageyama R. Oscillations in Notch signaling regulate maintenance of neural progeni-tors.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Neuron 2008; 58:52-64; PMID:18400163; https://doi.org/10.1016/j.neuron.2008.02.014 [21] Shimojo H, Isomura A, Ohtsuka T, Kori H, Miyachi H, Kageyama R. Oscillatory control of Delta-like1 in cellinteractions regulates dynamic gene expression and tissuemorphogenesis.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Genes Dev 2016; 30:102-16; https://doi.org/10.1101/gad.270785.115 [22] Kageyama R, Shimojo H, Imayoshi I.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Comms 2014; 5:3399; https://doi.org/10.1038/ncomms4399 [24] Mizutani KI, Yoon K, Dang L, Tokunaga A, Gaiano N. Differential Notch signalling distinguishes neural stem cells from intermediate progenitor s. Nature 2007; 449:351-5; PMID:17721509; https://doi.org/10.1038/nature06090 [25] Kawaguchi A, Ikawa T, Kasukawa T, Ueda HR, Kurimoto K, Saitou M, Matsuzaki F. Single-cell gene pro ﬁling deﬁnes differential progenitor subclasses in mammalian neurogenesis.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Development 2008; 135:3113-24;PMID:18725516; https://doi.org/10.1242/dev.022616 [26] Nelson BR, Hodge RD, Bedogni F, Hevner RF.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"J Neurosci 2013;33:9122-39; PMID:23699523; https://doi.org/10.1523/JNEUROSCI.0791-13.2013 [27] Vasconcelos FF, Sessa A, Laranjeira C, Raposo AA, Teix- eira V, Hagey DW, Tomaz DM, Muhr J, Broccoli V, Cas-tro DS.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell Rep 2016; 17:469-83; PMID:27705795; https://doi.org/10.1016/j.celrep.2016.09.024 [28] Giachino C, Taylor V. Notching up neural stem cell homogeneity in homeostasis and disease.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Front Neurosci.2014; 8:32; PMID:24611040; https://doi.org/10.3389/fnins.2014.00032 [29] Bian S, Xu TL, Sun T. Tuning the cell fate of neurons and glia by microRNAs.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
Curr Opin Neurobiol 2013;23:928-34; PMID:23978589; https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell Tissue Res 2014; 359:47-64; PMID:25172833; https://doi.org/10.1007/s00441-014-1981-y [31] La Torre A, Georgi S, Reh TA.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"J Neurosci 2008; 28:10415-21; PMID:18842901; https://doi.org/10.1523/JNEUROSCI.3219-08.2008 [33] Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S. MicroRNA-9 regulates neurogenesis in mouse telenceph-alon by targeting multiple transcription factors.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"J Neuro-sci 2011; 31:3407-22; PMID:21368052; https://doi.org/10.1523/JNEUROSCI.5085-10.2011 [34] Wu ZQ, Li D, Huang Y, Chen XP, Huang W, Liu CF, Zhao HQ, Xu RX, Cheng M, Schachner M, et al.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cerebral Cortex 2016; 27:1369-85;PMID:26740489; https://doi.org/10.1093/cercor/bhv318 [35] Mitzutani KI, Saito T. Progenitors resume generating neurons after temporary inhibition of neurogenesis byNotch activation in the mammalian cerebral cortex.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Development 2005; 132:1295-304; PMID:15750183; https://doi.org/10.1242/dev.01693 [36] Corbin JG, Gaiano N, Juliano SL, Poluch S, Stancik E, Haydar TF.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"J Neurochem 2008;106:2272-87; PMID:18819190; https://doi.org/10.1111/j.1471-4159.2008.05522.x [37] Le Dr /C19eau G, Mart /C19ıE.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Devel Neurobio 2012; 72:1471-81; https://doi.org/10.1002/dneu.22015 [38] Baek JH, Hatakeyama J, Sakamoto S, Ohtsuka T, Kageyama R. Persistent and high levels of Hes1 expres-sion regulate boundary formation in the developing cen-tral nervous system.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Development 2006; 133:2467-76;PMID:16728479; https://doi.org/10.1242/dev.02403 [39] Krichevsky AM, Sonntag KC, Isacson O, Kosik KS.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Stem Cells 2006; 24:857-64; PMID:16357340;https://doi.org/10.1634/stemcells.2005-0441 [40] Zhao J, Lin Q, Kim KJ, Dardashti FD, Kim J, He F, Sun Y. Ngn1 inhibits astrogliogenesis throughinduction of miR-9 during neuronal fate speci ﬁcation.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Elife 2015; 4:e06885; https://doi.org/10.7554/eLife.06885 [41] Jeon SJ, Fujioka M, Kim SC, Edge AS.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.Neurosci Bull 2013; 29:129-43; PMID:23494530; https://doi.org/10.1007/s12264-013-1318-y [43] Buller B, Chopp M, Ueno Y, Zhang L, Zhang RL, Morris D, Zhang Y, Zhang ZG.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Glia 2012;60:1906-14; PMID:22907787; https://doi.org/10.1002/glia.22406 [44] Guentchev M, McKay RD.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Euro J Neurosci 2006; 23:2289-96; PMID:16706837; https://doi.org/10.1111/j.1460-9568.2006.04766.x [45] Alvarez-Buylla A, Kohwi M, Nguyen TM, Merkle FT.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cold Spring HarbSymp Quant Biol 2008; 73:357-65; PMID:19022766;https://doi.org/10.1101/sqb.2008.73.019 [46] Katz S, Cussigh D, Urb /C19an N, Blom ﬁeld I, Guillemot F, Bally- Cuif L, Coolen M. A nuclear role for miR-9 and Argonaute proteins in balancing quiescent and activated neural stem cell states.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell Rep 2016; 17:1383-98; PMID:27783951;https://doi.org/10.1016/j.celrep.2016.09.088 [47] Rani N, Nowakowski TJ, Zhou H, Godshalk SE, Lisi V, Kriegstein AR, Kosik KS.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Neuron 2016; 90:1174-88; PMID:27263970;https://doi.org/10.1016/j.neuron.2016.05.005 [48] Ma M, Wu W, Li Q, Li J, Sheng Z, Shi J, Zhang M, Yang H, Wang Z, Sun R, et al.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Sci Rep 2015; 5:12740; PMID:26238256;https://doi.org/10.1038/srep12740 [49] Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I,et al.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cancer Res 2005; 65:2353-63; PMID:15781650;https://doi.org/10.1158/0008-5472.CAN-04-1890 [50] Giachino C, Boulay J-L, Ivanek R, Alvarado A, Tos- tado C, Lugert S, Tchorz J, Coban M, Mariani L, Bet-tler B, et al.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cancer Cell2015; 28:730-42; PMID:26669487; https://doi.org/ 10.1016/j.ccell.2015.10.008 [51] Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A,Kharenko O, et al.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"BrainPathol 2009; 19:375-83; PMID:18624795; https://doi.org/10.1111/j.1750-3639.2008.00184.x [52] Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, St€uhler K, Meyer HE, Reifenberger G. Identi ﬁcation andfunctional characterization of microRNAs involved in the malignant progression of gliomas.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Brain Pathol 2010;20:539-50; PMID:19775293; https://doi.org/10.1111/j.1750-3639.2009.00328.x [53] Tan X, Wang S, Yang B, Zhu L, Yin B, Chao T, Zhao J, Yuan J, Qiang B, Peng X.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"PLoS One 2012; 7:e49570; PMID:23185366; https://doi.org/10.1371/journal.pone.0049570 [54] Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E, ScrepantiI, et al.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"EMBO J 2008; 27:2616-27; PMID:18756266;https://doi.org/10.1038/emboj.2008.172 [55] Laneve P, Di Marcotullio L, Gioia U, Fiori ME, Ferretti E, Gulino A, Bozzoni I, Caffarelli E. The interplay betweenmicroRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblas-toma cells.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell StemCell 2010; 6:323-35; PMID:20362537; https://doi.org/10.1016/j.stem.2010.02.015 [57] Pel /C19aez N, Carthew RW.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Current Topics inDevelopmental Biology 2012:237-55; PMID:22365741;https://doi.org/10.1016/B978-0-12-387038-4.00009-4 [58] Ebert MS, Sharp PA.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell 2012; 149:515-24;PMID:22541426; https://doi.org/10.1016/j.cell.2012.04.005 [59] Zhao C, Sun G, Li S, Shi Y.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Struct MolBiol 2009; 16:365-71; PMID:19330006; https://doi.org/10.1038/nsmb.1576 [60] Laneve P, Gioia U, Andriotto A, Moretti F, Bozzoni I, Caffarelli E. A minicircuitry involving REST and CREBcontrols miR-9-2 expression during human neuronal dif-ferentiation.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nucleic Acids Res 2010; 38:6895-905;PMID:20624818; https://doi.org/10.1093/nar/gkq604 [61] Davila JL, Goff LA, Ricupero CL, Camarillo C, Oni EN, Swerdel MR, Toro-Ramos AJ, Li J, Hart RP.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"PLoS One 2014; 9:e94348; PMID:24714615; https://doi.org/10.1371/journal.pone.0094348 [62] Phillips NE, Manning CS, Pettini T, Biga V, Marinopou- lou E, Stanley P, Boyd J, Bagnall J, Paszek P, Spiller DG,et al.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Elife 2016; 5:e16118; https://doi.org/10.7554/eLife.16118 [63] Cassidy JJ, Jha AR, Posadas DM, Giri R, Venken KJT, Ji J, Jiang H, Bellen HJ, White KP, Carthew RW.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell 2013; 155:1556-67;PMID:24360277; https://doi.org/10.1016/j.cell.2013.10.057 [64] Dai W, Li W, Hoque M, Li Z, Tian B, Makeyev EV.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Comms2015; 6:7576; https://doi.org/10.1038/ncomms8576 [65] Yoo AS, Staahl BT, Chen L, Crabtree GR.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nature 2009; 460:642-6 PMID: 19561591;https://doi.org/10.1038/nature08139 [66] Eda A, Tamura Y, Yoshida M, Hohjoh H. Systematic gene regulation involving miRNAs during neuronal differentia-tion of mouse P19 embryonic carcinoma cell.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"BiochemBiophys Res Commun 2009; 388:648-53; PMID:19679099; https://doi.org/10.1016/j.bbrc.2009.08.040 [67] Nowak JS, Choudhury NR, de Lima Alves F, Rappsilber J, Michlewski G. Lin28a regulates neuronal differentiationand controls miR-9 production.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Comms 2014; 5:3687;https://doi.org/10.1038/ncomms4687 [68] Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, Lee-Messer C, Dolmetsch RE, Tsien RW, CrabtreeGR.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nature 2011; 476:228-31;PMID:21753754; https://doi.org/10.1038/nature10323 [69] Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, S€udhof TC, Wernig M. Direct conversion of ﬁbroblasts to functional neurons by de ﬁned factors.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nature 2010; 463:1035-41; PMID:20107439; https://doi.org/10.1038/ nature08797 [70] Xue Y, Ouyang K, Huang J, Zhou Y, Ouyang H, Li H, Wang G, Wu Q, Wei C, Bi Y, et al.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Cell 2013; 152:82-96; PMID:23313552;https://doi.org/10.1016/j.cell.2012.11.045 [71] Xue Y, Qian H, Hu J, Zhou B, Zhou Y, Hu X, Karakhan- yan A, Pang Z, Fu XD.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
"Nat Neurosci 2016; 19:807-15; PMID:27110916; https://doi.org/10.1038/nn.4297 [72] Liu Z, Keller PJ.",OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
Dev Cell 2016;36:597-610; PMID:27003934; https://doi.org/10.1016/j.devcel.2016.02.016NEUROGENESIS e1313647-11,OADS,/arxiv_data1/oa_pdf/40/ce/kngs-04-01-1313647.PMC5443189.pdf
http://d.g.wanfangdata.com.,Non-OADS,/arxiv_data1/oa_pdf/a9/7b/etm-13-05-1813.PMC5443219.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2017.01.002 2211-3835 &2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/e9/59/main.PMC5443236.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/59/main.PMC5443236.pdf
Zhang and coworkers92at the Broad Institute developed an online tool called CRISPR Design(http://www.genome-engineering.org/ ) to assist in the design of sgRNA and evaluate off-target effects.,OADS,/arxiv_data1/oa_pdf/e9/59/main.PMC5443236.pdf
http://d.g.wanfangdata.com.cn/Periodical_ xdkf201210028.aspx 15.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/etm-13-05-1922.PMC5443299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/49/kfx045.PMC5443304.pdf
Available at: https://www.ebi.ac.uk/arrayexpress/ experiments/E-GEOD-39707/.,OADS,/arxiv_data1/oa_pdf/f1/49/kfx045.PMC5443304.pdf
Available at: https://cran.r-project.org/web/packages/MAMA/index.html.,Non-OADS,/arxiv_data1/oa_pdf/f1/49/kfx045.PMC5443304.pdf
Available at: https://www.bioconductor.org/packages/release/bioc/html/GeneMeta.html.,OADS,/arxiv_data1/oa_pdf/f1/49/kfx045.PMC5443304.pdf
"MeSH Keywords:  Anterior Spinal Artery Syndrome • Anterior Wall Myocardial Infarction • Echocardiography  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901233Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Hematology, Harbin Medical University Cancer Hospital, Harbin,  Heilongjiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/28/5f/medscimonit-23-2324.PMC5443357.pdf
"MeSH Keywords:  Chemotherapy, Cancer, Regional Perfusion • Pancreatectomy • Pancreatic Neoplasms • Radiotherapy •  Survival  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904393Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center,  Fudan University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/f8/60/medscimonit-23-2315.PMC5443358.pdf
"MeSH Keywords:  Fatty Acids • Fatty Liver • MicroRNAs  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901377Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Ultrasound, The Second Affiliated Hospital of Shaanxi University  of Chinese Medicine, Xianyang, Shaanxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/31/cf/medscimonit-23-2299.PMC5443364.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"5, 1073 –1077 http://dx.doi.org/10.1080/21645515.2016.1276139",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
Sequences were analyzed with BLAST ( http:// blast.ncbi.nlm.nih.gov/Blast.cgi ) or MUSCLE ( http://www.ebi.,OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"To deter- mine the repeat count for each locus, the sequence of 6 loci wasperformed as described previously, 28The assignment of MLVA type was based on the combination of repeat counts for VNTRs1, 3a, 3b, 4, 5, and 6 and was consistent with internationalnomenclature ( http://www.mlva.net/ ).",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
Clin Microbiol Rev 2005; 18(2):326-82; PMID: 15831828; http://dx.doi.org/10.1128/CMR.18.2.326-382.2005 [2] Guiso N. Bordetella pertussis: why is it still circulating?,Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"J Infect 2014; 68 (Suppl 1):S119-24; PMID: 24103807; http://dx.doi.org/10.1016/j.jinf.2013.09.022 [3] Sealey KL, Belcher T, Preston A. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Infect Genet Evol2016; 40:136-43; PMID: 26932577; http://dx.doi.org/10.1016/j.meegid.2016.02.032 [4] Sali M, Buttinelli G, Fazio C, Vacca P, La Sorda M, Carannante A, Spanu T, Valentini P, Stefanelli P. Pertussis in infants less than6 months of age and household contacts, Italy, April 2014.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"PediatrInfect Dis J 2004; 23(11):985-9; PMID: 15545851; http://dx.doi.org/ 10.1097/01.inf.0000145263.37198.2b [6] Fedele G, Carollo M, Palazzo R, Stefanelli P, Pandol ﬁE, Gesualdo F, Tozzi AE, Carsetti R, Villani A, Nicolai A, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Infection 2016; PMID: 27614887; http://dx.doi.org/10.1007/s15010-016-0943-6 [7] van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N, Wirsing von Ko /C19/C19nig CH, Vestrheim DF, Dalby T, et al.",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Eur J Clin Micro- biol Infect Dis 2015; 34(4):821-30; PMID: 25527446; http://dx.doi.org/10.1007/s10096-014-2297-2 [8] Rota MC, D ’Ancona F, Massari M, Mandolini D, Giammanco A, Carbonari P, Salmaso S, Cio ﬁdegli Atti ML.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
2014; 19(40); PMID: 25323077; http://dx.doi.org/10.2807/1560-7917.ES2014.19.40.20921 [10] ECDC.,OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Pertussis case de ﬁnition [Available: http://ecdc.europa.eu/en/ healthtopics/pertussis/Pages/pertusis-case-de ﬁnition.aspx ] [11] Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Clin Vaccine Immunol 2014; 21 (2):119-25; PMID: 24256623; http://dx.doi.org/10.1128/CVI.00717-13 [13] van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, Miller E. T h en u m b e ro fd e a t h sa m o n gi n f a n t su n d e ro n ey e a ro fa g ei nE n g l a n dwith pertussis: results of a capture/ recapture analysis for the period 2001 to 2011.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Euro Surveill 2013; 18(9); PMID:23470020; Available at: http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20414 [14] Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
Lancet2014; 384(9953):1521-8; PMID: 25037990; http://dx.doi.org/10.1016/ S0140-6736(14)60686-3 [15] (Italy) MdS.,Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"[Available: http://www.salute.gov.it/imgs/C_17_tavole_20_allegati_iitemAllega ti_2_ ﬁ leAllegati_itemFile_0_ ﬁle.pdf ] [16] Tozzi AE, Pandol ﬁE, Celentano LP, Massari M, Salmaso S, Cio ﬁ degli Atti ML; EUVAC-NET Study Group.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Vaccine 2007; 25(2):291-7; PMID: 16920230; http://dx.doi.org/10.1016/j.vaccine.2006.07.023 [17] Vittucci AC, Spuri Vennarucci V, Grandin A, Russo C, Lancella L, Tozzi AE, Bartuli A, Villani A. Pertussis in infants: an underesti- mated disease.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"BMC Infect Dis 2016; 16(1):414; PMID: 27528377; http://dx.doi.org/10.1186/s12879-016-1710-0 [18] Nicolai A, Nenna R, Stefanelli P, Carannante A, Schiavariello C, Pier- angeli A, Scagnolari C, Moretti C, Papoff P, Bonci E, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"BMC Infect Dis 2013; 13:526; PMID: 24209790;http://dx.doi.org/10.1186/1471-2334-13-526 [19] Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, Lan R. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008 –2010.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"J Infect Dis 2012; 205(8):1220-4; PMID: 22416243; http://dx.doi.org/10.1093/infdis/jis178 [20] Litt DJ, Neal SE, Fry NK.",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"J Clin Microbiol 2009; 47(3):680-8; PMID: 19158267; http://dx.doi.org/10.1128/JCM.01838-08 [21] Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM.",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Emerg Infect Dis 2012; 18(8):1248-55; PMID: 22841154; http://dx.doi.org/10.3201/eid1808.120082 [22] Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, Shibayama K, Kamachi K. Genetic analysis of Bordetella pertussis isolates from the 2008 – 2010 pertussis epidemic in Japan.",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"PLoS One 2013; 8(10):e77165;PMID: 24124606; http://dx.doi.org/10.1371/journal.pone.0077165 [23] Tchidjou HK, Vescio MF, Sanou Sobze M, Souleyman A, Stefanelli P, Mbabia A, Moussa I, Gentile B, Colizzi V, Rezza G. Low vaccine cov- erage among children born to HIV infected women in Niamey,Niger.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Hum Vaccin Immunother 2016; 12(2):540-4; PMID:26237156; http://dx.doi.org/10.1080/21645515.2015.1069451 [24] Vodzak J, Queenan AM, Souder E, Evangelista AT, Long SS.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Clin Infect Dis 2016; PMID: 27624959; http://dx.doi.org/10.1093/cid/ciw632 [25] Fry NK, Duncan J, Vaghji L, George RC, Harrison TG.",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"Eur J Clin Microbiol Infect Dis 2010; 29(9):1183-5; PMID: 20521155;http://dx.doi.org/10.1007/s10096-010-0976-1 [26] Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK, Saubolle M, Lee B, Long J, Harrison AR Jr, et al.",OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"J Clin Microbiol 2003; 41(3):1167-72; PMID: 12624047; http://dx.doi.org/ 10.1128/JCM.41.3.1167-1172.2003 [27] Fry NK, Duncan J, Wagner K, Tzivra O, Doshi N, Litt DJ, Crowcroft N, Miller E, George RC, Harrison TG.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"2009; 58(Pt 8):1023-9; PMID: 19528165;http://dx.doi.org/10.1099/jmm.0.009878-0 [28] Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR.",Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
J Bacteriol 2004; 186(16):5496-505; PMID: 15292152; http://dx.doi.org/10.1128/JB.186.16.5496-5505.2004HUMAN VACCINES & IMMUNOTHERAPEUTICS 1077,Non-OADS,/arxiv_data1/oa_pdf/a1/ad/khvi-13-05-1276139.PMC5443365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"5, 1084 –1090 http://dx.doi.org/10.1080/21645515.2016.1271518",Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
2015 [cited 2016 September 29]; Available from: http://www.state.gov/j/prm/releases/ docsforcongress/247770.htm .,OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
[cited 2016 September 29]; Available from: http://www.cdc.gov/immigrantrefugeehealth/about-refugees.html .,Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
[cited2016 September 20]; Available from: http://www.cdc.gov/immigran trefugeehealth/exams/medical-examination.html .,Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
[cited 2016 September 29]; Available from: http://www.cdc.gov/immigrantrefugee health/guidelines/domestic/i mmunizations-guidelines.html .,Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
15:1201; PMID:25563658; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
2016 [cited 2016 November 14]; Available from: http://www.cdc.gov/immigran trefugeehealth/pdf/burmese-refugee-health-pro ﬁle.pdf .,Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"Vaccine 2012; 30(2):317-21; PMID:22085555;http://dx.doi.org/10.1016/j.vaccine.2011.10.091 [13] Stoecker C, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"Pediatrics 2013; 132(2):e324-32; PMID:23821695; http://dx.doi.org/10.1542/peds.2012-3350 [14] Hoerger TJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
Diabetes Care 2013; 36(1):63-9; PMID:22933435; http://dx.doi.org/10.2337/dc12-0759 [15] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
2016 [cited 2016 September 29]; Available from: http://www.who.int/mediacentre/fact sheets/fs286/en/ .,OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
[cited 2017 Janu- ary 17]; Available from: http://www.huf ﬁngtonpost.com/2015/02/02/ 27-counties-in-california_n_6582016.html.,Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"Measles outbreak in a highly vaccinated popula- tion, San Diego, 2008: role of the intentionally undervaccinated.Pediatrics 2010; 125(4):747-55; PMID:20308208; http://dx.doi.org/10.1542/peds.2009-1653 [20] Chen SY, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"203(11):1517-25; PMID:21531693; http://dx.doi.org/ 10.1093/infdis/jir115 [21] Dayan GH, et al.",OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
Pediat- rics 2005; 116(1):e1-4; PMID:15995008; http://dx.doi.org/10.1542/ peds.2004-2512 [22] Bureau of Labor Statistics.,OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
[cited 2016 September 20]; Available from: http://www.cdc.,OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"[cited 2016 September 29]; Available from:http://kff.org/other/state-indicator/ expenses-per-inpatient-day-by-owner ship/?currentTimeframe D3&sortModel D%7B%22colId%22:%22Locati on%22,%22sort%22:%22asc%22%7D .",OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
[cited 2016 September 20]; Available from: http://www.bls.gov/data/in ﬂation_ calculator.htm .,OADS,/arxiv_data1/oa_pdf/dd/13/khvi-13-05-1271518.PMC5443367.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"5, 1136 –1140 http://dx.doi.org/10.1080/21645515.2016.1267082",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Vaccine 2012; 30 (Suppl 1):A3-6;PMID:22520133; http://dx.doi.org/10.1016/j.vaccine.2011.10.007 [2] Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch JR, Steele AD, et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"HumanVaccines 2011; 7(12):1282-90; PMID:22108032; http://dx.doi.org/ 10.4161/hv.7.12.18321 [3] Marshall GS, Adams GL, Leonardi ML, Petrecz M, Flores SA, Ngai AL, Xu J, Liu G, Stek JE, Foglia G, et al.",OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Pediatrics 2015; 136 (2):e323-32; PMID:26216331; http://dx.doi.org/10.1542/peds.2014- 4102 [4] Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: current prospects and future challenges.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Lancet 2006; 368(9532):323-32; PMID:16860702; http://dx.doi.org/10.1016/S0140-6736(06)68815-6 [5] Thrane SE, Wanless S, Cohen SM, Danford CA.",OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"J Pediatr Nurs 2016; 31(1):e23-32;PMID:26424196; http://dx.doi.org/10.1016/j.pedn.2015.09.002 [6] Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R, Hesitancy SWGoV.",OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
Vaccine2015; 33(34):4165-75; PMID:25896384; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Vaccine 2013; 31(46):5466-70; PMID:24076175; http://dx.doi.org/10.1016/j.vaccine.2013.08.104 [8] Taddio A, Flanders D, Weinberg E, Lamba S, Vyas C, Ilersich AF, Ipp M, McNair C. A randomized trial of rotavirus vaccine versussucrose solution for vaccine injection pain.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
Vaccine 2015; 33(25):2939-43; PMID:25917674; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Clin J Pain 2015; 31(3):189-97; PMID:24810648; http://dx.doi.org/10.1097/AJP.0000000000000103 [10] Kassab M, Foster JP, Foureur M, Fowler C. Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Cochrane Database Syst Rev 2012; 12:CD008411; PMID:23235662; http://dx.doi.org/10.1002/14651858.CD008411.pub2 [11] Schechter NL, Zempsky WT, Cohen LL, McGrath PJ, McMurtry CM, Bright NS.",OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Pediatrics 2007; 119(5):e1184-98; PMID:17473085; http://dx.doi.org/10.1542/peds.2006-1107 [12] Stevens B, Yamada J, Ohlsson A, Haliburton S, Shorkey A. Sucrose for analgesia in newborn infants undergoing painful procedures.Cochrane Database Syst Rev 2016; 7:CD001069; PMID:27420164;http://dx.doi.org/10.1002/14651858.CD001069.pub5 [13] Taddio A, McMurtry CM, Shah V, Riddell RP, Chambers CT, Noel M, MacDonald NE, Rogers J, Bucci LM, Mousmanis P, et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"CMAJ2015; 187(13):975-82; PMID:26303247; http://dx.doi.org/10.1503/ cmaj.150391 [14] Suhrabi Z, Taghinejad H, Valian K, Sayehmiri K, Taheri S. A com- parative study on the ef ﬁcacy of glucose and sucrose on the vaccina- tion pain: a randomized controlled clinical trial.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"J Clin Diagn Res2014; 8(10):PC01-3; PMID:25478418; http://dx.doi.org/10.7860/ JCDR/2014/10057.5053 [15] Bueno M, Yamada J, Harrison D, Khan S, Ohlsson A, Adams-Web- ber T, Beyene J, Stevens B.",OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Early Hum Dev 2004; 77(1-2):57-65; PMID:15113632; http://dx.doi.org/10.1016/j.earlhumdev.2004.01.003 [17] Harrison D, Johnston L, Loughnan P. Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Pain Manag Nurs 2013; 14(4):e95-105; PMID:24315282; http://dx.doi.org/10.1016/j.pmn.2011.08.002 [20] Curry DM, Brown C, Wrona S. Effectiveness of oral sucrose for pain management in infants during immunizations.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
Pain Manag Nurs 2012; 13(3):139-49; PMID:22929601; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Lancet 2010; 376(9748):1225-32; PMID:20817247; http://dx.doi.org/10.1016/S0140-6736(10)61303-7 [22] Eriksson M, Gradin M, Schollin J.",OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of ran-domized controlled trials and quasi-randomized controlled trials.Clin Ther 2009; 31(Suppl 2):S48-76; PMID:19781436; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Arch Pediatr Adolesc Med 2009; 163(5):469-72; PMID:19414694; http://dx.doi.org/10.1001/ archpediatrics.2009.35 [28] Taddio A, Shah V, McMurtry CM, MacDonald NE, Ipp M, Riddell RP, Noel M, Chambers CT, HelpinKids Adults T. Procedural andphysical interventions for vaccine injections: systematic review of randomized controlled trials and quasi-randomized controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"Clin J Pain 2015; 31(10 Suppl):S20-37; PMID:26352919; http://dx.doi.org/10.1097/AJP.0000000000000264 [29] Ipp M, Taddio A, Sam J, Gladbach M, Parkin PC.",Non-OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
Arch Dis-ease Child 2007; 92(12):1105-8; PMID:17686797; http://dx.doi.org/10.1136/adc.2007.1186951140 H.-C. YIN ET AL.,OADS,/arxiv_data1/oa_pdf/7d/b7/khvi-13-05-1267082.PMC5443369.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"5, 1051 –1058 http://dx.doi.org/10.1080/21645515.2016.1265715",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
Clin Infect Dis 2007; 44(Suppl 1):S1-26; PMID:17143845; http://dx.doi.org/10.1086/510206 [4] Lee BW.,OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Trop Med Int Health 1998; 3(11):886-90; PMID:9855401; http://dx.doi.org/10.1046/j.1365-3156.1998.00316.x [5] Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, McQuillan GM, Wharton M, Fehrs LJ, Cossen CK, et al.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"J Med Virol 2003; 70(Suppl 1):S111-8; PMID:12627498; http://dx.doi.org/10.1002/jmv.10364 [6] Araujo LQ, Macintyre CR, Vujacich C. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Vaccine 2007; 25(45):7866-72; PMID:17919788; http://dx.doi.org/10.1016/j.vaccine.2007.07.036 [8] Tseng HF, Chi M, Smith N, Marcy SM, Sy LS, Jacobsen SJ.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"J Infect Dis 2012; 206(2):190- 6; PMID:22669900; http://dx.doi.org/10.1093/infdis/jis334 [9] Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of Herpes Zoster and its complications.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"J Infect 2013; 67(5):463-9; PMID:23872209; http://dx.doi.org/10.1016/j.jinf.2013.06.016 [10] Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Mayo Clin Proc 2011; 86(2):88-93; PMID:21220354; http://dx.doi.org/10.4065/mcp.2010.0618 [11] Volpi A, Gatti A, Pica F. Frequency of herpes zoster recurrence.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Mayo Clin Proc 2011; 86(6):586; author reply -7; PMID:21628622; http://dx.doi.org/10.4065/mcp.2011.0096 [12] Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domi- ngo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, et al.",OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"N Engl J Med 2016; 375(11):1019-32; PMID:27626517;http://dx.doi.org/10.1056/NEJMoa1603800 [13] Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, et al.Efﬁcacy of an adjuvanted herpes zoster subunit vaccine in older adults.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"J Infect Dis 2013; 208(12):1953-61; PMID:23904292; http://dx.doi.org/10.1093/infdis/jit365 [15] Chlibek R, Smetana J, Pauksens K, Rombo L, Van den Hoek JA, Richardus JH, Plassmann G, Schwarz TF, Ledent E, Heineman TC.",OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Vaccine 2014; 32(15):1745-53; PMID:24508036; http://dx.doi.org/10.1016/ j.vaccine.2014.01.019 [16] Berkowitz EM, Moyle G, Stellbrink HJ, Schurmann D, Kegg S, Stoll M, El Idrissi M, Oostvogels L, Heineman TC.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Blood 2014; 124(19):2921-9; PMID:25237196; http://dx.doi.org/10.1182/ blood-2014-04-573048 [18] Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapeliere P, Vassilev V, Ledent E, Heineman TC.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
J Infect Dis 2012; 206(8):1280-90; PMID:22872734; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"Expert Rev Vaccines 2011; 10(4):471-86; PMID:21506645; http://dx.doi.org/10.1586/erv.11.29 [20] Kawai K, Gebremeskel BG, Acosta CJ.",Non-OADS,/arxiv_data1/oa_pdf/59/9d/khvi-13-05-1265715.PMC5443374.pdf
"ORCID Yusuke Tanaka http://orcid.org/0000-0002-3987-1589 References [1] Morimoto A, Ueda Y, Egawa-Takata T, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Kanzaki H, et al.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"Int J Clin Oncol 2015; 20(3):549-55; PMID:25001869; http://dx.doi.org/10.1007/s10147-014-0723-1 [2] Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan ’s sus- pension of its HPV vaccine recommendation.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"Hum Vaccin Immun-other 2014; 10(9):2543-50; PMID:25483472; http://dx.doi.org/ 10.4161/21645515.2014.969618 [3] Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan ’s failure to vaccinate girls against human papilloma- virus.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"Am J Obstet Gynecol 2015; 212(3):405-6; PMID:25434842; http://dx.doi.org/10.1016/j.ajog.2014.11.037 CONTACT Yutaka Ueda ZVF03563@nifty.ne.jp Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"5, 1167 –1168 http://dx.doi.org/10.1080/21645515.2016.1267085",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"Lancet 2015; 385(9987):2571; PMID:26122153; http://dx.doi.org/10.1016/S0140-6736(15)61152-7 [5] Tanaka Y, Ueda Y, Egawa-Takata T, Yagi A, Yoshino K, Kimura T. Outcomes for girls without HPV vaccination in Japan.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"Lancet Oncol 2016; 17(7):868-9; PMID:27396634; http://dx.doi.org/10.1016/S1470-2045(16)00147-9 [6] Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, et al.",OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"BMC Public Health 2016; 16(1):1013; PMID:27663658; http://dx.doi.org/10.1186/s12889-016-3676-7 [7] Van Damme P, Meijer CJ, K ieninger D, Schuyleman A, Thomas S, Luxembourg A, Baudin M. A phase III clinical study to compare the immunogenicity and safety of the 9-val-ent and quadrivalent HPV vaccines in men.",Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
Vaccine 2016; 34 (35):4205-12; PMID:27354258; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/90/65/khvi-13-05-1267085.PMC5443375.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"5, 1198 –1206 http://dx.doi.org/10.1080/21645515.2016.1269992",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"ORCID Lale Ozisik http://orcid.org/0000-0002-3494-8997 References [1] Dash GP, Fauerbach L, Pfeiffer J, Soule B, Bartley J, Barnard BM, Lundstrom T, Andrus M. Association for Professionals in Infection C, Epidemiology.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Am J Infect Control 2004; 32:123-5; PMID:15153921; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
http://www.cdc.gov/niosh/topics/healthcare/ [Accessed on 4 05 15].,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
http://www.resmigazete.gov.tr/eskiler/2014/05/20140522-14.htm .,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"[7] WHO Position Papers - Immunization of Health Care Workers, 2015 http://www.who.int/immunization/policy/Immunization_routi ne_table4.pdf?ua D1.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"The Australian Immunisation Handbook 10th edition (updated June 2015]) Recom- mended Vaccines for Healthcare Workers, http://www.immunise.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Vaccine 2011; 29:9557-62; PMID:21964058; http://dx.doi.org/10.1016/j.vaccine.2011.09.076 [10] Galanakis E, Jansen A, Lopalco PL, Giesecke J.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Euro Surveill 2013; 18:20627;PMID:24229791; http://dx.doi.org/10.2807/1560-7917.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Vac- cine 2009; 27:2631-2; PMID:19428870; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Vaccine 2014; 32:4866-8;PMID:24951862; http://dx.doi.org/10.1016/j.vaccine.2014.05.068 [13] European Commission.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
http://ec.europa.eu/health/ ph_threats/com/In ﬂuenza/docs/season ﬂu_rec2009_en.pdf .13.7.2009].,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Infect Control Hosp Epidemiol 2010; 31:987-95; PMID:20807037; http://dx.doi.org/ 10.1086/656558 [15] Black CL, Yue X, Ball SW, Donahue SM, Izrael D, de Perio MA, Laney AS, Lindley MC, Graitcer SB, Lu PJ, et al.",OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Available from: http://www.who.int/occupational_health/ WHO_health_assembly_en_web.pdf?ua D1[Accessed on 29 11 16].,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Available from: http://apps.who.int/ gb/ebwha/pdf_ ﬁles/WHA63-REC1/WHA63_REC1-en.pdf [Accessed on 29 11 16].,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"T €urkiye Enfeksiyon Hastal ıklar ıve Kli- nik Mikrobiyoloji Uzmanl ık Derne /C21gi,http://ekmud.org.tr/wp-con tent/uploads/EriskinBagisiklamaRehberi-web.pdf .",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Gerontology 1993; 39:109-16; PMID:8514200; http://dx.doi.org/10.1159/000213520 [20] Kurtoglu D, Gozalan A, Coplu N, Miyamura K, Ishida S, Morita M, Akin L, Esen B.",OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Hum Vaccin 2011; 7:197-201;PMID:21368583; http://dx.doi.org/10.4161/hv.7.2.13918 [23] Ortac Ersoy E, Tanriover MD, Ocal S, Ozisik L, Inkaya C, Topeli A.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Severe measles pneumonia in adults with respiratory failure: role ofribavirin and high-dose vitamin A. Clin Respir J 2016; 10:673-5;PMID:25619709; http://dx.doi.org/10.1111/crj.12269 [24] Baer G, Bonhoeffer J, Schaad UB, Heininger U. Seroprevalence and immunization history of selected vaccine preventable diseases inmedical students.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Bun-desgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011; 54:238-42; PMID:21290279; http://dx.doi.org/10.1007/s00103-010- 1198-5 [26] Maltezou HC, Poland GA. Vaccination policies for healthcare work- ers in Europe.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Vaccine 2013; 31:2874-8; PMID:23623863; http://dx.doi.org/10.1016/j.vac cine.2013.04.031 [28] Unal S, Durusu Tanr ı€over M, Ta ¸sE ,G €uner _I,¸Cetin €OY, Sayar _I.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Infection 2009; 37:390-400; PMID:19768382; http://dx.doi.org/10.1007/s15010-009-8467-y [30] Turkish Society of Internal Medicine.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Pharm World Sci 2008; 30:39-43; PMID:17602309; http://dx.doi.org/ 10.1007/s11096-007-9137-8 [33] Tariq L, Mangen MJ, Hovels A, Frijstein G, de Boer H. Modelling the return on investment of preventively vaccinating healthcare workers against pertussis.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"BMC Infect Dis 2015; 15:75; PMID:25879422;http://dx.doi.org/10.1186/s12879-015-0800-8 [34] The Joint Commission on Accreditation of Healthcare Organiza- tions.2011 Tdap Vaccination Strategies for Adolescents and Adults, Including Health Care Personnel.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
http://www.jointcommission.org/ assets/1/6/Tdap_Monograpgh.pdf .,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"J Med Syst 2010; 34:139-45; PMID:20433052; http://dx.doi.org/10.1007/ s10916-008-9225-x [36] Kadir Bibero /C21glu SB €OM, Bilgir O, Aslan L, Bolaman Z, Y €uksel B, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Eri ¸skin _Imm €unizasyonu http://www.tihud.org.tr/main/content?ref D 2&child D179.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"BMC Infect Dis 2010; 10:281; PMID:20863386; http://dx.doi.org/ 10.1186/1471-2334-10-281 [40] Sevencan F, Ertem M, Ozcullu N, Dorman V, Kubat NK.",OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Hum Vaccin 2011; 7:945-51; PMID:21892007; http://dx.doi.org/10.4161/hv.7.9.16368 [41] Torun SD, Torun F. Vaccination against pandemic in ﬂuenza A/ H1N1 among healthcare workers and reasons for refusing vaccina-tion in Istanbul in last pandemic alert phase.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Vaccine 2010; 28:5703- 10; PMID:20600497; http://dx.doi.org/10.1016/j.vaccine.2010.06.049 [42] Arda B, Durusoy R, Yamazhan T, Sipahi OR, Tasbakan M, Pullukcu H, Erdem E, Ulusoy S. Did the pandemic have an impact on in ﬂu- enza vaccination attitude?",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"BMC Infect Dis 2011; 11:87; PMID:21473763; http://dx.doi.org/ 10.1186/1471-2334-11-87 [43] Meral Ak ¸cay Ciblak NN, Ilhan Gurbuz, Selim Badur, Dilek Guldal.",OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Eur J Intern Med 2014; 25:528-32; PMID:24814432; http://dx.doi.org/10.1016/j.ejim.,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Am J Infect Control 2006; 34:583-7; PMID:17097453; http://dx.doi.org/10.1016/j.ajic.2006.04.213 [48] Aypak C, Bayram Y, Eren H, Altunsoy A, Berktas M. Susceptibility to measles, rubella, mumps, and varicella-zoster viruses among health- care workers.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"J Nippon Med Sch 2012; 79:453-8; PMID:23291844; http://dx.doi.org/10.1272/jnms.79.453 [49] Alp E, Cevahir F, Gokahmetoglu S, Demiraslan H, Doganay M. Pre- vaccination screening of health-care workers for immunity to mea- sles, rubella, mumps, and varicella in a developing country: What do we save?",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
J Infect Public Health 2012; 5:127-32; PMID:22541258;http://dx.doi.org/10.1016/j.jiph.2011.11.003 [50] European Centre for Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Morb Mortal Wkly Rep 2016; 65:1026-31; PMID:27684642;http://dx.doi.org/10.15585/mmwr.mm6538a2 [54] CDC.,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Flu Vaccination Coverage, United States, 2015 –16 In ﬂuenza Season http://www.cdc.gov/ ﬂu/ﬂuvaxview/coverage-1516estimates.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"MMWR Surveill Summ 2016; 65:1-36; http://dx.doi.org/ 10.15585/mmwr.ss6501a1 [56] Hollmeyer HG, Hayden F, Poland G, Buchholz U.",OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Vaccine 2009; 27:3935-44; PMID:19467744; http://dx.doi.org/10.1016/j.vaccine.2009.03.056 [57] Beguin C, Boland B, Ninane J.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Low vaccination rate among hospital health care workers.Am J Med Qual 1998; 13:223-7; PMID:9833335; http://dx.doi.org/ 10.1177/106286069801300408 [58] Hofmann F, Ferracin C, Marsh G, Dumas R. In ﬂuenza vaccination of healthcare workers: a literature review of attitudes and beliefs.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Infec-tion 2006; 34:142-7; PMID:16804657; http://dx.doi.org/10.1007/ s15010-006-5109-5 [59] European Centre for Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Stockholm: ECDC; 2015. http://ecdc.europa.eu/en/ publications/Publications/vaccine-hesitancy-among-healthcare-work ers.pdf [Accessed on 29 11 2016].,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Eur J Intern Med 2012; 23:338-41; PMID:22560381; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Health Promot Int 2009; 24:285-96;PMID:19372101; http://dx.doi.org/10.1093/heapro/dap014HUMAN VACCINES & IMMUNOTHERAPEUTICS 1205,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
http://ec.europa.eu/chafea/docu ments/news/Comparative_report_on_health_literacy_in_8_EU_member_states.pdf .,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
http://www.sagliksen.org.tr/cdn/ uploads/gallery/pdf/8dcec50aa18c21cdaf86a2b33001a409.pdf [Accessed on 29 11 2016].,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Hum Vaccin Immunother 2014; 10:2130-5; PMID:25424830; http://dx.doi.org/10.4161/hv.29603 [68] Castro-Sanchez E, Chang PW, Vila-Candel R, Escobedo AA, Holmes AH.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"Int J Infect Dis 2016; 43:103-10; PMID:26751238; http://dx.doi.org/ 10.1016/j.ijid.2015.12.019 [69] Jacobson TA, Thomas DM, Morton FJ, Offutt G, Shevlin J, Ray S. Use of a low-literacy patient education tool to enhancepneumococcal vaccination rates.",Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
BMJ 2008; 336:754-7; PMID:18309964; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
Euro Surveill 2014; 19:20979; PMID:25496574; http://dx.doi.org/10.2807/1560-7917.ES2014.19.48.209791206 L. OZISIK ET AL.,OADS,/arxiv_data1/oa_pdf/39/37/khvi-13-05-1269992.PMC5443379.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"5, 1155 –1157 http://dx.doi.org/10.1080/21645515.2016.1271519",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"Am J Prev Med 2011; 40(5):548-55;PMID:21496754; http://dx.doi.org/10.1016/j.amepre.2010.12.025 [2] Siddiqui M, Salmon DA, Omer SB.",OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"Hum Vaccin Immunother 2013; 9(12):2643-8; PMID:24247148; http://dx.doi.org/10.4161/hv.27243 [3] Opel DJ, Mangione-Smith R, Robinson JD, Heritage J, DeVere V, Salas HS, Zhou C, Taylor JA.",OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"The in ﬂuence of provider communica- tion behaviors on parental vaccine acceptance and visit experience.Am J Public Health 2015; 105(10):1998-2004; PMID:25790386; http://dx.doi.org/10.2105/AJPH.2014.302425 [4] Nyhan B, Rei ﬂer J, Richey S, Freed GL.",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Vaccine2005; 23(23):3010-5; PMID:15811647; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
2016. http://www.schoolscience.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Comic books/C15Viral Attack: Askabiologist http://askabiologist.asu.edu/sites/default/ ﬁles/resources/activities/body_depot/viral_attack/viral_attack.pdf /C15Vaccines work.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
https://medium.com/the-nib/vaccines-work-here-are-the-facts-5de3d0f9ffd0#.mx9r6tz5r /C15Immunity Warriors: Invasion of the Alien Zombies!,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
www.immunitywarriors.com Videos /C15Immunity and Vaccines Explained: Pbs.org http://www.pbs.org/video/2365317280/ /C15Immune System.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Kidshealth.org http://kidshealth.org/en/kids/ismovie.html /C15Surgeon General and Elmo team up to talk vaccinations https://youtu.be/ZpOHIzkLP-g /C15Cybersleuth Kids.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
http://cybersleuth-kids.com/videos/Immune-System_v2755 /C15Getvaxed.org –a resource for teens and young adults http://www.getvaxed.org/videos.htm Games /C15Vax Pack Hero: “Team up with vaccine heroes to beat germs and keep patients healthy ”http://www.phillyvoice.com/chop-releases-vaccine-themed- video-game-kids/ /C15Flu Mania: https://itunes.apple.com/au/app/ ﬂumania/id970486995?mt D8 /C15Sid the Science Kid “Super Duper Antibodies ”http://pbskids.org/sid//germs.html /C15Pox.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Save the People https://itunes.apple.com/en/app/pox-save-the-people/id475604824?mt D81156 K. WILSON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Internet Res 2013; 15(5):e103; PMID:23715762; http://dx.doi.org/ 10.2196/jmir.2409 [8] Chaudron S. Young children (0-8) and digital technology.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
[Available at: https://medium.com/the-nib/vaccines-work- here-are-the-facts-5de3d0f9ffd0-.a4gpnb8in ].,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"J Behav Med 2014; 37(2):218-33; PMID:23188480;http://dx.doi.org/10.1007/s10865-012-9480-7 [12] Merkt M, Weigand S, Heier A, Schwan S. Learning with videos vs. learning with print: The role of interactive features.",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Information Management 2006; 43(1):15-27; http://dx.doi.org/10.1016/j.im.2005.01.004 [14] Downs JS.,OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Health Promot Pract 2016; 17(5):731-8;PMID:27091608; http://dx.doi.org/10.1177/1524839916631537 [16] Dahlstrom MF.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
103: Scho- lastic Co;1994 [Available at: http://www.scholastic.com/magicschool bus/tv/index.htm ].,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
2015 [Available at: https://www.youtube.com/ watch?v DZpOHIzkLP-g&feature Dyoutu.be ].,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"Comput Educ2013; 67:156-67; http://dx.doi.org/10.1016/j.compedu.2013.02.019 [21] Girard C, Ecalle J, Magnan A.",OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"J Comput Assist Learn 2013; 29(3):207-19; http://dx.doi.org/10.1111/j.1365-2729.2012.00489.x [22] Flanagan M. Tiltfactor, POX: Save the People; 2011[Available at: https://itunes.apple.com/en/app/pox-save-the-people/id475604824?mtD8.].",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
Vax Pack Hero: 2016 [Available from: http://vaxpackhero.com/ ].,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"Public health 2014; 128(12):1066-75;PMID:25443388; http://dx.doi.org/10.1016/j.puhe.2014.09.009 [27] Erickson SJ, Gerstle M, Feldstein SW. Brief interventions and moti- vational interviewing with children, adolescents, and their parents inpediatric health care settings: a review.",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"Arch Pediatr Adolesc Med2005; 159(12):1173-80; PMID:16330743; http://dx.doi.org/10.1001/ archpedi.159.12.1173 [28] Miller MK, Wickliffe J, Jahnke S, Linebarger J, Humiston SG.",OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"J Commun Health 2014; 39(5):835-41; PMID:24664875; http://dx.doi.org/10.1007/s10900-014-9858-2 [29] Krawczyk A, Lau E, Perez S, Delisle V, Amsel R, Rosberger Z.",Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
J Am Coll Health 2012; 60(4):316-22;PMID:22559091; http://dx.doi.org/10.1080/07448481.2011.615355 [30] Quote Investigator.,Non-OADS,/arxiv_data1/oa_pdf/03/45/khvi-13-05-1271519.PMC5443382.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"5, 1105 –1108 http://dx.doi.org/10.1080/21645515.2016.1276682",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"ORCID Jason Roszik http://orcid.org/0000-0002-4561-6170 References [1] Farkona S, Diamandis EP, Blasutig IM.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
BMC Med 2016; 14:73;PMID:27151159; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"TrendImmunol 2016; 37:462-76; PMID:27216414; http://dx.doi.org/ 10.1016/j.it.2016.04.01010.1016/j.it.2016.04.010 [3] Gubin MM, Artyomov MN, Mardis ER, Schreiber RD.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Sci Rep 2016; 6:35848; PMID:27762323; http://dx.doi.org/10.1038/srep3584810.1038/srep35848 [5] Granados-Principal S, Liu Y, Guevara ML, Blanco E, Choi DS, Qian W, Patel T, Rodriguez AA, Cusimano J, Weiss HL, et al.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Breast Cancer Res 2015; 17:25; PMID:25849745;http://dx.doi.org/10.1186/s13058-015-0527-x10.1186/s13058-015- 0527-x [6] Cianchi F, Cortesini C, Fantappi /C18e O, Messerini L, Schiavone N, Van- nacci A, Nistri S, Sardi I, Baroni G, Marzocca C, et al.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Am J Pathol 2003; 162:793-801; PMID:12598314; http://dx.doi.org/10.1016/S0002-9440(10)63876-X10.1016/S0002-9440(10)63876-X [7] Grimm EA, Ellerhorst J, Tang CH, Ekmekcioglu S. Constitutive intracellular production of iNOS and NO in human melanoma: pos- sible role in regulation of growth and resistance to apoptosis.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
NitricOxide 2008; 19:133-7; PMID:18472017; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Inter J Cancer 2006; 119:861-6; PMID:16557582; http://dx.doi.org/10.1002/ijc.2176710.1002/ijc.21767 [9] Bogdan C, Rollinghoff M, Diefenbach A.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Immunol Rev 2000; 173:17-26; PMID:10719664;http://dx.doi.org/10.1034/j.1600-065X.2000.917307.x10.1034/j.1600- 065X.2000.917307.x [10] Vannini F, Kash ﬁK, Nath N. The dual role of iNOS in cancer.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
Redox Biol 2015; 6:334-43; PMID:26335399; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Oncotarget2016; 7:52993-3004; PMID:27367029; http://dx.doi.org/10.18632/ oncotarget.10323 [12] Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regu- lators of the immune system.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Nat Rev Immunol 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri250610.1038/nri2506 [13] Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Immunology 2013; 138:105- 15; PMID:23216602; http://dx.doi.org/10.1111/imm.1203610.1111/imm.12036 [14] Jayaraman P, Parikh F, Lopez-Rivera E, Hailemichael Y, Clark A, Ma G, Cannan D, Ramacher M, Kato M, Overwijk WW, et al.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"J Immunol 2012; 188:5365-76; http://dx.doi.org/10.4049/jimmunol.110355310.4049/ jimmunol.1103553 [15] Ito H, Ando T, Seishima M. Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Cancer Res 2010; 70:68-77; PMID:20028852; http://dx.doi.org/10.1158/0008-5472.CAN-09-258710.1158/0008-5472.CAN-09-2587 [17] Sera ﬁni P, Mgebroff S, Noonan K, Borrello I. Myeloid-derived sup- pressor cells promote cross-tolerance in B-cell lymphoma by expand- ing regulatory T cells.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Cancer Res 2008; 68:5439-49; PMID:18593947;http://dx.doi.org/10.1158/0008-5472.CAN-07-662110.1158/0008-5472.CAN-07-6621 [18] Jayaraman P, Alfarano MG, Svider PF, Parikh F, Lu G, Kidwai S, Xiong H, Sikora AG.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
Clin Cancer Res 2014; 20:6439-51; PMID:25278453; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Cancer Res 2016; 76:6006-16; PMID:27742673; http://dx.doi.org/10.1158/0008-5472.CAN-16- 058710.1158/0008-5472.CAN-16-0587 [20] Majano PL, Medina J, Zub /C19ıa I, Sunyer L, Lara-Pezzi E, Maldonado- Rodr /C19ıguez A, L /C19opez-Cabrera M, Moreno-Otero R. N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in humanhepatocytes.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"J Hepatol 2004; 40:632-7; PMID:15030979; http://dx.doi.org/10.1016/j.jhep.2003.12.00910.1016/j.jhep.2003.12.009 [21] Qian BZ, Pollard JW.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j.cell.2010.03.01410.1016/j.cell.2010.03.014 [22] Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization.",OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Annu Rev Immunol 2015; 33:643-75; PMID:25861979; http://dx.doi.org/10.1146/annurev-immunol-032414-11222010.1146/annurev-immunol-032414-112220 [23] Lu G, Zhang R, Geng S, Peng L, Jayaraman P, Chen C, Xu F, Yang J, Li Q, Zheng H, et al.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
Myel oid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization.Nat Communicat 2015; 6:6676; PMID:25813085; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Cancer Immunol Immunoth 2015; 64:429-36; PMID:25567751; http://dx.doi.org/ 10.1007/s00262-014-1644-610.1007/s00262-014-1644-6 [25] Mao Y, Eissler N, Blanc KL, Johnsen JI, Kogner P, Kiessling R. Tar- geting suppressive myeloid cells potentiates checkpoint inhibitors to control spontaneous neuroblastoma.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
Clin Cancer Res 2016; 22:3849- 59; PMID:26957560; http://dx.doi.org/10.1158/1078-0432.CCR-15-191210.1158/1078-0432.CCR-15-1912HUMAN VACCINES & IMMUNOTHERAPEUTICS 1107,Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Cancer Res 2014; 74:5057-69; PMID:25082815; http://dx.doi.org/10.1158/0008-5472.CAN-13-372310.1158/0008-5472.CAN-13-3723 [28] Green KA, Wang L, Noelle RJ, Green WR.",Non-OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
J Virol 2015; 89:9693-8; PMID:26157131; http://dx.doi.org/10.1128/ JVI.00888-1510.1128/JVI.00888-151108 S. EKMEKCIOGLU ET AL.,OADS,/arxiv_data1/oa_pdf/61/67/khvi-13-05-1276682.PMC5443387.pdf
"Pub lished with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"5, 1169 –1176 http://dx.doi.org/10.1080/21645515.2016.1261772",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"ORCID Jin Han Kang http://orcid.org/0000-0003-1610-6742 References [1] Gray BM, Dillon HC.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Pediatr Infect Dis 1986; 5:201-7; PMID:3952010; http://dx.doi.org/10.1097/00006454-198603000-00009 [2] Austrian R, Gold J. Pneumococcal bacteremia with speci ﬁc reference to bacteremic pneumococcal pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Ann Intern Med 1964;60:759 –76; PMID:14156606; http://dx.doi.org/10.7326/0003-4819- 60-5-759[3] Dagan R, Englehard D, Piccard E, Israeli Pediatric Bacteremia and Meningitis Group.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"JAMA 1992; 268:3328-32; PMID:1364814;http://dx.doi.org/10.1001/jama.1992.03490230058028 [4] Obaro S, Adegbola R. The pneumococcus: carriage, disease and con- jugate vaccines.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Med Microbiol 2002; 51:98-104; PMID:11863272;http://dx.doi.org/10.1099/0022-1317-51-2-98 [5] Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"JAMA 1993; 270:1826-31;PMID:8411526; http://dx.doi.org/10.1001/jama.1993.03510150060030 [6] Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"N Engl J Med 1991;325:1453-60; PMID:1944423; http://dx.doi.org/10.1056/ NEJM199111213252101 [7] Douglas RM, Paton JC, Duncan SJ, Hansman DJ.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Infect Dis 1983; 148:131-7; PMID:6886479; http://dx.doi.org/ 10.1093/infdis/148.1.131 [8] Lee CJ, Wang TR.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Crit Rev Microbiol 1994; 20:1-12; http://dx.doi.org/ 10.3109/10408419409113544 [9] Forrester HL, Jahningen DW, LaForce FM.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Am J Med 1987; 83:425-30;PMID:3661581; http://dx.doi.org/10.1016/0002-9343(87)90751-0 [10] Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendel- man PM.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Pediatr 1996; 128:649-53; PMID:8627437; http://dx.doi.org/10.1016/S0022-3476(96)80130-2 [11] Black S, Shine ﬁeld H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Pediatr Infect Dis J 2000; 19:187-95;PMID:10749457; http://dx.doi.org/10.1097/00006454-200003000-00003 [12] Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, Mendelman PM, Bohidar N, Yagupsky P. Reductionof nasopharyngeal carriage of pneumococci during the second yearof life by a heptavalent conjugate pneumococcal vaccine.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Infect Dis 1996; 174:1271-8; PMID:8940218; http://dx.doi.org/10.1093/infdis/ 174.6.1271 [13] Dagan R, Givon-Lavi N, Zamir O, Sikuler-Cohen M, Guy L, Janco J, Yagupsky P, Fraser D. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneu- mococcal conjugate vaccine to toddlers attending day care centers.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"JInfect Dis 2002; 185:927-36; PMID:11920317; http://dx.doi.org/ 10.1086/339525 [14] Black S, Shine ﬁeld H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B. Postlicensure surveillance for pneumococcalinvasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Pediatr Infect Dis J 2004; 23:485-9; PMID:15194827; http://dx.doi.org/10.1097/01.inf.0000129685.04847.94 [15] Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lyn- ﬁeld R, Reingold A, Cieslak PR, Pilishvili TD, Jackson D, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Net-work.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"N Engl J Med 2003; 348:1737-46; PMID:12724479; http://dx.doi.org/10.1056/NEJMoa022823 [16] Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Pediatrics 2004; 113:443-9; PMID:14993532; http://dx.doi.org/10.1542/peds.113.3.443 [17] Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"ClinInfect Dis 2005; 41:21-9; PMID:15937758; http://dx.doi.org/10.1086/430604 [18] Albrich WC, Baughman W, Schmotzer B, Farley MM.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Clin Infect Dis 2007; 44:1569-76; PMID:17516400; http://dx.doi.org/10.1086/518149 [19] Gerdts V, Littel-van den Hurk Sv, Griebel PJ, Babiuk LA.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Future Microbiol 2007; 2:667-75; PMID:18041907; http://dx.doi.org/10.2217/ 17460913.2.6.667 [20] Alonso De Velasco E, Dekker BA, Verheul AF, Feldman RG, Verhoef J, Snippe H. Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: Rela tionships with protection against Streptococcus pneumoniae infection in mice.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Infect Dis 1995; 172:562-5; PMID:7622906; http://dx.doi.org/10.1093/infdis/172.2.562 [21] Musher DM, Johnson B Jr, Watson DA.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Microb Pathog 2000; 29:81-91; PMID:10906263; http://dx.doi.org/ 10.1006/mpat.2000.0363 [23] Vidarsson G, Jonsdottir I, Jonsson S, Valdimarsson H. Opsonization and antibodies to capsular and cell wall polysaccharides of Strepto- coccus pneumoniae .",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Infect Dis 1994; 170:592-9; PMID:8077716; http://dx.doi.org/10.1093/infdis/170.3.592 [24] Fernsten P, Mason KW, Yu X, Tummolo D, Belanger KA, Tsao H, Zhu D, Cooper D, Hagen M, Jansen KU.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"HumVaccin 2011; 7 Suppl:75-84; PMID:21266856; http://dx.doi.org/ 10.4161/hv.7.0.14566 [25] Chiavolini D, Pozzi G, Ricci S. Animal models of Streptococcus pneu- moniae disease.",OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
Clin Microbiol Rev 2008; 21:666-85; PMID: 18854486; http://dx.doi.org/10.1128/CMR.00012-08 [26] Steinhoff MC; The Pneumococcal Vaccine Animal Model Consensus Group.,Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Paediatr Drugs 2013; 15:403- 23; PMID:24030738; http://dx.doi.org/10.1007/s40272-013-0047-z [28] McCool TL, Harding CV, Greenspan NS, Schreiber JR. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-speci ﬁc immunogenicity.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Infect Immun 2007; 75:1643-50; PMID:17220309; http://dx.doi.org/10.1128/IAI.01371-06 [31] Arulanandam BP, Lynch JM, Briles DE, Hollingshead S, Metzger DW.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Infect Immun 2001; 69:6718-24; PMID:11598043; http://dx.doi.org/ 10.1128/IAI.69.11.6718-6724.2001 [32] Tian H, Weber S, Thorkildson P, Kozel TR, Pirofski LA.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"Infect Immun 2009; 77:1502-13; PMID:19168739; http://dx.doi.org/10.1128/IAI.01075-08 [33] Brito DA, Ramirez M, de Lencastre H. Serotyping Streptococcus pneumoniae by multiplex PCR.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"J Clin Microbiol 2003; 41:2378- 84; PMID:12791852; http://dx.doi.org/10.1128/JCM.41.6.2378- 2384.2003 [34] Lee DG, Murakami Y, Andes DR, Craig WA.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
Antimicrob Agents Chemother 2013; 57:1434-41; PMID:23295932; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
Infect Chemother 2011; 43:251-7; http://dx.doi.org/ 10.3947/ic.2011.43.3.2511176 C. PARK ET AL.,OADS,/arxiv_data1/oa_pdf/a7/69/khvi-13-05-1261772.PMC5443391.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"5, 1149 –1154 http://dx.doi.org/10.1080/21645515.2016.1263779",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"ReadyVax isavailable through the Apple iTunes store, at https://itunes.apple.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
2015; http://www.cdc.gov/pertussis/outbreaks/trends.html .,OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"Impact of a pertussis epidemic on infant vaccination in Washington state.Pediatrics 2014; 134(3):456-64; PMID:25136046; http://dx.doi.org/ 10.1542/peds.2013-3637 [6] Frew PM, Owens LE, Saint-Victor DS, Benedict S, Zhang S, Omer SB.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"Hum Vaccin Immunother 2014; 10(9):2576-83;PMID:25483468; http://dx.doi.org/10.4161/hv.32248 [7] Marsh HA, Malik F, Shapiro E, Omer SB, Frew PM.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
Matern Child Health J 2014; 18(7):1639-47; PMID:24337776; http://dx.doi.org/10.1007/s10995-013-1404-9 [8] Pew Research Center.,Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
2012; http://www.pewin ternet.org/2012/11/08/mobile-health-2012/ .,Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"J Med Syst 2012; 36(5):3135-9; PMID:22052129; http://dx.doi.org/10.1007/s10916-011-9798-7 [12] Katz-Sidlow RJ, Ludwig A, Miller S, Sidlow R. Smartphone use dur- ing inpatient attending rounds: prevalence, patterns and potential for distraction.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
J Med Internet Res 2012; 14(5):e128; PMID:23017375; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"Am J Public Health 2003; 93(4):635-41; PMID:12660210; http://dx.doi.org/10.2105/AJPH.93.4.635 [15] Chamberlain AT, Seib K, Wells K, Hannan C, Orenstein WA, Whitney EA, Hinman AR, Berkelman RL, Omer SB.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"Biosecur Bioterror 2012; 10(1):142-50; PMID:22360580; http://dx.doi.org/10.1089/bsp.2011.0077 [16] Moriarty LF, Omer SB, Seib K, Chamberlain A, Wells K, Whitney E, Berkelman R, Bednarczyk RA.",OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"Matern Child Health J 2012; 16(9):1743-7; PMID:22198260; http://dx.doi.org/10.1007/s10995-011-0936-0 [19] Petty R, Cacioppo J. Communication and Persuasion: Central and peripheral routes to attitude chan ge.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
Vaccine 2015; 33(30):3571-9; PMID:26044495; http://dx.doi.org/10.1016/j.vaccine.2015.05.048[22] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
2015; http://www.cdc.gov/vaccines/hcp/acip-recs/ .,Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
"2015; https://www.comscore.com/Insights/Mar ket-Rankings/comScore-Reports-March-2015-US-Smartphone-Subscriber-Market-Share Accessed December 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
2014; http://www.nielsen.com/us/en/insights/news/ 2014/tech-or-treat-consumers-are-sweet-on-mobile-apps.html .,Non-OADS,/arxiv_data1/oa_pdf/b3/bb/khvi-13-05-1263779.PMC5443394.pdf
7(1): 70-74  ISSN: 2226 -4485 (Print)  Original Article   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.,Non-OADS,/arxiv_data1/oa_pdf/70/dc/OpenVetJ-7-70.PMC5443402.pdf
http://www.openveterinaryjournal.com   W. de Moraes  et al.,Non-OADS,/arxiv_data1/oa_pdf/70/dc/OpenVetJ-7-70.PMC5443402.pdf
http://www.openveterinaryjournal.com   W. de Moraes  et al.,Non-OADS,/arxiv_data1/oa_pdf/70/dc/OpenVetJ-7-70.PMC5443402.pdf
http://www.openveterinaryjournal.com   W. de Moraes  et al.,Non-OADS,/arxiv_data1/oa_pdf/70/dc/OpenVetJ-7-70.PMC5443402.pdf
Available from:  http://www.icmbio.gov.br/portal/biodiversidade/fa una-brasileira/lista -de-especies/5607 -especie - 5607.html .,Non-OADS,/arxiv_data1/oa_pdf/70/dc/OpenVetJ-7-70.PMC5443402.pdf
http://www.openveterinaryjournal.com   W. de Moraes  et al.,Non-OADS,/arxiv_data1/oa_pdf/70/dc/OpenVetJ-7-70.PMC5443402.pdf
7(1): 75 -80  ISSN: 2226 -4485 (Print)  Short Communication   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.12     ______________________________________________________________________________________________________ __  *Corresponding Author:  Prof. Simon Bailey.,Non-OADS,/arxiv_data1/oa_pdf/51/bb/OpenVetJ-7-75.PMC5443403.pdf
http://www.openveterinaryjournal.com   C.L.,Non-OADS,/arxiv_data1/oa_pdf/51/bb/OpenVetJ-7-75.PMC5443403.pdf
http://www.openveterinaryjournal.com   C.L.,Non-OADS,/arxiv_data1/oa_pdf/51/bb/OpenVetJ-7-75.PMC5443403.pdf
http://www.openveterinaryjournal.com   C.L.,Non-OADS,/arxiv_data1/oa_pdf/51/bb/OpenVetJ-7-75.PMC5443403.pdf
http://www.openveterinaryjournal.com   C.L.,Non-OADS,/arxiv_data1/oa_pdf/51/bb/OpenVetJ-7-75.PMC5443403.pdf
http://www.openveterinaryjournal.com   C.L.,Non-OADS,/arxiv_data1/oa_pdf/51/bb/OpenVetJ-7-75.PMC5443403.pdf
7(1): 65-69  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.,Non-OADS,/arxiv_data1/oa_pdf/a9/ee/OpenVetJ-7-65.PMC5443404.pdf
http://www.openveterinaryjournal.com   H. Itoh  et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/ee/OpenVetJ-7-65.PMC5443404.pdf
http://www.openveterinaryjournal.com   H. Itoh et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/ee/OpenVetJ-7-65.PMC5443404.pdf
http://www.openveterinaryjournal.com   H. Itoh  et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/ee/OpenVetJ-7-65.PMC5443404.pdf
http://www.openveterinaryjournal.com   H. Itoh et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/ee/OpenVetJ-7-65.PMC5443404.pdf
"https://doi.org/10.1177/1178638817710666 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Nutrition and Metabolic Insights Volume 10: 1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178638817710666 Introduction Obesity has recently been considered a disease requiring treat- ment as a consequence of its association with increased risk of several serious diseases and disorders of chronic nature.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/10.1177_1178638817710666.PMC5443416.pdf
The open reading frame (ORF) ofSpLQM was identified using the National Center for Biotechnology Information ORF Finder (http://www.ncbi.nlm.nih.gov/gorf/gorf.html).,OADS,/arxiv_data1/oa_pdf/24/4c/ieu062.PMC5443418.pdf
Characteristic domains or motifs were identified using PROSITEdatabase at ExPASy proteomics server (http://ca.expasy.org/; Bairoch et al.,OADS,/arxiv_data1/oa_pdf/24/4c/ieu062.PMC5443418.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/3b/jis14-0140.PMC5443460.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/e0/jis14-0141.PMC5443471.pdf
"(http://www.faunaeur.org ), (accessed 1 September 2012) .",Non-OADS,/arxiv_data1/oa_pdf/47/e0/jis14-0141.PMC5443471.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/9b/jis14-0143.PMC5443472.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/6b/jis14-0144.PMC5443473.pdf
"Therefore, the efficacy of this control method was evaluated by monitoring the male flight activ-ity with bottle traps baited with the commercial rubber septum lures(Isagro Italia, http://www.isagro.it ) loaded with 0.01 and 0.25 mg of sex pheromone in 2008 and 2009, respectively.",Non-OADS,/arxiv_data1/oa_pdf/e5/6b/jis14-0144.PMC5443473.pdf
(http://eur-lex.europa.eu/LexUriServ/LexUri Serv.do?uri ¼OJ:L:2009:309:0071:0086:en:PDF ) (accessed 5 August 2014) .,Non-OADS,/arxiv_data1/oa_pdf/e5/6b/jis14-0144.PMC5443473.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/79/jis14-0145.PMC5443474.pdf
(http://orthoptera.speciesﬁle.org/ HomePage.aspx ) (accessed 10 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/c5/79/jis14-0145.PMC5443474.pdf
(http://www.members.tripod.com/Cesa88/orthtr.htm ) (accessed 07 December 2013) .,Non-OADS,/arxiv_data1/oa_pdf/c5/79/jis14-0145.PMC5443474.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/d9/jis14-0146.PMC5443491.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/b8/jis14-0149.PMC5443580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/de/jis14-0172.PMC5443591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/51/jis14-0153.PMC5443592.pdf
"Daily minimum and maximum temperatures from Florida were obtained from 91 weather stationsthrough the Applied Climate Information System (Climate Information for Management and Operational Decisions, Southeast Regional Climate Center; http://acis.sercc.com).",OADS,/arxiv_data1/oa_pdf/41/51/jis14-0153.PMC5443592.pdf
"The DegDay program version 1.01, which is an Excel (Microsoft Redmond, WA) application developed by University of California-Davis (http://biomet.ucdavis.edu ),was used to calculate accumulated degree-days for C. lebetis .",OADS,/arxiv_data1/oa_pdf/41/51/jis14-0153.PMC5443592.pdf
(http://www.nappfast.org/usermanual/nappfast-manual.pdf ) (accessed 14 September 2012) .,Non-OADS,/arxiv_data1/oa_pdf/41/51/jis14-0153.PMC5443592.pdf
(http://www2.sas.com/pro ceedings/sugi31/204-31.pdf ) (accessed 14 September 2012) .,Non-OADS,/arxiv_data1/oa_pdf/41/51/jis14-0153.PMC5443592.pdf
(http://plants.ifas.uﬂ.edu/osceola/hydrilla_mngmt_ﬂ/hydrilla_management_ﬂorida.html ) (accessed 14 September 2012) .,OADS,/arxiv_data1/oa_pdf/41/51/jis14-0153.PMC5443592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/bc/jis14-0173.PMC5443593.pdf
Putative promoter DNA sequence was submitted to NCBI (http://www.ncbi.nlm.nih.gov/blast ) and similar sequences were identified using the CLUSTAL 2.1 program at EMBL-EBI web site (http://www.ebi.ac.uk/ Tools/msa/clustalw2/ ).,OADS,/arxiv_data1/oa_pdf/de/bc/jis14-0173.PMC5443593.pdf
Bioinformatic analysis was performed using the Berkeley Drosophila Genome Project online Promoter analysis program (http://www.fruitfly.org/seq_tools/promoter.html ) and the Web Promoter Scan Service (http://www-bimas.cit.nih.gov/molbio/proscan/).,OADS,/arxiv_data1/oa_pdf/de/bc/jis14-0173.PMC5443593.pdf
Two sets of primers were used for real-time PCR experiments designed by webtool of http://www.idtdna.com/PrimerQuest/ .,Non-OADS,/arxiv_data1/oa_pdf/de/bc/jis14-0173.PMC5443593.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/83/jis14-0154.PMC5443595.pdf
(http://www.ento.csiro.au/thysanoptera/symposium.,Non-OADS,/arxiv_data1/oa_pdf/39/83/jis14-0154.PMC5443595.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/7d/jis14-0158.PMC5443596.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/ea/jis14-0180.PMC5443597.pdf
(http://apps.who.int/iris/bitstream/10665/75303/1/9789241504034_eng.pdf ) (accessed 4 January 2013) .,OADS,/arxiv_data1/oa_pdf/27/ea/jis14-0180.PMC5443597.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/2a/jis14-0274.PMC5443598.pdf
"(http://www.sel.barc.usda.gov:591/ 1WF/whiteﬂy_catalog.htm ).Gennadius, P. 1889.",Non-OADS,/arxiv_data1/oa_pdf/f8/2a/jis14-0274.PMC5443598.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/c9/jis14-0159.PMC5443599.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
Rapid assessment program (RAP) biodiver- sity survey database (https://rap.conservation.org/rap/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
The Rio Grande valley’s nature site: Lantana Scrub- hairstreak– Strymon bazochii : life cycle study (http://www.thedauphins.net/ lantana_scrub_hairstreak_life_cycle_study.html ).,Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
Catalogue of the Eulophidae in the Neotropical region (http://www.neotropicaleulophidae.com/pdfs/Catalogue.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
"Ph.D. thesis, Universidade Estadual de Campinas, Campinas, SP, Brasil (http://cutter.unicamp.br/document/?code ¼vtls000029108 ).",Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
Estac¸a˜o meteorolo ´gica (http://www.recor.org.br ).,Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
Butterﬂies of America (http://www.butterﬂiesofamerica.com/ L/Lycaenidae.htm ).,Non-OADS,/arxiv_data1/oa_pdf/58/a5/jis14-0184.PMC5443601.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/jis14-0162.PMC5443602.pdf
(http://viceroy.eeb.ucom.edu/ estimates ) (accessed 10 December 2012) .,Non-OADS,/arxiv_data1/oa_pdf/dc/73/jis14-0162.PMC5443602.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/0d/jis14-0189.PMC5443603.pdf
"Vienna, Austria, (http://www.R-project.org) (accessed 22 June 2011, version 2.13.0).",Non-OADS,/arxiv_data1/oa_pdf/d7/0d/jis14-0189.PMC5443603.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/9c/jis14-0165.PMC5443604.pdf
"aegypti , and C. quinquefasciatus available in VectorBase (http://www.vectorbase.org ).The CPR gene of the Norway rat ( Rattus norvegicus ) was used as a representative of vertebrates for comparison.",OADS,/arxiv_data1/oa_pdf/0f/9c/jis14-0165.PMC5443604.pdf
Information on the intron–exon organization of the rat CPR gene wasobtained from Ensemble (http://www.ensembl.org ).,OADS,/arxiv_data1/oa_pdf/0f/9c/jis14-0165.PMC5443604.pdf
2005 ).A transmembrane spanning region was predicted by TMpred (http://embnet.vital-it.ch/software/TMPRED_form.html ) and TMHMM Server 2.0 (http://www.cbs.dtu.dk/services/TMHMM).,OADS,/arxiv_data1/oa_pdf/0f/9c/jis14-0165.PMC5443604.pdf
"In addition to putative conserved domains identified as part of the BlastP search, the identification of binding domains (for FMN, FAD,and NADPH) and catalytic residues were predicted by Pfam 26.0(http://pfam.sanger.ac.uk ).A multiple sequence alignment between A. stephensi CPR and other mosquito CPRs was performed by ClustalW (Larkin et al.",OADS,/arxiv_data1/oa_pdf/0f/9c/jis14-0165.PMC5443604.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/fa/jis14-0191.PMC5443605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/jis14-0166.PMC5443606.pdf
": N5252-5G) were purchased from Sigma-Aldrich (St. Louis, MO, USA) (http://www.sigmaaldrich.com ) Distilled water was purified “in-house” using a Milli- Q system (Bedford, MA, USA) (http://www.millipore.com).",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/jis14-0166.PMC5443606.pdf
The polar and lipophilic phases were analyzed using a LECO Pegasus IVGC-TOF/MS system (http://www.leco.com ).,OADS,/arxiv_data1/oa_pdf/b3/4e/jis14-0166.PMC5443606.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/4d/jis14-0147.PMC5443607.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/18/jis14-0167.PMC5443608.pdf
(doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/18/jis14-0167.PMC5443608.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium, provided the original work is prop- erly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
ORCID Peter Barfoot http://orcid.org/0000-0003- 0081-7275 REFERENCES American Soybean Association Conservation Tillage Study.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available at: https://soygrowers.com/asa-study-conﬁrms-environmental-beneﬁts-of-biotech-soybeans/ Angers DA, Eriksen-Hamel NS.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Agri-culture, Ecosystems Environment 2007; 118:1-5; http://dx.doi.org/10.1016/j.agee.2006.05.014 Benbrook C. A review and assessment of impact of geneti- cally engineered crops on pesticide use in the US – the ﬁrst sixteen years.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Environmental Sci Europe 2012; 24:24; http://dx.doi.org/10.1186/2190-4715-24-24 Bernacchi CJ, Hollinger SE, Meyers T. The conversion of the corn/soybean ecosystem to no-till agriculture may result in a carbon sink.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Global Change Biol 2005; 11(11):1867-72; http://dx.doi.org/10.1111/j.1365-2486.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Soil SciSoc Am J 2008; 72:693-701; http://dx.doi.org/ 10.2136/sssaj2007.0233 Brimner T, Gallivan G, Stephenson G. Inﬂuence of herbi- cide-resistant canola on the environmental impact of weed management.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Pest Management Science 2005; 61:47-52; PMID:15593073; http://dx.doi.org/10.1002/ps.967Brookes G. The beneﬁts of adopting GM insect resistant (Bt) maize in the EU: ﬁrst results from 1998–2006.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Int J Biotechnol 2008; 10:148-66; http://dx.doi.org/ 10.1504/IJBT.2008.018351 Brookes G. The farm-level impact of herbicide-tolerant soybeans in Romania.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: environmental effects 1996–2008.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available on the World Wide Web:http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: environmental effects 1996–2009.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"GM Crops 2011; 2(1):34-49; PMID:21844697; http://dx.doi.org/10.4161/ gmcr.2.1.15529 Brookes G, Barfoot P. Global impact of biotech crops: environmental effects 1996–2010.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"GM Crops 2012;3:129-37; http://dx.doi.org/10.4161/gmcr.20061 Brookes G, Barfoot P. Environmental impacts of GM crop use 1996–2013: impacts on pesticide use and carbonemissions.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
GM Crops 2015; 6:103-33; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"AgbioForum 2006; 8(2&3):187-96, Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996–2005.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available on the WorldWide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996–2006.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available on theWorld Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Key environmental impacts of global GM crop use 1996–2011.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"GM Crops 2013; 4:1-11; http://dx.doi.org/10.4161/gmcr.22748 Brookes G, Barfoot P. Key environmental impacts of GM crops 1996–2012.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"GM Crops 2014; 5:149-160; http://dx.doi.org/10.4161/gmcr.28449 Brookes G, Carpenter J, McHughen A.",OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Agronomy J 2000; 100:1013-9; http://dx.doi.org/10.2134/agronj2007.0121 Canola Council of Canada.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: http://www.canolacouncil.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available athttp://www.ctic.org/media/pdf/Biotech2003.pdf Derpsch R, Friedrich T, Kassam A, Hongwen L. Current status of adoption on no-till farming in the world and some of its main beneﬁts.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Soil Science Society Am J 2003;67:1831-41; http://dx.doi.org/10.2136/sssaj2003.1831 Fernandez-Cornejo J, Wechsler S, Livingston M, Mitchell L. Genetically engineered crops in the United States.2014.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available at: https://www.ers.usda.gov/webdocs/ publications/err162/43668_err162.pdf Fisher J, Tozer P. Evaluation of the environmental and economic impact of Roundup Ready Canola in the Western Australian Crop Production System.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: https://www.abca.com.au/wp-con tent/uploads/2010/01/news_pdf_068_WA_Curtin_Uni versity_canola_study.pdf Galveo A.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available on the World Wide Web: http://www.ipccnggip.iges.or.jp/public/2006 gl/pdf/4_Volume4/V4_02_Ch2_Generic.pdf Ismael Y, Bennett R, Morse S, Buthelezi T. Bt cotton, pes- ticides, labour and health: A case study of smallholderfarmers in the Makhathini Flats, Republic of SouthAfrica.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Soil TillageResearch 2005; 83:73-94; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Plos One 2014; 9(11):e111629; PMID:25365303; http://dx.doi.org/10.1371/ journal.pone.0111629 Kniss A, Coburn C. Quantitativ e evaluation of the environ- mental impact quotient (EIQ) for comparing herbicides.PLOS One 2015; 10(6):e0131200; PMID:26121252; http://dx.doi.org/10.137 1/journal.pone.0131200 Kovach J, Petzoldt C, Degni J, Tette J.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Land Degradation Dev 2005; 17:197-209; http://dx.doi.org/10.1002/ldr.696134 Brookes and Barfoot,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Science 2004; 304:1623-7; PMID:15192216; http://dx.doi.org/ 10.1126/science.1097396 Lazarus WF.,OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available at: http://www.minnesotafarmguide.com/news/regional/machinery-cost-estimates/pdf_a5a9623c-636a-11e3-8546-0019bb2963f4.html Leibig M, Morgan J, Reeder J, Elert B, Gollany H, Schu- man G. Greenhouse gas contributions and mitigationpotential of agriculture practices in north-western USA and Western Canada.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Soil Tillage Res 2005; 83:25-52; http://dx.doi.org/10.1016/j.still.2005.02.008 Michigan State University.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: http://surf.kbs.msu.edu Monsanto Brazil.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Applied Environmental Soil Sci 2013; 2013:10; http://dx.doi.org/10.1155/2013/617504 Peterson R, Schleier J.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Peer J 2014; 2:e364; PMID:24795854; http://dx.doi.org/10.7717/peerj.364 Pray C, Huang J, Hu R, Roselle S. Five years of Bt cotton in China – the beneﬁts continue.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Plant Journal 2002;31(4):423-30; PMID:12182701; http://dx.doi.org/ 10.1046/j.1365-313X.2002.01401.x Qaim M, De Janvry A. Bt cotton and pesticide use in Argen- tina: economic and environmental effects, Environmentand Development Economics.",OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Agricultural Eco- nomics 2005; 32(1), 73–86; http://dx.doi.org/10.1111/ j.0169-5150.2005.00006 Reeder R. No-till beneﬁts add up with diesel fuel savings.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: http://www.thelandonline.com/ archives/no-till-beneﬁts-add-up-with-diesel-fuel-savings/article_035dfdc8-1569-5d9b-8b14-1d9e60c96871.html Reicosky D. Conservation tillage and carbon cycling: soil as a source or sink for carbon.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Science 2000; 289:1922-125; PMID:10988070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Weed Technol 2011; 25:492- 500; http://dx.doi.org/10.1614/WT-D-10-00164.1 Traxler G, Godoy-Avilla S, Falck-Zepeda J, Espinoza- Arellano J. Transgenic cotton in Mexico: Economicand environmental impacts.",OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: https://www.researchgate.net/publication/ 228584807_Transgenic_Cotton_in_Mexico_Economic_and_Environmental_Impacts University of Illinois.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: http://www.farmdoc.illinois.edu/manage/newsletters/fefo06_07/fefo06_07.html USDA Energy Estimator: tillage.,OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Available at: http://ecat.sc.egov.usda.gov USDA.,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Available at: http://www.cometvr.colostate.edu/ West T, Post W. Soil Organic Carbon Sequestration Rates by Tillage and Crop Rotation: A Global Analysis.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"Soil Sci Society Am J 2002; 66:930-1046; http://dx.doi.org/10.2136/sssaj2002.1930 Wutzler T, Reichstein M. Soils apart from equilibrium – consequences for soil carbon balance modelling.",Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
Bio-geosciences Discuss 2006; 3:1679-714; http://dx.doi.org/10.5194/bgd-3-1679-2006ENVIRONMENTAL IMPACTS OF GM CROP USE 1996–2015 135,Non-OADS,/arxiv_data1/oa_pdf/22/63/kgmc-08-02-1309490.PMC5443613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"ORCID Roger Thilmony http://orcid.org/0000- 0002-6591-6699 REFERENCES Allan AC, Hellens RP, Laing WA.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Trends Plant Sci 2008; 13:99-102; PMID:18280199; http://dx.doi.org/10.1016/j.tplants.2007.11.012 Azuma A, Yakushiji H, Koshita Y, Kobayashi S. Flavonoid biosynthesis-related genes in grape skin are differentially regulated by temperature an d light conditions.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Planta 2012; 236:1067-80; PMID:225 69920; http://dx.doi.org/ 10.1007/s00425-012-1650-x Azuma A, Kobayashi S, Yakushui H, Yamada M, Mitani N, Sato A. VvmybA1 genotype determines grape skin color.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Ban Y, Honda C, Hatsuyama Y, Igarashi M, Bessho H, Moriguchi T. Isolation and functional analysis of a MYB transcription factor gene that is a key regulator for the development of red coloration in apple skin.Plant Cell Physiol 2007; 48:958-70; PMID:17526919;http://dx.doi.org/10.1093/pcp/pcm066102 Dasgupta et al.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Physiol 2010; 154:1428-38; PMID:20807862;http://dx.doi.org/10.1104/pp.110.162735 Bradley JM, Davies KM, Deroles SC, Bloor SJ, Lewis DH.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant J 1998; 13(3):381- 92; http://dx.doi.org/10.1046 /j.1365-313X.1998.00031.x Boase MR, Brendolise C, Wang L, Ngo H, Espley RV, Hel- lens RP, Schwinn KE, Davies KM, Albert NW.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Cell Rep 2015; 34:1817-23; PMID:26113165; http://dx.doi.org/10.1007/s00299-015-1827-4 Borevitz JO, Xia Y, Blount J, Dixon RA, Lamb C. Activation tagging identiﬁes a conserved MYB reg-ulator of phenylpropanoid bio synthesis.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
Plant Cell 2000; 12:2383-94; PMID:11148285; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"PlantCell 2012; 24:1242-55; PMID:22427337; http://dx.doi.org/10.1105/tpc.111.095232 Butelli E, Titta L, Giorgio M, Mock HP, Matros A, Peterek S, Schijlen EGWM, Hall RD, Bovy AG, LuoJ, et al.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Nature Biotechnol 2008; 26:1301-8;http://dx.doi.org/10.1038/nbt.1506 Chu H, Jeong JC, Kim WJ, Chung DM, Jeon HK, Ahn YO, Kim SH, Lee HS, Kwak SS, Kim CY.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Trends Plant Sci 2010; 15:573-81; PMID:20674465; http://dx.doi.org/10.1016/j.tplants.2010.06.005 Dutt M, Stanton D, Grosser JW.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant J 2007; 49(3):414-27;PMID:17181777; http://dx.doi.org/10.1111/j.1365- 313X.2006.02964.x Feller A, Machemer K, Braun EL, Grotewold E. Evolu- tionary and comparative analysis of MYB and bHLHplant transcription factors.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant J 2011; 66:94-116; PMID:21443626; http://dx.doi.org/10.1111/j.1365- 313X.2010.04459.x Geekiyanage S, Takase T, Ogura Y, Kiyosue T. Anthocyanin production by over-expression of grape transcription factor gene VlmybA2 in trans- genic tobacco and Arabidopsis.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant BiotechnolRep 2007; 1:11-8; http://dx.doi.org/10.1007/s11816- 006-0001-4 Goldsbrough AP, Tong Y, Yoder JI.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
Plant J 1996; 9:927-33; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Trends Plant Sci 2009; 14:237-41; PMID:19359211; http://dx.doi.org/ 10.1016/j.tplants.2009.02.001 Hernandez I, Alegre L, Breusegem FV, Munne-Bosch S. How relevant are ﬂavonoids as antioxidants in plants.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Trends Plant Sci 2009; 14:125-32; PMID:19230744;http://dx.doi.org/10.1016/j.tplants.2008.12.003 Hichri I, Barrieu F, Bogs J, Kappel C, Delrot S. Recent advances in the transcriptional regulation of the ﬂavo-noid biosynthetic pathway.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"J Exp Bot 2011; 62:2465- 83; PMID:21278228; http://dx.doi.org/10.1093/jxb/ erq442 Honda C, Kotoda N, Wada M, Kondo S, Kobayashi S, Soejima J, Zhang Z, Tsuda T, Moriguchi T. Anthocya- nin biosynthetic genes are coordinately expressed dur- ing red coloration in apple skin.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant PhysiolBiochem 2002; 40:955-62; http://dx.doi.org/10.1016/ S0981-9428(02)01454-7 Horsch RB, Klee HJ.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Proc Natl Acad Sci U S A 1986; 83:4428-32; PMID:16593716;http://dx.doi.org/10.1 073/pnas.83.12.4428 Huang W, Sun W, Lv H, Luo M, Zeng S, Pattanaik S, Yuan L, Wang Y.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
PLoS ONE 2013a; 8(8):e70778; PMID:23936468; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
Plant Cell Tiss Org Cult 2013b; 113:491-9; http://dx.doi.org/10.1007/ s11240-013-0291-5 Hunter RS.,Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
Tree Physiol 2006; 26(5):613-21;PMID:16452075; http://dx.doi.org/10.1093/treephys/ 26.5.613 Kutchan TM.,OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Physiol Plantar2010; 139:229-40; http://dx.doi.org/10.1111/j.1399- 3054.2010.01353.x Kobayashi S, Yamamoto NG, Hirochika H. Retrotranspo- son-induced mutations in grape skin color.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Science2004; 304:982; PMID:15143274; http://dx.doi.org/ 10.1126/science.1095011 Kobayashi S, Yamamoto NG, Hirochika H. Association ofVvmybA 1 gene expression with anthocyanin pro- duction in grape (Vitis vinifera) skin - color mutants.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"J Jpn Soc Hort Sci 2005; 74:196-203; http://dx.doi.org/10.2503/jjshs.74.196 Kortstee AJ, Khan SA, Helderman C, Trindade LM, Wu Y, Visser RG, Brendolise C, Allan AC,Schouten HJ, Jacobsen E. An thocyanin production as a potential visual selection marker during plant transformation.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Transgenic Res 2011; 20:1253-64;PMID:21340526; http://dx.doi.org/10.1007/s11248-011-9490-1 Lai B, Li X-J, Hu B, Qin YH, Huang XM, Wang HC, Hu GB.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
PLoS ONE 2014; 9(1):e86293;PMID:24466010; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Biotech Rep 2012; 6(203):203-11; http://dx.doi.org/10.1007/s11816-012-0215-6Lin-Wang K, Bolitho K, Grafton K, Kortstee A, Karunair- etnam S, McGhie TK, Espley RV, Hellens RP, Allan AC.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"BMC Plant Biol 2010; 10:50-66; PMID:20302676; http://dx.doi.org/10.1186/1471-22 29-10-50 Li H, Flachowsky H, Fischer TC, Hanke MV, Forkmann DG, Treutter , Schwab W, Hoffmann T, Szankowski I. Maize Lc transcription factor enhances biosynthesis of anthocyanins, distinct proanthocyanidins and phe-nylpropanoids in apple ( Malus domestica Borkh.).",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Transgenic Res 2011; 20:1087-97;PMID:21229312; http://dx.doi.org/10.1007/s11248- 010-9482-6 Lloyd AM, Schena M, Walbot V, Davis RW.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Science 1990; 247:449-450; PMID:17788612;http://dx.doi.org/10.1126/science.247.4941.449 Mano H, Ogasawara F, Sato K, Higo H, Minobe Y. Isola- tion of a regulatory gene of anthocyanin biosynthesisin tuberous roots of purple-ﬂeshed sweet potato.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Biol Plant 2014; 58(1):121-30; http://dx.doi.org/10.1007/s10535-013-0376-3 Neff MM, Chory J.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Physiol 1998; 118(1):27-35; PMID:9733523; http://dx.doi.org/10.1104/ pp.118.1.27 Kneissl ML, Deikman J.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Cell 1993; 5(9):1049-62; PMID:8400876; http://dx.doi.org/ 10.1105/tpc.5.9.1049 Niu SS, Xu CJ, Zhang WS, Zhang B, Li X, Lin-Wang K, Ferguson IB, Allan AC, Chen KS.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Cell Rep 2009; 28:387-95; PMID:19048258; http://dx.doi.org/10.1007/s00299-008-0646-2 Petroni K, Tonelli C. Recent advances on the regulation of anthocyanin synthesis in reproductive organs.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Sci 2011; 181:219-29; PMID:21763532; http://dx.doi.org/10.1016/j.plantsci.2011.05.009 Qiu J, Sun S, Luo S, Zhang J, Xiao X, Zhang L, Wang F, Liu S. Arabidopsis AtPAP1 transcription factor indu- ces anthocyanin production in transgenic Taraxacum brevicorniculatum .",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Cell Rep 2014; 33(4):669- 80; PMID:24556963; http://dx.doi.org/10.1007/s00299-014-1585-8 Ramsay NA, Glover BJ.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Trends Plant Sci 2005; 10:63-70; PMID:15708343; http://dx.doi.org/10.1016/j.tplants.2004.12.011 Spelt C, Quattrocchio F, Mol J, Koes R. ANTHOCYA- NIN1 of petunia controls pigment synthesis, vacuolarpH, and seed coat development by genetically distinct mechanisms.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Nat Prod Rep 2003; 20:288-303;PMID:12828368; http://dx.doi.org/10.1039/b109542k Stitt M, Sulpice R, Keurentjes J. Metabolic networks: how to identify key components in the regulation of metabolism and growth.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Physiol 2010;152:428-44; PMID:20018593; http://dx.doi.org/ 10.1104/pp.109.150821 Stover E, Avila Y, Li ZT, Gray D. Transgenic expression in citrus of Vitis MybA1 from a bi directional promoter resulted in variable anthocyanin expression and was not suitable as a screenable mark er without antibiotic selec- tion.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Curr Opin Plant Biol 2001; 4:447-56; PMID:11597504; http://dx.doi.org/10.1016/S1369-5266(00)00199-0 Takos AM, Jaffe FW, Jacob SR, Bogs J, Robinson SP, Walker AR.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant J2008; 54:733-49; PMID:18476875; http://dx.doi.org/ 10.1111/j.1365-313X.2008.03447.x This P, Lacomb T, Cadle-Davidson M, Owens C. Wine grape ( Vitis vinifera L.) color associates with allelic variation in the domestication gene VvmybA1 .",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Theor Appl Genet 2007; 114:723-30; PMID:17221259; http://dx.doi.org/10.1007/s00122-006-0472-2 Thompson JD, Higgins DG, Gibson TJ.",Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Nucleic Acids Res 1994; 22:4673-80; PMID:7984417; http://dx.doi.org/10.1093/nar/22.22.4673 Wang Y, Yau YY, Perkins-Balding D, Thomson JG.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant Cell Rep 2011; 30(3):267-85;PMID:20972794; http://dx.doi.org/10.1007/s00299-010-0938-1 Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"PLoS ONE 2011; 6(4):319455; http://dx.doi.org/10.1371/jour- nal.pone.0019455 Winkel-Shirley B. Flavonoid biosynthesis: a colorful model for genetics, biochemistry, c ell biology and biotechnol- ogy.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
Plant Physiol 2001; 126:485-93; PMID:11402179; http://dx.doi.org/10.1104/pp.126.2.485 Winkel-Shirley B.,Non-OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"Plant J 2004; 40:22-34; PMID:15361138;http://dx.doi.org/10.1111/j.1365-313X.2004.02183.x Zhou X, Carranco R, Vitha S, Hall TC.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
"New Phytol 2005; 168:313-22; PMID:16219071; http://dx.doi.org/10.1111/j.1469- 8137.2005.01489.x Zhou H, Lin-Wang K, Wang H, Gu C, Dare AP, Espley RV, He H, Allan AC, Han Y. Molecular genetics of blood-ﬂeshed peach reveals activation of anthocyaninbiosynthesis by NAC transcription factors.",OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
Plant J2015; 82(1):105-21; PMID:25688923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/9c/kgmc-08-02-1267897.PMC5443614.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/5/e1601898/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/91/67/1601898.PMC5443639.pdf
Data underpinning this publication can be accessed at http://dx.doi.org/10.17630/04280577-35c4-44e7-97d2-5c827ace7a4e.,Non-OADS,/arxiv_data1/oa_pdf/28/9f/1602983.PMC5443640.pdf
"†Information from DAVID (Database for Annotation, Visualization and Integrated Discovery) (https://david.ncifcrf.gov/) and GeneCards (www.genecards.org).",OADS,/arxiv_data1/oa_pdf/3b/65/1602404.PMC5443641.pdf
"We marked PCR duplicates with Picard Tools version 2.1.1 (https://broadinstitute.github.io/picard/), realigned arou nd indels, and fixed mate pairs after realigning with GATK version 3.5 ( 49).",Non-OADS,/arxiv_data1/oa_pdf/3b/65/1602404.PMC5443641.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/5/e1602404/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/3b/65/1602404.PMC5443641.pdf
"R Core Team, R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2016); https://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/3b/65/1602404.PMC5443641.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/5/e1602778/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/e8/19/1602778.PMC5443642.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/5/e1602522/DC1 table S1.,Non-OADS,/arxiv_data1/oa_pdf/de/95/1602522.PMC5443645.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/5/e1602829/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/f5/1602829.PMC5443646.pdf
The  median life span for males of this strain is 29.6 months ( http://phenome.jax.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/64/nihms855756.PMC5443651.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.MOBILE GENETIC ELEMENTS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"3, e1318201 (18 pages)https://doi.org/10.1080/2159256X.2017.1318201",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Proc Biol Sci 1992;249:119-24; PMID:1360673; https://doi.org/10.1098/rspb.1992.0093 [2] Vieira C, Nardon C, Arpin C, Lepetit D, Biemont C. Evolution of genome size in Drosophila.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genetics2007; 177:1277-90; PMID:18039867; https://doi.org/10.1534/genetics.107.075069 [4] Gregory TR, Johnston JS.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Heredity (Edinb) 2008; 101:228-38; PMID:18523443; https://doi.org/10.1038/hdy.2008.49 [5] SanMiguel P, Tikhonov A, Jin YK, Motchoulskaia N, Zakharov D, Melake-Berhan A, Springer PS, EdwardsKJ, Lee M, Avramova Z, et al.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nature 2001; 409:860-921; PMID:11237011;https://doi.org/10.1038/35057062 [7] Lannoy N, Hermans C. Principles of genetic variations and molecular diseases: Applications in hemophilia A. Crit RevOncol Hematol 2016; 104:1-8; PMID:27296059; https://doi.org/10.1016/j.critrevonc.2016.04.005 [8] Solyom S, Ewing AD, Rahrmann EP, Doucet T, N e l s o nH H ,B u r n sM B ,H a r r i sR S ,S i g m o nD F ,Casella A, Erlanger B, et al.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"GenomeRes 2012; 22:2328-38; PMID:22968929; https://doi.org/10.1101/gr.145235.112 [9] Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Breast Cancer Res Treat 2012; 136:129-42; PMID:23053642;https://doi.org/10.1007/s10549-012-2246-7 [10] Batzer MA, Deininger PL.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nat Rev Genet 2002; 3:370-9;PMID:11988762; https://doi.org/10.1038/nrg798 [11] Li W, Jin Y, Prazak L, Hammell M, Dubnau J. Transposable elements in TDP-43-mediated neurode- generative disorders.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nature 2011;479:534-7; PMID:22037309; https://doi.org/10.1038/ nature10531 [13] Reilly MT, Faulkner GJ, Dubnau J, Ponomarev I, Gage FH.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"J Neurosci 2013;33:17577-86; PMID:24198348; https://doi.org/10.1523/JNEUROSCI.3369-13.2013 [14] Kaminker JS, Bergman CM, Kronmiller B, Carlson J, Svirskas R, Patel S, Frise E, Wheeler DA, Lewis SE, Rubin GM, et al.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genome Biol 2002; 3:1-20; http://www.fruit ﬂy.org:9005/about/pubs/genome_biology/gb-2002-3- 12-research0084.pdf [15] Barr /C19on MG, Fiston-Lavier A-S, Petrov DA, Gonz /C19alez J.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
Annu Rev Genet 2014; 48:561-81;PMID:25292358; https://doi.org/10.1146/annurev- genet-120213-092359 [16] McClintock B.,Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Trends Genet 1989; 5:103-7;PMID:2543105; https://doi.org/10.1016/0168-9525(89)90039-5 [18] Lerat E, Capy P. Retrotransposons and retroviruses: Analysis of the envelope gene.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Curr Genomics2010; 11:115-28; PMID:20885819; https://doi.org/10.2174/138920210790886871 [20] Palazzo A, Marconi S, Specchia V, Bozzetti MP, Ivics Z, Caizzi R, Marsano RM.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"PLoS One 2013; 8:e79385; PMID:24244492; https://doi.org/10.1371/journal.pone.0079385 [21] Kapitonov VV, Jurka J. Helitrons on a roll: Eukary- otic rolling-circle transposons.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Trends Genet 2007;23:521-9; PMID:17850916; https://doi.org/10.1016/j.tig.2007.08.004 [22] Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nat Rev Genet 2009;10:691-703; PMID:19763152; https://doi.org/10.1038/ nrg2640 [24] Sheen FM, Levis RW.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genome Res 2001; 11:1527-40; PMID:11544196; https://doi.org/10.1101/gr.164201 [26] Russo J, Harrington AW, Steiniger M. Antisense tran- scription of retrotransposons in Drosophila: An originof endogenous small interfering RNA precursors.Genetics 2016; 202:107-21; PMID:26534950; https://doi.org/10.1534/genetics.115.177196 [27] Yin H, Lin H. An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell2013; 50:736-48; PMID:23665228; https://doi.org/10.1016/j.molcel.2013.04.006 [29] Vagin VV, Sigova A, Li C, Seitz H, Gvozdev V, Zamore PD.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Science 2006; 313:320-4; PMID:16809489; https://doi.org/10.1126/science.1129333 [30] Brennecke J, Aravin AA, Stark A, Dus M, Kellis M, Sachi- danandam R, Hannon GJ.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Cell 2007;128:1089-103; PMID:17346786; https://doi.org/10.1016/j.cell.2007.01.043 [31] Siomi MC, Miyoshi T, Siomi H. piRNA-mediated silencing in Drosophila germlines.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
Semin Cell Dev Biol2010; 21:754-9; PMID:20080197; https://doi.org/10.1016/j.semcdb.2010.01.011 [32] Pritham EJ.,OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"J Hered 2009; 100:648-55;PMID:19666747; https://doi.org/10.1093/jhered/esp065 [33] Mu ~noz-L /C19opez M, Garc /C19ıa-P/C19erez JL.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Curr Genomics2010; 11:115-28; PMID:20885819; https://doi.org/10.2174/138920210790886871 [34] Chalopin D, Naville M, Plard F, Galiana D, Volff J-N.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Comparative analysis of transposable elements high-lights mobilome diversity and evolution in vertebrates.Genome Biol Evol 2015; 7:567-80; PMID:25577199; https://doi.org/10.1093/gbe/evv005 [35] Caizzi R, Caggese C, Pimpinelli S. Bari-1, a new trans- poson-like family in Drosophila melanogaster with aunique heterochromatic organization.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"PLoS One 2016; 11: e0156014; PMID:27213270; https://doi.org/10.1371/journal.pone.0156014 [37] Karess RE, Rubin GM.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genetica2007; 130:105-20; PMID:16912840; https://doi.org/10.1007/s10709-006-0025-2 [39] Yuan Y-W, Wessler SR.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"BMC Genomics 2014; 15:727; PMID:25163909; https://doi.org/10.1186/1471-2164-15-727 [41] O ’Hare K, Rubin GM.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"The human THAP9 gene encodes an active P-element DNA transposase.Science 2013; 339:446-8; PMID:23349291; https://doi.org/10.1126/science.1231789 [43] Spradling AC, Bellen HJ, Hoskins RA.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Gen Genet 1992; 232:126-34;PMID:1313144; https://doi.org/10.1007/BF00299145 [45] Kidwell MG, Kidwell JF, Sved JA.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"G3(Bethesda) 2014; 4:1417-27; PMID:24902606; https://doi.org/10.1534/g3.114.011221 [51] Lemaitre B, Ronsseray S, Coen D. Maternal repression of the P element promoter in the germline of Drosoph-ila melanogaster: A model for the P cytotype.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Annu Rev Genet 1983; 17:315-44; PMID:6320712;https://doi.org/10.1146/annurev.ge.17.120183.001531 [53] Siebel CW, Rio DC.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Cell 1986; 44:7-19; PMID:3000622; https://doi.org/10.1016/0092-8674(86)90480-0 [55] Misra S, Rio DC.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Biol Evol 2003; 20:869-79; PMID:12717001;https://doi.org/10.1093/molbev/msg090 [58] Harrington AW, Steiniger M. Bioinformatic analyses of sense and antisense expression from terminal invertedrepeat transposons in Drosophila somatic cells.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Fly(Austin) 2016; 10:1-10; PMID:26986720; https://doi.org/10.1080/19336934.2016.1165372 [59] Kapitonov VV, Jurka J. Rolling-circle transposons in eukaryotes.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Microbiol Spectr 2015; 3; PMID:26350323; https://doi.org/10.1128/microbiolspec.MDNA3-0049-2014 [63] Thomas J, Vadnagara K, Pritham EJ.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mob DNA2014; 5:18; PMID:24959209; https://doi.org/10.1186/ 1759-8753-5-18 [64] Grabundzija I, Messing SA, Thomas J, Cosby RL, Bilic I, Miskey C, Gogol-D €oring A, Kapitonov V, Diem T, Dalda A, et al.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nat Commun 2016; 7:10716; PMID:26931494;https://doi.org/10.1038/ncomms10716 [65] Barbaglia AM, Klusman KM, Higgins J, Shaw JR, Han- nah LC, Lal SK.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genetics 2012; 190:965-75; PMID:22174072; https://doi.org/10.1534/genetics.111.136176 [66] Kalmykova A, Maisonhaute C, Gvozdev V. Retrotrans- poson 1731 in Drosophila melanogaster changes retro-virus-like expression strategy in host genome.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Virology2004; 318:183-91; PMID:14972546; https://doi.org/10.1016/j.virol.2003.09.026 [69] Stefanov Y, Salenko V, Glukhov I. Drosophila errantivi- ruses.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
Mob Genet Elements 2012; 2:36-45; PMID:22754751; https://doi.org/10.4161/mge.19234 [70] Engelman A. Retroviral integrase structure and DNA recombination mechanism.,OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
Microbiol Spectrum 2(6):MDNA3-0024-2014; https://doi.org/10.1128/microbiolspec.MDNA3-0024-2014.,Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Trends Genet 2008; 24:511-7; PMID:18778867; https://doi.org/10.1016/j.tig.2008.08.002 [74] Yang N, Kazazian HH.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nat Struct Mol Biol2006; 13:763-71; PMID:16936727; https://doi.org/10.1038/nsmb1141 [75] Mugnier N, Gueguen L, Vieira C, Bi /C19emont C. The heterochromatic copies of the LTR retrotransposons as a record of the genomic events that have shaped the Drosophila melanogaster genome.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Gene 2008;411:87-93; PMID:18281162; https://doi.org/10.1016/j.gene.2008.01.010 [76] la Chaux de N, Wagner A. BEL/Pao retrotransposons in metazoan genomes.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"BMC Evol Biol 2011; 11:154;PMID:21639932; https://doi.org/10.1186/1471-2148-11-154 [77] Nefedova LN, Mannanova MM, Kim AI.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Virus Genes2011; 42:297-306; PMID:21369828; https://doi.org/10.1007/s11262-010-0566-4 [78] Khan E, Mack JP, Katz RA, Kulkosky J, Skalka AM.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Cell 1988; 54:685-91; PMID:2842063; https://doi.org/10.1016/S0092-8674(88)80013-8 [80] Carbonare BD, Gehring WJ.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"PLoS Genet 2012; 8:e1002487;PMID:22291611; https://doi.org/10.1371/journal.pgen.1002487 [82] Rizzon C, Marais G, Gouy M, Bi /C19emont C. Recombina- tion rate and the distribution of transposable elements in the Drosophila melanogaster genome.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genome Res2002; 12:400-7; PMID:11875027; https://doi.org/10.1101/gr.210802 [83] Nefedova LN, Liubomirskaia NV, Il ’in IV, Kim AI.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genome Biol 2002; 3:RESEARCH0085;PMID:12537574; https://doi.org/10.1186/gb-2002-3-12-research0085 [86] Bergman CM, Bensasson D. Recent LTR retrotranspo- son insertion contrasts with waves of non-LTR insertion since speciation in Drosophila melanogaster.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Biol Evol 2004; 21:36-44; PMID:12949132;https://doi.org/10.1093/molbev/msg236 [88] Ganko EW, Greene CS, Lewis JA, Bhattacharjee V, McDonald JF.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"J Mol Evol 2006; 62:111-20; PMID:16408244; https://doi.org/10.1007/s00239-004-0312-4 [89] Merenciano M, Ullastres A, de Cara MAR, Barr /C19on MG, Gonz /C19alez J.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"PLoS Genet 2016; 12:e1006249; PMID:27517860; https://doi.org/10.1371/journal.pgen.1006249 [90] Song SU, Gerasimova T, Kurkulos M, Boeke JD, Corces VG.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"An env-like protein encoded by a Drosophila retro-element: Evidence that gypsy is an infectious retrovirus.Genes Dev 1994; 8:2046-57; PMID:7958877; https://doi.org/10.1101/gad.8.17.2046 [91] Kim A, Terzian C, Santamaria P, P /C19elisson A, Purd ’- homme N, Bucheton A. Retroviruses in invertebrates: The gypsy retrotransposon is apparently an infectiouse1318201-16 T. J. MCCULLERS AND M. STEINIGER",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell Biol 1994; 14:5392-401; PMID:8035817; https://doi.org/10.1128/MCB.14.8.5392 [94] Malik HS, Henikoff S, Eickbush TH.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genome Res 2000; 10:1307-18; PMID:10984449; https://doi.org/10.1101/gr.145000 [95] Friesen PD, Nissen MS. Gene organization and tran- scription of TED, a lepidopteran retrotransposon inte-grated within the baculovirus genome.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell Biol1990; 10:3067-77; PMID:1692964; https://doi.org/10.1128/MCB.10.6.3067 [96] Hansen LJ, Sandmeyer SB.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell Biol 2001; 21:7826-38; PMID:11604517; https://doi.org/10.1128/MCB.21.22.7826-7838.2001 [101] Moore SP, Rinckel LA, Gar ﬁnkel DJ.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell Biol 1998; 18:1105-14; PMID:9448008;https://doi.org/10.1128/MCB.18.2.1105 [102] Maertens G, Cherepanov P, Debyser Z, Engelborghs Y, Engelman A. Identi ﬁcation and characterization of a functional nuclear localization signal in the HIV-1integrase interactor LEDGF/p75.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"J Biol Chem 2004;279:33421-9; PMID:15163664; https://doi.org/10.1074/jbc.M404700200 [103] Meignin C, Bailly J-L, Arnaud F, Dastugue B, Vaury C. The 5 0untranslated region and Gag product of Ide ﬁx, a long terminal repeat-retrotransposon from Drosophila mela- nogaster, act together to initiate a switch between trans- lated and untranslated states of the genomic mRNA.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell Biol 1998;18:6859-69; PMID:9774699; https://doi.org/10.1128/MCB.18.11.6859 [106] Kapitonov VV, Tempel S, Jurka J.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
Gene 2009;448:207-13; PMID:19651192; https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"FrontGenet 2013; 4:63; PMID:23637706; https://doi.org/10.3389/fgene.2013.00063 [108] Luan DD, Korman MH, Jakubczak JL, Eickbush TH.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Cell 1993; 72:595-605;PMID:7679954; https://doi.org/10.1016/0092-8674(93)90078-5 [109] Kurzynska-Kokorniak A, Jamburuthugoda VK, Bibillo A, Eickbush TH.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"J Mol Biol 2007; 374:322-33; PMID:17936300; https://doi.org/10.1016/j.jmb.2007.09.047 [110] Stage DE, Eickbush TH.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Origin of nascent lineages and the mechanisms used to prime second-strand DNA syn-thesis in the R1 and R2 retrotransposons of Drosophila.Genome Biol 2009; 10:R49; PMID:19416522; https://doi.org/10.1186/gb-2009-10-5-r49 [111] Luan DD, Eickbush TH.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Cell Biol 1995; 15:3882-38;PMID:7540721; https://doi.org/10.1128/MCB.15.7.3882 [112] Fujimoto H, Hirukawa Y, Tani H, Matsuura Y, Hashido K, Tsuchida K, Takada N, Kobayashi M, Maekawa H.Integration of the 5 0end of the retrotransposon, R2Bm, can be complemented by homologous recombination.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Nucleic Acids Res 2004; 32:1555-65; PMID:14999096; https://doi.org/10.1093/nar/gkh304 [113] George JA, DeBaryshe PG, Traverse KL, Celniker SE, Pardue M-L. Genomic organization of the Drosophilatelomere retrotransposable elements.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genome Res 2006;16:1231-40; PMID:16963706; https://doi.org/10.1101/gr.5348806 [114] Christensen SM, Ye J, Eickbush TH.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Mol Biol Evol 2004;21:1620-4; PMID:15175413; https://doi.org/10.1093/molbev/msh180 [117] Pardue ML, Danilevskaya ON, Lowenhaupt K, Slot F, Traverse KL.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Trends Genet 1996; 12:48-52; PMID:8851970; https://doi.org/10.1016/0168-9525(96) 81399-0 [118] Fuller AM, Cook EG, Kelley KJ, Pardue M-L. Gag pro- teins of Drosophila telomeric retrotransposons: Collab-orative targeting to chromosome ends.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Genetics 2010;184:629-36; PMID:20026680; https://doi.org/10.1534/genetics.109.109744 [119] Pardue ML, Danilevskaya ON, Lowenhaupt K, Wong J, Erby K. The gag coding region of the Drosophila telomeric retrotransposon, HeT-A, has an internal frame shift and alength polymorphic region.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"J Mol Evol 1996; 43:572-83;PMID:8995054; https://doi.org/10.1007/BF02202105 [120] Rashkova S, Karam SE, Pardue ML.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"NucleicAcids Res 2009; 37:268-78; PMID:19036789; https://doi.org/10.1093/nar/gkn960 [122] Petit N, Pi ~neyro D, L /C19opez-Panad /C18es E, Casacuberta E, N a v a r r oA .H e T - A _ p i 1 ,ap i R N At a r g e ts e q u e n c ei n the Drosophila telomeric retrotransposon HeT-A, is extremely conserved across copies and species.Lalueza-Fox C, editor.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"PLoS One 2012; 7:e37405;PMID:22629389; https://doi.org/10.1371/journal.pone.0037405 [123] Shpiz S, Ryazansky S, Olovnikov I, Abramov Y, Kalmy- kova A. Euchromatic transposon insertions trigger pro-duction of novel Pi- and endo-siRNAs at the target sites in the drosophila germline.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"PLoS Genet 2014; 10: e1004138; PMID:24516406; https://doi.org/10.1371/journal.pgen.1004138 [124] Malik HS, Eickbush TH.",Non-OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"Speci ﬁc association of Piwi with rasiRNAs derived from retrotransposon and heterochromatic regions in the Drosophila genome.Genes Dev 2006; 20:2214-22; PMID:16882972; https://doi.org/10.1101/gad.1454806 [126] A /C14gren JA, Wright SI.",OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
Chromosome Res 2011; 19:777-86;PMID:21850458; https://doi.org/10.1007/s10577-011- 9229-0e1318201-18 T. J. MCCULLERS AND M. STEINIGER,OADS,/arxiv_data1/oa_pdf/69/01/kmge-07-03-1318201.PMC5443660.pdf
"However, despite the increased potential cardiovascular risk,\15% of patients with LDL-C C100 mg/dlEnhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/A51 7F0604525E899 .",Non-OADS,/arxiv_data1/oa_pdf/90/04/40744_2016_Article_49.PMC5443718.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any146 Rheumatol Ther (2017) 4:133–149",Non-OADS,/arxiv_data1/oa_pdf/90/04/40744_2016_Article_49.PMC5443718.pdf
"Keywords: Bone cancer; Bone sarcoma; Metastatic osteosarcoma; Osteosarcoma; Treatment for sarcomaEnhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/ 4527F0605329F539 .",Non-OADS,/arxiv_data1/oa_pdf/95/f6/40744_2016_Article_50.PMC5443719.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/95/f6/40744_2016_Article_50.PMC5443719.pdf
https://seer.cancer.gov/statfacts/html/bones.html .,Non-OADS,/arxiv_data1/oa_pdf/95/f6/40744_2016_Article_50.PMC5443719.pdf
"Retrieved November 3, 2016, from http://www.nccn.org/professionals/ physician_gls/PDF/bone.pdf .38 Rheumatol Ther (2017) 4:25–43",Non-OADS,/arxiv_data1/oa_pdf/95/f6/40744_2016_Article_50.PMC5443719.pdf
"Retrieved July 15, 2016, from http://www.cancer.org/ .",Non-OADS,/arxiv_data1/oa_pdf/95/f6/40744_2016_Article_50.PMC5443719.pdf
"Retrieved July 25, 2016, from http://www.cancer.org/cancer/osteosarcoma/index .",Non-OADS,/arxiv_data1/oa_pdf/95/f6/40744_2016_Article_50.PMC5443719.pdf
"Conclusions : The high prevalence of undiagnosed axial SpA in patients with chronic back pain visiting PMR physicians, orthopedists, and ophthalmologists suggests that these healthcare professionals may play a key role in the strategy developed to shorten the delay observed in the formal diagnosis of SpA.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5D47F06069E7B40D .",Non-OADS,/arxiv_data1/oa_pdf/19/64/40744_2016_Article_51.PMC5443720.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercialuse, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/19/64/40744_2016_Article_51.PMC5443720.pdf
Available from http://www.who.int/ medicines/areas/priori ty_medicines/MasterDoc June28_FINAL_Web.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/19/64/40744_2016_Article_51.PMC5443720.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a2/23/40744_2017_Article_52.PMC5443721.pdf
https://marketscan.truvenhealth.com/marketscan portal/portal.aspx .,Non-OADS,/arxiv_data1/oa_pdf/a2/23/40744_2017_Article_52.PMC5443721.pdf
20. http://www.bls.gov/cpi/data.htm .,Non-OADS,/arxiv_data1/oa_pdf/a2/23/40744_2017_Article_52.PMC5443721.pdf
In this study enthesitis and synovitis in the painful elbow were found equally in cases of established RA and PsA.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/CD7 7F06057687EB8 .,Non-OADS,/arxiv_data1/oa_pdf/1d/53/40744_2017_Article_53.PMC5443722.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/40744_2017_Article_53.PMC5443722.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0f/5f/40744_2017_Article_54.PMC5443723.pdf
"When tapering the bDMARD treatment of a patient, disease activity should be monitored closely,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2D87F060266F1CFA .",Non-OADS,/arxiv_data1/oa_pdf/ca/65/40744_2017_Article_55.PMC5443724.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ca/65/40744_2017_Article_55.PMC5443724.pdf
http://www.medicijnkosten.nl .,Non-OADS,/arxiv_data1/oa_pdf/ca/65/40744_2017_Article_55.PMC5443724.pdf
Keywords: ACBC analysis; Adaptive choice-based conjoint analysis; Osteoarthritis; Patient preferences; Pharmaceutical treatment INTRODUCTION National and international guidelines for the management of patients with osteoarthritisEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/4E87 F06057B18182 .,Non-OADS,/arxiv_data1/oa_pdf/a2/fd/40744_2017_Article_56.PMC5443725.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits anyTable 4 Characteristics of discrete choice and conjoint studies Attributes Number of attribute xlevel combinationsExperimental scenariosaScenarios MethodbStudy 6 attributes: 4 at 2 levels, 1 at 3 levels, 1 at 4 levels192 16 Pre-selected DCE (choice)Ryan et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/fd/40744_2017_Article_56.PMC5443725.pdf
2013. http://www.nice.org.uk/guidance/ cg177 .,Non-OADS,/arxiv_data1/oa_pdf/a2/fd/40744_2017_Article_56.PMC5443725.pdf
http://www.sawtoothsoftware.com/ download/techpap/formatt.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a2/fd/40744_2017_Article_56.PMC5443725.pdf
https://www.sawtoothsoftware.com/ download/techpap/acbc10.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a2/fd/40744_2017_Article_56.PMC5443725.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bd/84/40744_2017_Article_57.PMC5443726.pdf
"Geneva, Switzerland: World Health Organization; 2003.http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf .",Non-OADS,/arxiv_data1/oa_pdf/bd/84/40744_2017_Article_57.PMC5443726.pdf
NORDiMET /C210Summary of Product Characteristics http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/003983/WC500213203.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bd/84/40744_2017_Article_57.PMC5443726.pdf
"Rheumatoid arthritis is considered a chronic condition and has a major impact on the quality of life of patients [ 5], thus underlying theEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ C3F7F0602F129F4E .",Non-OADS,/arxiv_data1/oa_pdf/9a/86/40744_2017_Article_58.PMC5443727.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/9a/86/40744_2017_Article_58.PMC5443727.pdf
2015. http://www.who.int/chp/topics/rheumatic/en/ (cited 2015 Jul 24) .,OADS,/arxiv_data1/oa_pdf/9a/86/40744_2017_Article_58.PMC5443727.pdf
http://onlinelibrary.wiley.com/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/9a/86/40744_2017_Article_58.PMC5443727.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/42/d2/40744_2017_Article_59.PMC5443728.pdf
Outcomes for CZP monotherapy and CZP ?MTX combina- tion-therapy were compared.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 38F7F060237E7A26 .,Non-OADS,/arxiv_data1/oa_pdf/00/a1/40744_2017_Article_60.PMC5443729.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/a1/40744_2017_Article_60.PMC5443729.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/73/40744_2017_Article_61.PMC5443730.pdf
"2003. http://apps.who.int/iris/bitstream/10665/42682/1/ 9241545992.pdf Accessed 31 Aug 2016 6. van den Bemt BJ, Zwikker HE, van den Ende CH.",Non-OADS,/arxiv_data1/oa_pdf/00/73/40744_2017_Article_61.PMC5443730.pdf
The ﬁrst report of cutaneous hypersensi- tivity caused by a metallic orthopedic implantEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 1508F06019AC8C24 .,Non-OADS,/arxiv_data1/oa_pdf/bf/70/40744_2017_Article_62.PMC5443731.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/23857019 .,Non-OADS,/arxiv_data1/oa_pdf/bf/70/40744_2017_Article_62.PMC5443731.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/eb/e7/40744_2017_Article_63.PMC5443732.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1b/b6/40744_2017_Article_65.PMC5443733.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/40259_2017_Article_219.PMC5443869.pdf
2016. http://www.fda.gov/ downloads/Drugs/ …/Guidances/UCM192750.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/ca/40259_2017_Article_219.PMC5443869.pdf
2015. http://www.fda.gov/downloads/drugs/guidancecom plianceregulatoryinformation/guidances/ucm291128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/ca/40259_2017_Article_219.PMC5443869.pdf
2016. http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/ArthritisAdviso ryCommittee/UCM484860.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/ca/40259_2017_Article_219.PMC5443869.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2015. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM444661.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2015.http://www.fda.gov/downloads/Drugs/GuidanceComplianceReg- ulatoryInformation/Guidances/UCM291134.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2015. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2010. http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2010/01/WC500070039.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
Geneva: WHO; 2009. http://www.who.int/biologicals/ar eas/biological_therapeutics/ BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2009. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2017. https://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM537135.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2017. http://www.ema.europa.eu/ema/index.jsp?curl=pages/ medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
2017. http://www.accessdata.fda.gov/scripts/cder/ daf/index.cfm?event=BasicSearch.process .,OADS,/arxiv_data1/oa_pdf/6a/eb/40259_2017_Article_218.PMC5443883.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e8/37/40259_2017_Article_222.PMC5443886.pdf
Rapport de juillet 2009. http://ansm.sante.fr/ var/ansm_site/storage/original/application/419c130c7c1464b24d6c8c462b73f731.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e8/37/40259_2017_Article_222.PMC5443886.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/66/main.PMC5443891.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.02.021 250,OADS,/arxiv_data1/oa_pdf/90/66/main.PMC5443891.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/07/20/main.PMC5443895.pdf
E-mail address: marie.eckerstrom@neuro.gu.se http://dx.doi.org/10.1016/j.dadm.2017.04.006 2352-8729/ /C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/07/20/main.PMC5443895.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/20/main.PMC5443895.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2017.04.006 .,OADS,/arxiv_data1/oa_pdf/07/20/main.PMC5443895.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/42/main.PMC5443905.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.05.019 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b0/42/main.PMC5443905.pdf
"Di ﬀerences in regional cortical surface area, such as in lingual gyrus, post-central http://dx.doi.org/10.1016/j.nicl.2017.05.011 Received 2 February 2017; Received in revised form 16 May 2017; Accepted 17 May 2017⁎Correspondence to: E. Halgren, 3510 Dunhill Street, San Diego, CA 92121, USA.",Non-OADS,/arxiv_data1/oa_pdf/02/ad/main.PMC5443907.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/02/ad/main.PMC5443907.pdf
"To investigate this virotherapy-mediated immune response in an immunocompetent murine glioma model, we ﬁrst selected modi ﬁed Received 31 January 2017; accepted 2 May 2017; http://dx.doi.org/10.1016/j.omto.2017.05.001 .",OADS,/arxiv_data1/oa_pdf/48/92/main.PMC5443908.pdf
97 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/92/main.PMC5443908.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omto.2017.05.001 .,Non-OADS,/arxiv_data1/oa_pdf/48/92/main.PMC5443908.pdf
"8Thus, miRNAs participate in a variety of human dis- eases, including cancer.9Moreover, various miRNAs play critical roles in regulating resistance to chemotherapeutic drugs in human tumors.10,11 Received 26 February 2017; accepted 7 May 2017; http://dx.doi.org/10.1016/j.omtn.2017.05.006 .",OADS,/arxiv_data1/oa_pdf/49/81/main.PMC5443909.pdf
453 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/81/main.PMC5443909.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes one ﬁgure and ﬁve tables and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.,Non-OADS,/arxiv_data1/oa_pdf/49/81/main.PMC5443909.pdf
Direct link to deposited data https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96689 2.,OADS,/arxiv_data1/oa_pdf/a7/e5/main.PMC5443917.pdf
"http://dx.doi.org/10.1016/j.gdata.2017.05.012 Received 18 April 2017; Received in revised form 9 May 2017; Accepted 12 May 2017⁎Corresponding author at: UCSF, Cellular and Molecular Pharmacology, Box 2280, 600 16th St., San Francisco, CA 94143, USA.",OADS,/arxiv_data1/oa_pdf/a7/e5/main.PMC5443917.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/e5/main.PMC5443917.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/df/main.PMC5443919.pdf
http://dx.doi.org/10.1016/j.idcr.2017.03.011 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/df/main.PMC5443919.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  9  (2017)  25–27 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/f3/df/main.PMC5443919.pdf
"Reviewed  March  2014, available  at  http://www.who.int/mediacentre/factsheets/fs104/en/ .",Non-OADS,/arxiv_data1/oa_pdf/f3/df/main.PMC5443919.pdf
Available  at:  http://www.cdc.gov/tb/statistics/default.htm .,OADS,/arxiv_data1/oa_pdf/f3/df/main.PMC5443919.pdf
Available at:  http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_  eng.,OADS,/arxiv_data1/oa_pdf/f3/df/main.PMC5443919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/de/main.PMC5443920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/de/main.PMC5443920.pdf
http://dx.doi.org/10.1016/j.eucr.2017.04.014Urology Case Reports 13 (2017) 154 e157,Non-OADS,/arxiv_data1/oa_pdf/c2/de/main.PMC5443920.pdf
"http://dx.doi.org/10.1016/j.idcr.2017.04.017 Received 13 February 2017; Received in revised form 27 April 2017; Accepted 27 April 2017⁎Corresponding author at: Department of Infectious Disease, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.",Non-OADS,/arxiv_data1/oa_pdf/1c/5e/main.PMC5443922.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1c/5e/main.PMC5443922.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/5e/main.PMC5443922.pdf
"The following http://dx.doi.org/10.1016/j.gore.2017.05.003 Received 23 February 2017; Received in revised form 8 May 2017; Accepted 10 May 2017⁎Corresponding author at: Department of Obstetrics and Gynecology, University of Utah, 30N, 1900E, Suite 2B200, SLC, UT 84132, United States.",Non-OADS,/arxiv_data1/oa_pdf/66/28/main.PMC5443923.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/66/28/main.PMC5443923.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.04.020 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
"Park, Temporomandibular joint herniation into the external auditory canal, Laryngoscope 120 (11) (2010 Nov) 2284 e2288, http://dx.doi.org/10.1002/lary.21115 .",Non-OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
"17 (2) (2013 Sep) 90 e93, http://dx.doi.org/10.7874/ kja.2013.17.2.90 .",Non-OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
"34 (2016) 180 e186, http://dx.doi.org/10.1016/j.ijsu.2016.08.014 .",OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
"67 (8) (2009) 1747 e1751, http://dx.doi.org/10.1016/ j.joms.2008.12.065.6 .",OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
"81 (3) (2015) 339 e341, http://dx.doi.org/10.1016/j.bjorl.2015.02.001 .",OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
"125 (2011) 1279 e1281, http://dx.doi.org/10.1017/S0022215111002295 .K.H.",Non-OADS,/arxiv_data1/oa_pdf/ad/88/main.PMC5443924.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/44/main.PMC5443959.pdf
A  T1- weighted  axial  MRI  at  the  level  of  right  hepatic  vein  demonstrated http://dx.doi.org/10.1016/j.ijscr.2017.05.005 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7c/44/main.PMC5443959.pdf
"The three centers included were: Critical Care Unit, Hospital Dr. Enrique Erill, Escobar City, Buenos Aires State; Lysosomal Disease Unit, Neurosciences Center Los Manantiales, Gamma Group, Rosario City, Santa Fe State; and http://dx.doi.org/10.1016/j.ymgmr.2017.05.007 Received 14 March 2017; Received in revised form 18 May 2017; Accepted 18 May 2017⁎Corresponding author at: Centro de Neurociencias los Manantiales, Grupo Gamma.",Non-OADS,/arxiv_data1/oa_pdf/b1/12/main.PMC5443960.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/12/main.PMC5443960.pdf
e00306 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
"Dimethyl phthalate (DMP), Diethyl phthalate(DEP), Diisobutyl phthalate (DIBP), Di-n-butyl phthalate (DBP), Butyl benzyl Article No~e00306 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Extraction experiment Plastic materials were sent to Centre de technologie minérale et de plasturgie inc. (http://www.ctmp.ca ) to be ground into particles of 3 cm in diameter in order to obtain a homogeneous blend of material of approximately 100 g per group.,OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
"630-06-8), 17- Article No~e00306 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
"% Id.1Frequency2 Spouts/connectors Lateral line Main line Stearic acid 57-11-4 29, 7 1, 4, 8, 12 2, 5, 6 3, 7 2-(p-tolyl)pyridine 4467-06-05 36, 4 1 Caprolactam 105-60-2 48, 0 1, 4 1,1-Cyclopropanedimethanol, 2-methyl-a-phenyl- 108546-96-9 39, 7 4 Oleic acid 112-80-1 13, 9 2 Erucamide 112-84-5 65, 0 5, 6 7, 11 1-Oxaspiro[4.5]deca-6,9-dien-8-one, 7,9-bis(1,1-dimethylethyl)- 138345-00-3 50, 1 9, 10, 13 7 (1S,βS)-1,4,4a α,5,6,7,8,8a-Octahydro- β,2,5,5,8a β-pentamethyl-1 β-naphthalenepentanoic acid methyl ester 1438-55-7 37, 2 6 Octadecanoic acid 3-octadecyloxypropyl ester 17367-40-7 35, 4 3 Eicosamethylcyclodecasiloxane 18772-36-6 72, 0 3 Octadecyl 3-(3,5-di- tert-butyl-4-hydroxyphenyl)propionate 2082-79-3 88, 1 1, 4, 8, 12 2, 5, 6, 9, 10, 13 3, 7, 11, 14 2-(2H-Benzotriazol-2-yl)-4,6-di- tert-pentylphenol 25973-55-1 62, 4 1 2,4-Bis( α,α-dimethylbenzyl)phenol 2772-45-4 91, 8 1 L-Ascorbyl dipalmitate 28474-90-0 51, 2 1, 4, 8, 12 2, 5, 6 3, 7, 11, 14 Tri(2-ethylhexyl) trimellitate 3319-31-1 91, 7 2 3 1,3,5-Triazin-2-amine, 4,6-di-4-morpholinyl-N-2-propenyl- 332409-13-9 69, 7 2 3 4-Piperidinamine, 2,2,6,6-tetramethyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)- 34887-26-8 32, 9 6 3,3-Diphenylacrylonitrile 3531-24-6 46, 2 4 1,8-diazacyclotetradecane-2,7-dione 4266-66-4 91, 1 1, 4, 8, 12 Mono(2-ethylhexyl) phthalate 4376-20-9 20, 7 2 2-Cyclopentylcyclopentanone 4884-24-6 45, 5 4, 8, 12 Bis(2,2,6,6-tetramethyl-4-piperidyl)sebacate 52829-07-9 76, 6 1, 8 Myristic acid 544-63-8 36, 0 8, 12 (Continued ) Article No~e00306 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Sugarbush id Sample type (day)*Targeted plastic chemical residue (mg/L)** Di(2-ethylhexyl) phthalate (CAS 117-81-7) Octabenzone (CAS 1843-05-6) 01 Sap (flush) <LQ <LQ Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 02 Sap (flush) <LQ 6.80 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 03 Sap (flush) <LQ <LQ Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 04 Sap (flush) <LQ <LQ Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 05 Sap (flush) <LQ 0.01 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 06 Sap (flush) <LQ 0.03 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 07 Sap (flush) <LQ 87.15 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 08 Sap (flush) <LQ 35.68 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 09 Sap (flush) <LQ 0.48 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 10 Sap (flush) <LQ <LQ Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 11 Sap (flush) <LQ 0.92 Sap (1) <LQ <LQ Syrup (1) <LQ <LQ 12 Sap (flush) <LQ <LQ Sap (1) <LQ <LQ (Continued ) Article No~e00306 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Correlation of maple sap composition with bacterial and fungal communities determined by multiplex Article No~e00306 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
http://www.ec.gc.ca/ese- ees/FE291FCA-C989-4B8B-810C-5597F75147B4/RM%20Scope_BDTP_EN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
Article No~e00306 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00306 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/main.PMC5443961.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Quality measures Electronic health records Healthcare qualityChronic diseaseBlood pressure controlSeasonal variationPrimary carePublic healthPopulation health 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.04.007 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
http://www.cdc.gov/nccdphp/overview.htm .,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
http://www.cdc.gov/chronicdisease/states/pdf/new_york.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
NHLBI Morbidity and Mortality Chart Book 2012. http://www.nhlbi.nih.gov/research/reports/2012-mortality-chart-book.htm .,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
http://www.weather.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
http://www.phii.org/sites/default/ ﬁles/resource/pdfs/eHealth- strategy%20FINAL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
https://support.sas.,Non-OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
"NC: SAS Institute Inc 1st print- ing, January 2004. https://support.sas.com/documentation/onlinedoc/91pdf/sasdoc_ 91/stat_ug_7313.pdf .",OADS,/arxiv_data1/oa_pdf/5f/27/main.PMC5443962.pdf
A http://dx.doi.org/10.1016/j.mmcr.2017.05.002 Received 26 April 2017; Accepted 17 May 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/75/16/main.PMC5443963.pdf
This is an open access article under the CC  BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/16/main.PMC5443963.pdf
"INTRODUCTION Many genetic disorders, such as color blindness,1–4cystic ﬁbrosis,5,6 hemochromatosis,7,8hemophilia,9–15phenylketonuria,16,17polycystic kidney disease,18,19and sickle cell disease ( https://ghr.nlm.nih.gov/ condition/sickle-cell-disease ), are caused by simple point mutations.",Non-OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5443964.pdf
"In this model system, the expression ofWT MRP1/ABCC1 mainly forms mature protein with an apparent Received 23 February 2017; accepted 5 May 2017; http://dx.doi.org/10.1016/j.omtn.2017.05.005 .",OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5443964.pdf
429 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5443964.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2017.05.005 .,Non-OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5443964.pdf
"While DTI has demonstrated sensitivity to changes in tissue microstructure, such as demyelination and axonal loss ( Budde et al., http://dx.doi.org/10.1016/j.nicl.2017.05.010 Received 17 March 2017; Received in revised form 4 May 2017; Accepted 17 May 2017⁎Corresponding author at: 1161 21st Avenue South, Nashville, TN, USA.",Non-OADS,/arxiv_data1/oa_pdf/39/10/main.PMC5443965.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/10/main.PMC5443965.pdf
NODDI ﬁtting was performed using the NODDI MATLAB Toolbox (http://nitrc.org/projects/noddi_tolbox ).,OADS,/arxiv_data1/oa_pdf/39/10/main.PMC5443965.pdf
Incorporating http://dx.doi.org/10.1016/j.jare.2017.05.006 2090-1232/ /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.,Non-OADS,/arxiv_data1/oa_pdf/dd/56/main.PMC5443966.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of Cairo University.,Non-OADS,/arxiv_data1/oa_pdf/dd/56/main.PMC5443966.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/56/main.PMC5443966.pdf
Available from: < http://www.aapd.org/media/ policies_guidelines/g_cariesriskassessment.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/dd/56/main.PMC5443966.pdf
e00301 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Each profile was subsequently digitized and Article No~e00301 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Differences in level from the water edge and the base of the volcanic scarp is about 5 m. Article No~e00301 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
September 2005 megadike emplacement in the Article No~e00301 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
Article No~e00301 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00301 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC5443967.pdf
17 Received 28 November 2016; accepted 3 May 2017; http://dx.doi.org/10.1016/j.omtn.2017.05.004 .,Non-OADS,/arxiv_data1/oa_pdf/7b/27/main.PMC5443968.pdf
439 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/27/main.PMC5443968.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seven ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2017.,Non-OADS,/arxiv_data1/oa_pdf/7b/27/main.PMC5443968.pdf
"Biophysical Journal 112, 2231–2243, May 23, 2017 2231http://dx.doi.org/10.1016/j.bpj.2017.04.011 /C2112017 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/1b/0f/main.PMC5443973.pdf
V memimages were ﬂat-ﬁeld corrected using the software MetaMorph (Mo- lecular Devices; https://www.moleculardevices.com/systems/metamorph- research-imaging ).,OADS,/arxiv_data1/oa_pdf/1b/0f/main.PMC5443973.pdf
Predictive modeling A quantitative model of the stochastic branching between cryptic and DH morphologies across multiple rounds of regeneration was implemented us- ing JavaScript ( https://www.javascript.com/ ) and the HTML5 canvas func- tion.,OADS,/arxiv_data1/oa_pdf/1b/0f/main.PMC5443973.pdf
http://dx.doi.org/10.4172/2329-6577.,Non-OADS,/arxiv_data1/oa_pdf/1b/0f/main.PMC5443973.pdf
"Biophysical Journal 112, 2051–2055, May 23, 2017 2051http://dx.doi.org/10.1016/j.bpj.2017.04.018 /C2112017 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/29/d3/main.PMC5444008.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
"Received February 22, 2017 /C15Accepted March 15, 2017 /C15Available online 18 March 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.003 Original Article 494MOLECULAR METABOLISM 6 (2017) 494 e502/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/main.PMC5444017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
"Received February 21, 2017 /C15Revision received March 10, 2017 /C15Accepted March 15, 2017 /C15Available online 28 March 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.004 Original Article 482MOLECULAR METABOLISM 6 (2017) 482 e493/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC5444018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
"Received February 27, 2017 /C15Revision received March 16, 2017 /C15Accepted March 18, 2017 /C15Available online 31 March 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.006 Original Article MOLECULAR METABOLISM 6 (2017) 503 e511/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
http://dx.doi.org/10.1056/ NEJMoa1603827(0) [null].,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC5444019.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)PTK2B –Tau interaction in Alzheimer ’s disease P Dourlen et al 883 Molecular Psychiatry (2017), 874 –883",Non-OADS,/arxiv_data1/oa_pdf/3c/6e/mp201659a.PMC5444024.pdf
"Measuring the relationship between Ahi1 expression and fear learning across the BXD recombinant inbred strains We employed GeneNetwork (http://www.genenetwork.org), a website that integrates data sets of complex traits with software for quantifyingcorrelations among traits.33,39The data sets include both biological traits — neuroanatomical, pharmacological, and behavioral —and microarray-based gene expression data from numerous brain regions across recombinantinbred (RI) lines, which were generated by crosses of C57BL/6J and DBA/2(BXD) inbred strains.",OADS,/arxiv_data1/oa_pdf/ee/c8/mp201629a.PMC5444025.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Alterations in expression of a neurodevelopmental gene exert A Lotan et al 899 Molecular Psychiatry (2017), 884 –899",Non-OADS,/arxiv_data1/oa_pdf/ee/c8/mp201629a.PMC5444025.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
"Received March 3, 2017 /C15Revision received March 16, 2017 /C15Accepted March 22, 2017 /C15Available online 29 March 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.008 Original Article 512MOLECULAR METABOLISM 6 (2017) 512 e523/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a2/main.PMC5444075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
"Received January 20, 2017 /C15Revision received March 16, 2017 /C15Accepted March 21, 2017 /C15Available online 25 March 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.007 Original Article 524MOLECULAR METABOLISM 6 (2017) 524 e534/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
602587 ( http://www.hum-en.eu/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC5444078.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/eor-2-28.PMC5444079.pdf
https://www.nice.org.uk/guidance/cg177 (date last accessed 10 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/eor-2-28.PMC5444079.pdf
https://www.nice.org.uk/guidance/ipg491 (date last accessed 10 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/eor-2-28.PMC5444079.pdf
"METHODS Data were obtained from national, open-access databases that are organised and maintained by the government.DATASUS is the online portal for an administrative data- base Sistema de Informações Hospitalares/Sistema Único de Saúde (SIH/SUS) (http://www2.datasus.gov.br).",OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
11Instituto Brasileiro de Geogra ﬁa e Estatistica (IBGE) is the national geographic and statistical database (http://www.ibge.gov.br).,OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
"Using proprietary software from Redivis (https:// http://www.redivis.com), the geographic location ofthese hospitals was mapped and 2-hour distance was cal- culated.",OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
"Finally, the geographic area of the map generated to simulate2-hour access was compared against the population density, from WorldPop (http://www.worldpop.org.uk), to calculate the percentage of the population with2-hour access to an included facility.",OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
http://portal.cfm.org.,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
2015. http://www.caixa.gov.,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
2015. http://media.wix.com/ugd/346076_ 26d4a927dc074b128be2e61f34e14018.pdf (accessed 2/2/2016).,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
http://www.maismedicos.gov.br/conheca-programa.,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
http://www.ans.gov.br/aans/noticias-ans/numeros-do-setor/3030-dados-do-setor-de-saude-suplementar.,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
Secondary Razão entre óbitos informados e estimados —F.11 –2006 10/1/2015 2006. http://fichas.ripsa.org.br/2006/F-11/?l=en_US.,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
2017. http://www.who.int/surgery/publications/imeesc/en/.,Non-OADS,/arxiv_data1/oa_pdf/21/b2/bmjgh-2016-000226.PMC5444087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
"Received February 18, 2017 /C15Revision received March 17, 2017 /C15Accepted March 24, 2017 /C15Available online 8 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.011 Original Article MOLECULAR METABOLISM 6 (2017) 459 e470/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1016/j.cmet.2014.12.020 .,OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
Current Diabetes Reports 14(11):551. http://dx.doi.org/ 10.1007/s11892-014-0551-8 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/ng.2870 .,OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/ng.3768 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1074/jbc.M110.215822 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1007/s00125-015-3734-1 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1371/journal.pone.0011499 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1177/002215540104900412 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1016/j.tig.2013.05.010 .,OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1126/science.aaa0355 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/ 10.1186/gb-2009-10-11-r130 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1172/JCI58447 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/nm.3828 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/ 10.1186/gb-2013-14-4-r36 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1093/nar/gkt214 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
Genome Biology 15(12):550.http://dx.doi.org/10.1186/s13059-014-0550-8 .,OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1074/jbc.M507496200 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.2337/db07-1469 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/ nm.4054 .,OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1210/me.2015-1227 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.2337/db15-0280 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
Diabetologia 58(1):31 e36.http://dx.doi.org/10.1007/s00125-014-3405-7 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/nature05616 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/ tpj.2010.22 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/ 10.2337/db09-0551 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/ 10.1038/ng.2915 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1074/jbc.C300063200 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1038/nature13425 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.2337/db16-0361 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1136/gutjnl-2015-310625 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
"Cancer Causes & Control, 1e15.http://dx.doi.org/10.1007/s10552-016-0741-6 .",Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1371/ journal.pone.0062438 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/ 10.1177/1932296814553622 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/10.1007/s00125- 015-3553-4 .,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
http://dx.doi.org/ 10.1126/science.1209038 .Original Article 470MOLECULAR METABOLISM 6 (2017) 459 e470/C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/cc/main.PMC5444093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
"Abbreviations: GPCR, G protein-coupled receptor; PGE 2, prostaglandin E 2; EP1-4, E-Prostanoid Receptors 1-4; PLC, phospholipase C; IP 3, inositol 1,4,5-trisphosphate; DAG, diacylglycerol; PL, placental lactogen; PT, pertussis toxin; PKA, protein kinase A; COX-2, cyclooxygenase-2 Received February 13, 2017 /C15Revision received March 30, 2017 /C15Accepted April 3, 2017 /C15Available online 5 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.002 Original Article 548MOLECULAR METABOLISM 6 (2017) 548 e559 Published by Elsevier GmbH.",Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
The remainder of donor islets (n ¼24 donors) was obtained from islet isolation centers participating in the Integrated Islet Distribution Pro- gram ( http://iidp.coh.org/ ).,OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/a0/main.PMC5444094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
"Received March 8, 2017 /C15Revision received March 17, 2017 /C15Accepted March 30, 2017 /C15Available online 12 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.013 Brief Communication 574MOLECULAR METABOLISM 6 (2017) 574 e584/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/main.PMC5444095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
"Abbreviations: T2D, type 2 diabetes; mTOR, mammalian target of Rapamycin; TORC1, TORC2, target of Rapamycin complex 1, 2; AA, amino acids Received December 12, 2016 /C15Revision received March 14, 2017 /C15Accepted March 22, 2017 /C15Available online 28 March 2017 http://dx.doi.org/10.1016/j.molmet.2017.03.010 Original Article 560MOLECULAR METABOLISM 6 (2017) 560 e573 Published by Elsevier GmbH.",Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
"Different parameters (total number, Ki67, Pdx1, and Ngn3) were co unted using ImageJ software version 1.50 g [25] and the Image-Based Tool for Counting Nuclei (ITCN) plug-in version 1.6 from the Center for Bio-Image Infor- matics ( http://www.bioimage.ucsb.edu/automatic-nuclei-counter- plug-in-for-imagej ) after contrast enhancement using theEnhance Local Contrast (CLAHE) http://imagej.net/Enhance_Local_ Contrast_(CLAHE) tool for ImageJ, “Contrast limited adaptive histogram equalization ”,Graphics gems IV ,A c a d e m i cP r e s s Professional, Inc., pp.",OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/98/main.PMC5444096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
"Abbreviations: ACC, acetyl-CoA carboxylase; ACC DKI, ACC1-S79A and ACC2-S212A double knock-in; AKT, protein kinase B; AMPK, AMP-activated protein kinase; BAT, brown adipose tissue; COX, cytochrome coxidase; CreERT2, Cre recombinase eestrogen receptor T2; CNS, central nervous system; DAG, diacylglycerol; FFA, free fatty acid; FGF21, ﬁbroblast growth factor 21; FGFR1c, ﬁbroblast growth factor receptor 1c; GTT, glucose tolerance test; gWAT, gonadal white adipose tissue; H&E, hematoxylin and eosin; HFD, high fat diet; i b1b2AKO, inducible AMPK b1b2 adipocyte knockout; ITT, insulin tolerance test; iWAT, inguinal white adipose tissue; KLB, beta klotho; RER, respiratory exchange ratio; mTORC1, mammalian target of rapamycin; NAFLD, non-alcoholic fatty liver disease; TAG, triacylglycerol; UCP1, uncoup ling protein 1; WAT, white adipose tissue; WT, wildtype Received March 1, 2017 /C15Revision received March 28, 2017 /C15Accepted April 2, 2017 /C15Available online 5 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.001 Original Article MOLECULAR METABOLISM 6 (2017) 471 e481/C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1172/ JCI23606 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Scienti ﬁc Reports 5:11382. http://dx.doi.org/10.1038/srep11382 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Cell Metabolism 17(5):790 e 797. http://dx.doi.org/10.1016/j.cmet.2013.03.019 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1111/joim.12580 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
"http://dx.doi.org/10.1126/scitranslmed.3002669 , 113ra126.",Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1016/j.cmet.2016.02.001 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/ 10.1016/j.cmet.2013.08.005 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Cell Metabolism 23(3):441 e 453. http://dx.doi.org/10.1016/j.cmet.2016.01.006 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Molecular Metabolism 2(1):31 e37.http://dx.doi.org/10.1016/ j.molmet.2012.08.007 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/ 10.1016/j.celrep.2015.04.046 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1016/j.celrep.2015.10.021 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Molecular Metabolism 4(9):605 e609 http://dx.doi.org/10.1016/j.molmet.2015.06.008 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Nature Medicine 19(9):1147 e 1152. http://dx.doi.org/10.1038/nm.3249 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1152/physrev.00011.2008 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1016/j.cmet.2015.09.009 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1016/j.cellsig.2015.02.008 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1016/j.cmet.2015.09.001 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1016/j.cmet.2016.06.006 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/ 10.1113/jphysiol.2007.128652 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/ 10.1210/en.2013-1191 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1210/en.2008-0816 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1210/en.2009-0221 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1172/JCI67353 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.2337/db10-0193 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1038/nm.3372 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1371/ journal.pone.0040164 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1074/jbc.M110.102434 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.2337/db13-1398 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1073/ pnas.1105062108 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/10.1038/nm788 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Nature 510(7503):84 e91.http://dx.doi.org/10.1038/nature13478 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
Cell Reports 17(1):29 e36.http://dx.doi.org/ 10.1016/j.celrep.2016.08.086 .,OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
http://dx.doi.org/ 10.1126/science.1215327 .,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/0d/main.PMC5444097.pdf
"282 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/5a/ntw188.PMC5444098.pdf
2016. http://savutonsuomi.fi/en/.,Non-OADS,/arxiv_data1/oa_pdf/4d/5a/ntw188.PMC5444098.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
"Received March 20, 2017 /C15Revision received April 2, 2017 /C15Accepted April 4, 2017 /C15Available online 11 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.003 Brief Communication MOLECULAR METABOLISM 6 (2017) 585 e593/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/main.PMC5444109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
"Received April 7, 2017 /C15Accepted April 19, 2017 /C15Available online 22 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.005 Brief Communication 594MOLECULAR METABOLISM 6 (2017) 594 e601/C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7c/main.PMC5444110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
"Abbreviations: AT2, aldrithiol; CMV, cytomegalovirus; Dz, diazoxide; DTT, dithiotreitol; FCCP, carbonyl cyanide-p-tri ﬂuoromethoxyphenylhydrazone; GSIS, glucose stimulation of insulin secretion; GRX1, glutaredoxin 1; [Ca2þ]i, intracellular Ca2þconcentration; IDH, isocitrate dehydrogenase; KRB, Krebs solution; ME, malic enzyme; WT, wild-type; NNT, nicotinamide nucleotide transhydrogenase; OCR, oxygen consumption rate Received February 28, 2017 /C15Revision received April 10, 2017 /C15Accepted April 18, 2017 /C15Available online 21 April 2017 http://dx.doi.org/10.1016/j.molmet.2017.04.004 Original Article MOLECULAR METABOLISM 6 (2017) 535 e547/C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/main.PMC5444111.pdf
Available from: http://www.ncrpindia.,Non-OADS,/arxiv_data1/oa_pdf/86/8a/IJA-61-369.PMC5444213.pdf
Available from: https://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/46/81/IJA-61-373.PMC5444214.pdf
Available from: http://www.psychiatrictimes.com/ electroconvulsive-therapy/ketamine-anesthesia-electroconvul sive-therapy/page/0/2.,Non-OADS,/arxiv_data1/oa_pdf/46/81/IJA-61-373.PMC5444214.pdf
Available from: http://www.aagbi.org/ sites/default/files/anaphylaxis03.pdf.,OADS,/arxiv_data1/oa_pdf/4e/fb/IJA-61-387.PMC5444216.pdf
Visit http://www.njisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/4e/fb/IJA-61-387.PMC5444216.pdf
Visit http://www.cjisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/42/55/IJA-61-393.PMC5444217.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/28/86/IJA-61-404.PMC5444219.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/28/86/IJA-61-404.PMC5444219.pdf
Available  from: http://www.ijaweb.org/text.asp?2007/51/5/434/61178.,Non-OADS,/arxiv_data1/oa_pdf/dd/44/IJA-61-444.PMC5444230.pdf
Available  from: http://www.ijaweb.org/text.asp?2007/51/5/434/61178.,Non-OADS,/arxiv_data1/oa_pdf/41/37/IJA-61-446.PMC5444231.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/8e/85/eor-2-1.PMC5444233.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/03/6a/eor-2-13.PMC5444234.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.Table 2.",Non-OADS,/arxiv_data1/oa_pdf/6e/c5/eor-2-21.PMC5444235.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/39/31/eor-2-7.PMC5444236.pdf
http://bscos.org.uk/resources/Downloads/  Blue-Book-Infection.pdf (date last accessed 05 December 2016).,Non-OADS,/arxiv_data1/oa_pdf/39/31/eor-2-7.PMC5444236.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/7e/ckw100.PMC5444238.pdf
[26/03/2014]; Available at: http://www.cvz.nl/ verzekering/onverzekerbare+vreemdelingen.,Non-OADS,/arxiv_data1/oa_pdf/2f/7e/ckw100.PMC5444238.pdf
"Published by Oxford University Press and Sixth Afﬁliated Hospital of Sun Yat-Sen University This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/2d/gox001.PMC5444240.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/f9/bbw022.PMC5444242.pdf
A colour version of this ﬁgure is available at BIB online: https://academic.oup.com/bib.The BRaliBase dent |307,Non-OADS,/arxiv_data1/oa_pdf/c8/f9/bbw022.PMC5444242.pdf
A colour version of this ﬁgure is available at BIB online: https://academic.oup.com/bib.308 | L€owes et al.,Non-OADS,/arxiv_data1/oa_pdf/c8/f9/bbw022.PMC5444242.pdf
A colour version of this ﬁgure is available at BIB online: https://academic.oup.com/bib.The BRaliBase dent |309,Non-OADS,/arxiv_data1/oa_pdf/c8/f9/bbw022.PMC5444242.pdf
Supplementary data Supplementary data are available online at http://bib.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/c8/f9/bbw022.PMC5444242.pdf
A colour version of this ﬁgure is available at BIB online: https://academic.oup.com/bib.310 | L€owes et al.,Non-OADS,/arxiv_data1/oa_pdf/c8/f9/bbw022.PMC5444242.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/c5/bbw023.PMC5444249.pdf
The averaged read quality was obtained using fastqc version 0.11.4 (http://www.bioinformatics.babraham.ac.,OADS,/arxiv_data1/oa_pdf/b5/c5/bbw023.PMC5444249.pdf
"Smc6, Nse4 and ‘No tag (negative control)’ ChIP-seq data for a 100-bp bin with gene annotation obtained from the Saccharomyces Genome Database (http://www.yeastgenome.org).",OADS,/arxiv_data1/oa_pdf/b5/c5/bbw023.PMC5444249.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
"Department of Basic Education (2006) Rights and Responsibilities of Parents, Learners and Public Schools: Public School Policy Guide 2005. http://www.education.",Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
http://www.education.gov.za/LinkClick.aspx?ﬁleticket ¼p8% 2F3b6jxko0%3D&tabid ¼358&mid ¼1802 (last accessed 2 September 2016).,Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
http://www.education.gov.za/Portals/0/ Documents/Policies/Norms%20and%20Standards%20on% 20School%20Infrastructure.pdf?ver ¼2015-02-04-090131- 173 (last accessed 2 September 2016).Department of Basic Education (2015) National Education Infrastructure Management System (NEIMS) Standard Reports as at 12 May 2015. http://www.education.gov.za/LinkClick.aspx?ﬁleticket ¼X36y4Qhe5E0%3d&tabid ¼358&mid ¼1994 (last accessed 2 September 2016).,Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
http://www.biomedcentral.com/1471-2458/10/43 (last ac- cessed 2 September 2016).,Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
http://www.schools-for-health.eu/uploads/ﬁles/English_South African health promoting schools monitoring questionnaire 269,Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
"The Fourth International Conference on Health Promotion:New Players for a New Era - Leading Health Promotion intothe 21st Century, meeting in Jakarta from 21 to 25 July 1997. http://www.who.int/healthpromotion/conferences/ previous/jakarta/declaration/en/ (last accessed 2 September2016).",Non-OADS,/arxiv_data1/oa_pdf/c5/88/daw074.PMC5444250.pdf
"Published by Oxford University Press and Sixth Afﬁliated Hospital of Sun Yat-Sen University This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/f6/gow041.PMC5444255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/b0/ckw114.PMC5444256.pdf
"Published by Oxford University Press and Sixth Afﬁliated Hospital of Sun Yat-Sen University This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/gow047.PMC5444258.pdf
"Published by Oxford University Press and Sixth Afﬁliated Hospital of Sun Yat-Sen University This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/96/gow045.PMC5444259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/08/cww107.PMC5444261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/ee/bbw016.PMC5444266.pdf
"Methods TCGA data The study uses 102 GBM tumor and 4 normal brain (organ-spe- cific control) samples from TCGA (http://cancergenome.nih.gov),in which both RNA-seq and exon-array transcriptome quantifica- tion were performed ( Supplementary Table S1 ).",OADS,/arxiv_data1/oa_pdf/f7/ee/bbw016.PMC5444266.pdf
"The raw expression files, down-loaded from the Cancer Genomics Hub (https://cghub.ucsc.edu/), were used as the starting point for all subsequent analyses.",OADS,/arxiv_data1/oa_pdf/f7/ee/bbw016.PMC5444266.pdf
Supplementary data Supplementary data are available online at http://bib.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/f7/ee/bbw016.PMC5444266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attributio n Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any mediu m, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/56/hyw187.PMC5444320.pdf
"313 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/ce/hyw209.PMC5444335.pdf
http://www.nccn.org/profession als/physician_gls/pdf/colon.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/ce/hyw209.PMC5444335.pdf
http://www.nccn.org/professionals/ physician_gls/pdf/rectal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/ce/hyw209.PMC5444335.pdf
"213 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/f0/hyw189.PMC5444337.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/c4/11/hgv201718.PMC5444338.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017Case report on early onset of Fazio-Londe syndrome MA Hossain et al 3 Ofﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2017) 17018",Non-OADS,/arxiv_data1/oa_pdf/c4/11/hgv201718.PMC5444338.pdf
"MeSH Keywords:  Endothelial Cells • Heart Transplantation • Muscle, Smooth, Vascular •   Transient Receptor Potential Channels  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901920Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Physiology, Dalian Medical University, Dalian, Liaoning, P.R.",Non-OADS,/arxiv_data1/oa_pdf/bf/be/medscimonit-23-2340.PMC5444344.pdf
2014;4(3):1-3. http://dx.doi.org/10.4322/acr.2014.021,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2005; 57(4):489- 94. http://dx.doi.org/10.1002/ ana.20426.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2007; 36(1):64- 8.  http://dx.doi.org/10.1016/j.neuroimage.2007.02.039.,OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2012; 379(9811):136- 42. http://dx.doi.org/10.1016/ S0140-6736(11)61483-9.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2012; 156(2):123- 30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
1983; 308(17):1000- 5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2012; 28(7):1807- 22. http://dx.doi.org/10.1007/ s10554-012-0012-x.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2009; 250( 3):897- 904. http://dx.doi.org/10.1148/ radiol.2503080421.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/autopsy-04-03001.PMC5444391.pdf
2014;4(3):5-7.  http://dx.doi.org/10.4322/acr.2014.022 Picture provided by Dr. Stephen A. Geller - personal archive.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
http://dx.doi.org/10.1007/s00105-003-0675-2.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
1987; 316(21):1348- 9. http://dx.doi.org/10.1056/ NEJM198705213162120.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2013; 11(1):151. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2005; 3(1):13. http://dx.doi.org/10.1186/1477-7819-3- 13.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2005; 3(1):4. http://dx.doi.org/10.1186/1477-7819-3-4.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2010; 47(1):65- 9. http://dx.doi.org/10.4103/0019- 509X.58862.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2013; 17(10):1832- 5. http://dx.doi.org/10.1007/ s11605-013-2257-7.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
Available from: http://ispub.com/IJGE/3/1/10047 9.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
"1997; 174(6):619- 22, discussion 622-3. http://dx.doi.org/10.1016/S0002- 9610(97)00178-5.",Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
1966; 19(10):1113- 7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2014; 35(1):73- 4. http://dx.doi.org/10.1016/j.revmed.2013.04.006.,OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
1965; 18(7):907- 15. http://dx.doi.org/10.1002/1097-0142(196507)18:7<907::AID- CNCR2820180721>3.0.CO;2-U.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
1984; 10(4):610- 5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
1999; 94(7):1949- 50. http://dx.doi.org/10.1111/j.1572- 0241.1999.01236.x.,Non-OADS,/arxiv_data1/oa_pdf/58/92/autopsy-04-03005.PMC5444392.pdf
2014;4(3):9-11. http://dx.doi.org/10.4322/acr.2014.023,Non-OADS,/arxiv_data1/oa_pdf/c4/10/autopsy-04-03009.PMC5444393.pdf
2014; 4(2):9-20. http://dx.doi.org/10.4322/ acr.2014.012.Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/10/autopsy-04-03009.PMC5444393.pdf
1987; 317(13):781- 7.  http://dx.doi.org/10.1056/NEJM198709243171301.,Non-OADS,/arxiv_data1/oa_pdf/c4/10/autopsy-04-03009.PMC5444393.pdf
2009; 30(1):36-9.  http://dx.doi.org/10.1097/PAF.0b013e3181873835.,Non-OADS,/arxiv_data1/oa_pdf/c4/10/autopsy-04-03009.PMC5444393.pdf
"2014;4(3):13-20. http://dx.doi.org/10.4322/acr.2014.024 ABSTRACT Sphingomonas paucimobilis is an aerobic Gram-negative bacillus that, although rare in humans, most commonly infects  immunocompromised and hospitalized patients.",Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
http:// http://dx.doi.org/10.4067/S0716-10182013000100007.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2009; 15(1):133- 4. http://dx.doi.org/10.3201/ eid1501.080465.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2011; 8(7):537- 9. http://dx.doi.org/10.7150/ijms.8.537.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1977; 27(2):133- 46.  http://dx.doi.org/10.1099/00207713-27-2-133.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1990; 34(2):99-119.  http://dx.doi.org/10.1111/j.1348-0421.1990.tb00996.x.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1998; 392(9):557- 8.  http://dx.doi.org/10.1038/33302.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1981; 246(9):985- 7. http://dx.doi.org/10.1001/ jama.1981.03320090047030.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
http://dx.doi.org/10.1016/j.patbio.2006.03.001.,OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1996; 32(3):199- 206. http://dx.doi.org/10.1016/S0195- 6701(96)90146-2.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2008; 10(2):142 -4.  http://dx.doi.org/10.1111/j.1399-3062.2007.00262.x.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2005; 33(2):93-5. http://dx.doi.org/10.1007/ s15010-005-4048-x.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2008; 29(10):990- 2. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1998; 26(3):676- 81. http://dx.doi.org/10.1086/514595.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2010; 43(1): 35-42.  http://dx.doi.org/10.1016/S1684-1182(10)60005-9.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2011 ;48(9):723-5. http://dx.doi.org/10.1007/s13312- 011-0114-x.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1991; 13(6):1072- 6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2010; 75(3):153- 7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
2011; 44(4):289- 95. http://dx.doi.org/10.1016/j.jmii.2010.08.007.,OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
1982; 712(3):571- 5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/autopsy-04-03013.PMC5444394.pdf
"2014;4(3):21-30. http://dx.doi.org/10.4322/acr.2014.025 CASE REPORT A male newborn with 38 weeks and 6 days of  gestational age, weighing 3410 g with an Apgar score  of 10/10/10, was born through an uneventful cephalic  presentation vaginal delivery after an oxytocin-induced labor.",Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2014; 11(6):323- 34. http://dx.doi.org/10.1038/nrcardio.2014.34.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2001; 120( 4):1368- 71. http://dx.doi.org/10.1378/ chest.120.4.1368.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
http://dx.doi.org/10.1590/ S0102-76382004000100009.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2014; 11(6):323- 34. http://dx.doi.org/10.1038/nrcardio.2014.34.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2006; 16(4):339- 68. http://dx.doi.org/10.1017/S1047951106000291.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
1990; 10(6):931- 43.  http://dx.doi.org/10.3109/15513819009064728.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2013; 17(2):105- 16. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2012; 59(1 Suppl):S1- 42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2005; 6(5):687- 93. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2004; 109(19):2326- 30. http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2014; 129( 3):285- 92. http://dx.doi.org/10.1161/ CIRCULATIONAHA.113.003711.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2001; 103( 9):1269- 73. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
1999; 41(6):728- 32.  http://dx.doi.org/10.1046/j.1442-200x.1999.01154.x .,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2011; 21(S2  Suppl 2):148- 58. http://dx.doi.org/10.1017/ S1047951111001739.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
1983; 308(1):23- 6. http://dx.doi.org/10.1056/ NEJM198301063080106.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
http://dx.doi.org/10.1590/S0066-782X2007000300016.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2014; 46(2):e51- 4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2006 ;131(1):163- 171. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
2007 ;84(4):1294- 300. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
"2008; 85(6):2063- 70, discussion 2070-1. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c5/5d/autopsy-04-03021.PMC5444395.pdf
"2014;4(3):31-7.  http://dx.doi.org/10.4322/acr.2014.026 ABSTRACT Although the Pseudomonas aeruginosa infection is well known and frequently found in hospitals and nursing care facilities,  many cases are also reported outside these boundaries.",Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2000; 31(6):1349- 56. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2011; 39(3):265- 9. http://dx.doi.org/10.1007/s15010-011-0096-6.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2014; 64(5):224- 30. http://dx.doi.org/10.1111/ pin.12162.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2001; 42(3):190- 3. http://dx.doi.org/10.1007/ s002840010202.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2007 ;84(4):273-8. http://dx.doi.org/10.1097/ OPX.0b013e3180439c3e.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2002; 162(16):1849- 58. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1999; 160(2):397- 405. http://dx.doi.org/10.1164/ajrccm.160.2.9808045.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1990; 69(5):307- 16.  http://dx.doi.org/10.1097/00005792-199009000-00004.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1996; 51(10):1010- 6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1991 ;46(7):508-11.  http://dx.doi.org/10.1136/thx.46.7.508.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2010; 35(3):598- 605. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2002; 165(6):766- 72. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2003; 36(3):e55- 7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2005; 11(5):415- 8. http://dx.doi.org/10.1111/ j.1469-0691.2005.01102.x.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1996; 275(2):134- 41.  http://dx.doi.org/10.1001/jama.1996.03530260048030.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1992; 18(7):430- 2. http://dx.doi.org/10.1007/ BF01694348.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1983; 250(15):2027- 9.  http://dx.doi.org/10.1001/jama.1983.03340150069030.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2011; 79(11):4730- 8. http://dx.doi.org/10.1128/ IAI.05371-11.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1991; 100(3):628- 30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2012; 51(17):2473- 8.  http://dx.doi.org/10.2169/internalmedicine.51.7596.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1999; 53(12):620- 5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
1995; 11(1):1-7. http://dx.doi.org/10.1007/ BF01719939.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
2005; 83(1):155- 65. http://dx.doi.org/10.1093/toxsci/ kfi007.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/autopsy-04-03031.PMC5444396.pdf
"2014;4(3):39-46. http://dx.doi.org/10.4322/acr.2014.027 ABSTRACT Septic pelvic thrombophlebitis (SPT) is a rare and severe entity, which may occur after abortion, delivery, gynecological  diseases, or surgeries.",Non-OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
1999; 181(1):143- 8. http://dx.doi.org/10.1016/S0002- 9378(99)70450-3.,Non-OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
2010; 50(3):299- 301. http://dx.doi.org/10.1111/j.1479- 828X.2010.01159.x.,Non-OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
2006; 24(5):636- 7. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
1981; 36(2):57- 66. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
2012; 67(9):893 -8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
1999; 24(1):85-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
"Available from: http://www2.massgeneral.org/id/hms/handouts2002/es.pdf Conflict of interest: None Submitted on: July 16, 2014   Accepted on: September 10, 2014 Correspondence  Divisão de Clínica Médica Hospital Universitário da Universidade de São Paulo Av.",Non-OADS,/arxiv_data1/oa_pdf/49/09/autopsy-04-03039.PMC5444397.pdf
"2014;4(3):47-52. http://dx.doi.org/10.4322/acr.2014.028 ABSTRACT Small-cell ovarian carcinoma (SCOC) is a rare and aggressive neoplasia, predominantly affecting young women who are  frequently first diagnosed with advanced stage disease.",Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
1994; 18(11):1102- 16.  http://dx.doi.org/10.1097/00000478-199411000-00004.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2006; 100( 2):233- 8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
1982; 49(1):188- 97. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2010; 102(Suppl  1):S2- 9. http://dx.doi.org/10.1038/sj.bjc.6605599.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
1991; 83(12):855- 61. http://dx.doi.org/10.1093/ jnci/83.12.855.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2002; 20(24):4665- 72. http://dx.doi.org/10.1200/JCO.2002.12.111.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2009; 19(3):348- 53. http://dx.doi.org/10.1111/IGC.0b013e3181a1a116.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
1995; 56(3):452- 5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
1985; 22(2):233- 9. http://dx.doi.org/10.1016/0090- 8258(85)90031-9.,OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2007; 18(12):1985- 9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2011; 28(3):766- 70. http://dx.doi.org/10.1007/s12032- 010-9509-0.,Non-OADS,/arxiv_data1/oa_pdf/13/a0/autopsy-04-03047.PMC5444398.pdf
2014;4(3):53-8. http://dx.doi.org/10.4322/acr.2014.029 ABSTRACT Cardiac angiosarcoma is a rare entity.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1999; 68(4):1236- 41.  http://dx.doi.org/10.1016/S0003-4975(99)00700-6.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2012; 21(5):436- 43. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1996; 77(1):107. http://dx.doi.org/10.1016/ S0002-9149(97)89149-7.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2001; 85(2):218- 22. http://dx.doi.org/10.1136/ heart.85.2.218.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2007; 19(10):748- 56. http://dx.doi.org/10.1016/j.clon.2007.06.009.,OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2009; 2009: 1-4. http://dx.doi.org/10.1155/2009/591512.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1968; 21(3):413- 9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2005; 53(1):1-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1995; 46(2):123- 8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1999; 19(6):1421- 34. http://dx.doi.org/10.1148/ radiographics.19.6.g99no031421.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2000; 15(2):186- 91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1986; 57(4):852- 9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2009; 193( 2):377- 87. http://dx.doi.org/10.2214/ AJR.08.1895.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2010; 35(2):134- 7.  http://dx.doi.org/10.1097/RLU.0b013e3181c7c0a2 .,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2013; 22(6):424- 7. http://dx.doi.org/10.1016/j.carpath.2013.04.006.,OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1997; 63(4):1160- 1. http://dx.doi.org/10.1016/S0003- 4975(96)01395-1.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1997; 62(3):273- 5. http://dx.doi.org/10.1016/S0167- 5273(97)00259-3.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2002; 21(10):1135- 9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2012; 19(8):2707- 15. http://dx.doi.org/10.1245/s10434-012-2334-2.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2007; 18(12):2030- 6. http://dx.doi.org/10.1093/annonc/ mdm381.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1998; 22(6):683- 97. http://dx.doi.org/10.1097/00000478- 199806000-00005.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
1999; 86(10):2034- 7. http://dx.doi.org/10.1002/ (SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P .,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
2011 ;80(2):257-63. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/9e/autopsy-04-03053.PMC5444399.pdf
"2014;4(3):59-63. http://dx.doi.org/10.4322/acr.2014.030 ABSTRACT Although the incidence of microperforated hymen (MH) is unclear, this hymenal subocclusive anomaly is considered a rare  entity.",Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2008; 51(2):223- 36.  http://dx.doi.org/10.1097/GRF.0b013e31816d2181.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
1987; 157(4 Pt 1):950- 6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
Available from: http://www.awmf.org/uploads/tx_szleitlinien/015-052l_S1_Weibliche_ genitale_Fehlbildungen.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
New York: Springer-Verlag; 1987. p. 36- 96.  http://dx.doi.org/10.1007/978-1-4757-1942-0.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
1975;87 (5):768- 70. http://dx.doi.org/10.1016/S0022-3476(75)80306-4.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2000; 264( 1):49- 50. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
1995; 85(5 Pt 2):857- 60. http://dx.doi.org/10.1016/0029- 7844(94)00405-3.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2006; 19(2):95- 8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2008; 15(5):642- 3. http://dx.doi.org/10.1016/j.jmig.2008.05.002.,OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2012 ;27(6):1637 -9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2002; 266(1):58-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2003; 80(2):171- 2. http://dx.doi.org/10.1016/S0020- 7292(02)00345-4.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2003; 106(1):72-5.  http://dx.doi.org/10.1016/S0301-2115(02)00214-2.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
2012; 13(4):278- 80. http://dx.doi.org/10.5152/ jtgga.2012.46.,Non-OADS,/arxiv_data1/oa_pdf/7c/50/autopsy-04-03059.PMC5444400.pdf
"2014;4(3):65-9. http://dx.doi.org/10.4322/acr.2014.031 ABSTRACT The gastrointestinal (GI) tract has been increasingly affected by tuberculosis, especially in immunocompromised patients.",Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
"2007; 31(5):1087- 96, discussion 1097-8. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1992; 33(3):347- 51. http://dx.doi.org/10.1136/ gut.33.3.347.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1971; 22(1):104- 9. http://dx.doi.org/10.1016/S0009- 9260(71)80030-2.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1996; 39(10):1126- 9. http://dx.doi.org/10.1007/ BF02081413.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
2005; 28(2):257- 60.  http://dx.doi.org/10.4321/S1137-66272005000300010.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1986; 29(11):738- 41. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1992; 38(5):571- 4. http://dx.doi.org/10.1016/S0016-5107(92)70519-7.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1985; 31(2):68- 70. http://dx.doi.org/10.1016/S0016- 5107(85)71995-5.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
1992; 35(2):189- 92.  http://dx.doi.org/10.1007/BF02050677.,Non-OADS,/arxiv_data1/oa_pdf/35/04/autopsy-04-03065.PMC5444401.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02422615  77.,Non-OADS,/arxiv_data1/oa_pdf/d5/e0/onco-11-1-323.PMC5444409.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, andreproduction in any medium, provided the original author(s) and the source are credited.CHILDHOOD OBESITY June 2017 jVolume 13, Number 3 Mary Ann Liebert, Inc.DOI: 10.1089/chi.2016.0273 213",Non-OADS,/arxiv_data1/oa_pdf/b0/c1/chi.2016.0273.PMC5444411.pdf
"15  Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.116.308859Objective—Endoglin, a transforming growth factor-β  superfamily coreceptor, is predominantly expressed in endothelial cells  and has essential roles in vascular development.",Non-OADS,/arxiv_data1/oa_pdf/69/8a/atv-37-1115.PMC5444426.pdf
");  The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.116.308859/-/DC1.Correspondence to Hongyu Tian, PhD, or Gerard Blobe, MD, PhD, B354 LSRC Research Dr, Box 91004, Durham, NC 27708.",Non-OADS,/arxiv_data1/oa_pdf/69/8a/atv-37-1115.PMC5444426.pdf
"Endoglin Promotes VSMC Recruitment and  Spreading Via the Focal Adhesion Kinase Signaling To further investigate the mechanism by which endoglin pro- motes VSMC recruitment and spreading, we analyzed the dif- ferentially expressed genes regulated by endoglin in VSMCs  using the Kyoto Encyclopedia of Genes and Genomes data-base and DA VID software (https://david.ncifcrf.gov/).",OADS,/arxiv_data1/oa_pdf/69/8a/atv-37-1115.PMC5444426.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 19, Number 5, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2016.0454 315",Non-OADS,/arxiv_data1/oa_pdf/45/44/dia.2016.0454.PMC5444481.pdf
This article is available under the Creative Commons License CC-BY-NC (http://creativecommons.org/licenses/by-nc/4.0).,Non-OADS,/arxiv_data1/oa_pdf/91/1c/ars.2016.6733.PMC5444506.pdf
"1.48, http://imagej.nih.gov) based on a standard curve with puriﬁed Brx-roGFP2.",OADS,/arxiv_data1/oa_pdf/91/1c/ars.2016.6733.PMC5444506.pdf
"Secondary antibodiesused were horseradish peroxidase–linked anti-rabbit or anti-mouse, respectively (GE Healthcare, Piscataway, NJ, USA).Antibody/antigen complexes were detected using ECLWestern blot signal detection reagent (GE Healthcare).Chemiluminescence ﬁlm (BioMax XAR; Eastman Kodak,Rochester, NY , USA) was used to visualize protein signals.Each ﬁlm was digitized with a photographic scanner (EpsonPerfection 2400; Epson America, Inc., Long Beach, CA, USA).The band intensities for Western blot analysis were quantiﬁedusing ImageJ software (http://rsb.info.nih.gov/ij/index.htmlin the public domain by the National Institutes of Health,Bethesda, MD, USA) and normalized to GAPDH.",OADS,/arxiv_data1/oa_pdf/cc/c4/i1552-5783-58-5-2715.PMC5444548.pdf
Supplementary material Supplementary material for this paper can be found at thejournal website: http://journals.sagepub.com/home/jcb References 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/18/10.1177_0271678X17694187.PMC5444554.pdf
Available at: http://www.floshield.com/.,Non-OADS,/arxiv_data1/oa_pdf/6d/dc/e2017.00004.PMC5444557.pdf
Available at: http://www.medtronic.com/covidien/products/trocars-access/clearify-visualization-system/.,Non-OADS,/arxiv_data1/oa_pdf/6d/dc/e2017.00004.PMC5444557.pdf
2012 analysis; forecasts through 2016. http://lsintel.com/market-re-ports-page.php?id /H11005A562.,OADS,/arxiv_data1/oa_pdf/6b/01/e2017.00011.PMC5444558.pdf
Available at: http://investors.hologic.com/2014-04-22-Hologics-NovaSure-System-Reaches-a-Significant-Milestone-Over-Two-Million-Women-Have-Chosen-the-NovaSure-Procedure-to-Address-the-Problem-of-Heavy-Periods/.,Non-OADS,/arxiv_data1/oa_pdf/6b/01/e2017.00011.PMC5444558.pdf
Available at: http://www.novasure.com/sites/novasure/files/NovaSure_Physician_Brochure_ 2015_1.pdf/.,Non-OADS,/arxiv_data1/oa_pdf/6b/01/e2017.00011.PMC5444558.pdf
Available at: https://cancerstatisticscenter.cancer.org/#/cancer-site/Uterine%20 corpus/.,Non-OADS,/arxiv_data1/oa_pdf/6b/01/e2017.00011.PMC5444558.pdf
Available at: http://seer.cancer.gov/statfacts/html/corp.html.,Non-OADS,/arxiv_data1/oa_pdf/6b/01/e2017.00011.PMC5444558.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/dd/pcx034.PMC5444561.pdf
"Available online at www.phe.oxfordjournals.org This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"The switch from the language of ‘compassionate use’ to the expression MEUURI, adopted by theWHO Ebola Ethics Working Group (see: http://www.who.int/csr/resources/publications/ebola/eth-ical-evd-therapeutics/en/, accessed: August 2016),was partly motivated by concern that (i) the lan- guage of ‘compassionate use’ seems to imply that it would be beneﬁcial to receive the intervention inquestion (which may not be appropriate in the caseof interventions which have not previously beentested in humans), and (ii) because ‘compassionateuse’ is often technically deﬁned as use of an (un-registered) intervention when use within a clinicaltrial is not possible (whereas a key question regard- ing the potential Ebola interventions in question was whether or not their use should actually be part of aclinical trial, which was a live possibility).",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
The ﬁrst newborn ever surviving Ebola was reported on 3 December 2015 by MSF https://msf.exposure.,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"National Research Ethics Review Guideline, 5th edn, available from: http://www.most.gov.et/index.",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"In, News Releases, availablefrom: https://www.niaid.nih.gov/news/newsreleases/2016/Pages/CROI-ZMapp.aspx [accessed 12 August 2016].",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"Community Perceptions of Ebola Response Efforts in Liberia: Montserrado and NimbaCounties, Study Report for Oxfam, available from:http://www.ebola-anthropology.net/wp-content/up-loads/2015/02/Oxfam-MMinorPeters-Liberia-Anthro-report_Dec2014.pdf [accessed 12 August 2016] Ravinetto, R., Buve, A., Halidou, T., Lutumba, P., and Talisuna, A.",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"National Guidelines for Research Involving Humans as Research Participants, available from: http://www.uncst.go.ug/dmdocuments/ Human%20Subjects%20Protection%20Guideline- s%20July%202014.pdf [accessed 12 August 2016] Tierney, W. M., Nyandiko, W. N., Siika, A. M., Wools- Kaloustian, K., Sidle, J. E., Kiplagat, J., Bell, A., and Inui, T. S. (2013).",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"Ethical Issues Related to Study Design for Trials on Therapeutics for Ebola Virus Disease, available from: http://apps.who.int/iris/bitstream/ 10665/137509/1/WHO_HIS_KER_GHE_14.2_eng.",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"Ebola Situation Report 16 December 2015, available from: http://apps.who.int/ebola/cur- rent-situation/ebola-situation-report-16-december- 2015 [accessed 12 August 2016]ETHICS EBOLA RESEARCH /C1561",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/phw039.PMC5444563.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/2b/pcw191.PMC5444565.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/c1/pcx032.PMC5444567.pdf
(2005) http://faostat.fao.org/faostat/collections?subset=agriculture.,Non-OADS,/arxiv_data1/oa_pdf/f2/c1/pcx032.PMC5444567.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/ab/pcw213.PMC5444570.pdf
"A conserved domain search (http://www.ncbi.nlm.nih.gov/Structure/cdd/ wrpsb.cgi) predicted that GePTS1 includes the dirigent domain,and we found ﬁve amino acid motifs (I–V) characteristic of DIRand dirigent domain-containing proteins (Ralph et al.",OADS,/arxiv_data1/oa_pdf/f3/ab/pcw213.PMC5444570.pdf
"Basedon subcellular protein localizat ion prediction using WoLFPSORT (http://wolfpsort.org/), the presence of a putative signal peptide atthe N-terminus indicated extrace llular and/or vacuolar localiza- tion.",Non-OADS,/arxiv_data1/oa_pdf/f3/ab/pcw213.PMC5444570.pdf
"For soybean IFR, a search of the soybean cDNA clonedatabase of the National Bioresource Project (http://resourcedb.nbrp.jp/top.",OADS,/arxiv_data1/oa_pdf/f3/ab/pcw213.PMC5444570.pdf
"Phylogenetic analysis Deduced amino acid sequences of the selected GePTS1 orthologs were analyzed using the ClustalW program (http://clustalw.ddbj.nig.ac.jp/), and a phylogen-etic tree was produced using the Neighbor–Joining method in MEGA version 6.0 (Tamura et al.",OADS,/arxiv_data1/oa_pdf/f3/ab/pcw213.PMC5444570.pdf
"Acknowledgments We are grateful to the National BioResource Project–Lotus/Glycine (https://www.legumebase.brc.miyazaki-u.ac.jp/) for pro-viding cDNA clones (GMFL01-39-M10, GMFL01-23-H19 andLjFL3-013-AG11) and to Keisuke Yoneyama (Nihon University)for providing soybean cDNA samples for real-time PCR.",Non-OADS,/arxiv_data1/oa_pdf/f3/ab/pcw213.PMC5444570.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/4c/pcx001.PMC5444571.pdf
"Functional annota- tion of the DEGs was performed using the GO database, and the metabolic pathway analysis was conducted according to the Kyoto Encyclopedia ofGenes and Genomes (KEGG) pathway database (http://www.genome.jp/kegg/pathway.html) with the KAAS server (Moriya et al.",OADS,/arxiv_data1/oa_pdf/0d/4c/pcx001.PMC5444571.pdf
"All raw ﬁles from a biological replicate were searched against the RAP-DB Os-Nipponbare database (40,011 sequences; http://rapdb.dna.affrc.go.jp/download/irgsp1.html) and UniProt database with MASCOT2.3.02 software (Matrix Science).",OADS,/arxiv_data1/oa_pdf/0d/4c/pcx001.PMC5444571.pdf
"Here, we de-scribe improvements within the interface (available athttp://www.gabi-kat.de/db/genehits.php) and with regardto the database content that have been realized in the lastﬁve years.",OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
"One traditional start point for insertion mutant identi-ﬁcation is T-DNA Express (http://signal.salk.edu/cgi-bin/tdnaexpress), which is part of the SIGnAL (SALK InstituteGenomic Analysis Laboratory) website provided by the groupof Joe Ecker at the SALK Institute which also hosts the largest Plant Cell Physiol.",OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
"The NASC stock catalog (http://arabidopsis.info)also covers T-DNA insertion mutants comprehensively.Together, ABRC and NASC serve the scientiﬁc communitywith seed stocks of publicly available T-DNA insertion mutants.In addition, the RIKEN BioResource Center (BRC) ExperimentalPlant Division in Japan (http://epd.brc.riken.jp/en/arabidopsis) offers some unique resources including T-DNA activation tagged lines (Nakazawa et al.",OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
"T-DNA Express, NASC or TAIR/ABRC, link to the GABI-Kat database and the web interface SimpleSearch (http://www.gabi-kat.de/db/genehits.php) for de-tails of GABI-Kat lines.",OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
and the results have constantly been incorporated into T-DNA Express (see http://signal.salk.edu/Source/AtTOME_Data_Source.html).,OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
"We collect the literature data, alsoas a proof that the public money that funded GABI-Kat formany years was well-spent, and record the PubMed-ID (seehttp://www.gabi-kat.de/publications.html).",Non-OADS,/arxiv_data1/oa_pdf/8c/58/pcw205.PMC5444572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/29/pcx014.PMC5444573.pdf
Type-VItrichomes were counted using the ImageJ software (http://imagej.nih.gov/ij/) and density was expressed as number of type-VI trichomes per mm 2.,OADS,/arxiv_data1/oa_pdf/0e/29/pcx014.PMC5444573.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/59/29/10.1177_2325967117706511.PMC5444578.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/1f/a0/10.1177_2325967117706692.PMC5444580.pdf
"https://doi.org/10.1177/2055102917709375Health Psychology Open April-June 2017: 1 –12 © The Author(s) 2017Reprints and permissions:  sagepub.com/journalsPermissions.nav DOI: 10.1177/2055102917709375 journals.sagepub.com/home/hpo Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use,  reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2055102917709375.PMC5444581.pdf
The Kumu Systems Mapping Tool (https://kumu.io) was found to be an ideal way to produce the actual map while follow-ing guidelines described by the Omidyar Group (n.d.).,OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2055102917709375.PMC5444581.pdf
Available at: http://hdl.handle.net/2066/159498 (accessed 10 December 2016).,Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2055102917709375.PMC5444581.pdf
"Available at: http://www.biomedcentral.com/1471-2288/11/15 Sque M, Long T and Payne S (2003) Organ and Tissue Donation:  Exploring the Needs of Families (Final report of a three-year study commissioned by the British Organ Donor Society, funded by the National Lottery Community Fund).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2055102917709375.PMC5444581.pdf
Available at: https://www.dropbox.com/sh/ psb37ksjnkta918/AAA-g4wVYZK8Plxh7MVDBpn5a/Systems%20Practice%20Workbook%20012617.pdf?dl=0  (accessed 1 February 2017).,Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2055102917709375.PMC5444581.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/3a/bc/10.1177_2325967117706057.PMC5444582.pdf
http://www.brighamandwomens.org/Patients_Visitors/pcs/Rehabilit ationServices/Physical-Therapy- Standards-of-Care-and-Protocols/Knee%20-%20ACI.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/bc/10.1177_2325967117706057.PMC5444582.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/d7/pcw232.PMC5444583.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/02/a3/10.1177_2325967117705319.PMC5444584.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ec/2d/10.1177_2325967117706521.PMC5444586.pdf
http://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/ec/2d/10.1177_2325967117706521.PMC5444586.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/c3/tox074.PMC5444670.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/b7/hcw225.PMC5444672.pdf
"http://www.rerf.jp/general/research_e/radi tiondose.html (30 November 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/40/b7/hcw225.PMC5444672.pdf
"http://www.rerf.jp/news/pdf/residualrad_ ps_e.pdf (30 November 30 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/40/b7/hcw225.PMC5444672.pdf
"Published by Oxford University Press on behalf of Entomological Society of America.This is an Open Access article distributed unde r the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-com mercial reproduction and dis- tribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/ed/tox076.PMC5444675.pdf
July: 42-46 (http://www.pctonline.com/pct0713-preventing-resis tance-bait-products.aspx).,Non-OADS,/arxiv_data1/oa_pdf/93/ed/tox076.PMC5444675.pdf
Available online:http://www.pesticideresistance.org/display.php?page ¼species&arId ¼215 (accessed 7 November 2016).,Non-OADS,/arxiv_data1/oa_pdf/93/ed/tox076.PMC5444675.pdf
"(https://beeinformed.org/results/the-bee-informed-partnership-na tional-management-survey-2014-2015, accessed 28 February 2017) (BIP 2015b) Bee Informed Partnership National Management Survey Results 2015b .",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(https://beeinformed.org/results-categories/national-management/, accessed 28 February 2017) (BMBF) Brushy Mountain Bee Farms 2016 .",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www.brushymountainbee farm.com/searchprods.asp, accessed 28 February 2017) Brittain, C., N. Williams, C. Kremen, and A. M. Klein.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://capabees.org/capa-statement-on- honey-bees/, accessed 28 February 2017) Cavigli, I., K. F. Daughenbaugh, M. Martin, M. Lerch, K. Banner, E. Garcia, L. M. Brutscher, and M. L. Flenniken.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www.honeycouncil.ca/ honey_industry_overview.php., http://www.honeycouncil.ca/industry.php# stats, accessed 28 February 2017) Cornman, R. S., R. Tarpy, Y. Chen, L. Jeffreys, D. Lopez, and J. S. Pettis.",OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www2.gov.bc.ca/assets/gov/farming-nat ural-resources-and-industry/agriculture-and-seafood/animal-and-crops/ani mal-production/bee-assets/api_fs221.pdf, accessed 28 February 2017) (Recommendations for Management of Honey Bee Diseases and Pests in Alberta 2014-2015 (http://www1.agric.gov.ab.ca/$Department/deptdocs.nsf/all/prm13239/$FILE/2014-recommendations.pdf, accessed 28 February 2017)) Disease control recommendations 2015 (http://publications.gov.sk.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"ca/documents/20/84007-60f10eb7-cee7-481e-a4f0-6d1003bbad52.pdf, accessed 28 February 2017) 2013 Recommendations for administering anti- biotics and acaracides to honey bees (http://gov.mb.ca/agriculture/crops/production/pubs/2013_recommendations_may14_ﬁnal1.pdf, accessed 28 February 2017) (http://techtransfer.ontariobee.com/index.php?action ¼dis play&cat ¼52&v ¼76, accessed 28 February 2017) 2014 Ontario treatment rec- ommendations for honey bee disease and mite control (http://www.omafra.gov.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://capabees.org/content/uploads/2013/02/varroathreshold.pdf, last accessed February 28, 2017)Currie, R. W., F. Pernal, and N. E. Guzman.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(https://www.dadant.com/catalog/medications/m001261-api stan-c-10, accessed 28 February 2017) Eccles, L., M. Kempers, R. M. Gonzalez, D. Thurston, and D. Borges.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www.honeycouncil.ca/images2/pdfs/BMP_manual_-_Les_ Eccles_Pub_22920_-_FINAL_-_low-res_web_-_English.pdf, accessed 28 February 2017) Evans, J. D., K. Aronstein, Y. P. Chen, C. Hetru, J. L. Imler, H. Jiang, M. Kanost, G. J. Thompson, Z. Zou, and D. Hultmark.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www1.agric.gov.ab.ca/$department/deptdocs.nsf/all/ agdex14472/$ﬁle/821-62.pdf, accessed 28 February 2017) Mannlake 2016 .",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(https://www.mannlakeltd.com/shop-all-categories/hive-col ony-maintenance/medications-treatments-herbicides/varroa-mites, accessed 28 February 2017) Nagamuthu, N. 2016 .",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"To request a copy: (http://www.agr.gc.ca/eng/industry-markets-and-trade/statistics-and- market-information/by-product-sector/horticulture-industry/horticulture-sector-reports/?id ¼1368482338314, accessed 28 February 2017) Nasr, M. 2015 .",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www1.agric.gov.ab.ca/$Department/deptdocs.nsf/all/prm13239/ $FILE/2014-recommendations.pdf, accessed 28 February 2017) Ostermann, D., and R. W. Currie.",OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www.agr.gc.ca/resources/prod/doc/pdf/1453219857143- eng.pdf, accessed 28 February 2017) Parker, C. E., D. Domanski, A. J. Percy, A. G. Chambers, A. G. Camenzind, D. S. Smith, and C. H. Borchers.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"Evaluating Honey Bee Colonies for Pollination A Guide for Commercial Growers and Beekeepers A Paciﬁc Northwest Extension Publication Oregon State University, University of Idaho, Washington State University PNW 623, (https://catalog.extension.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www.statcan.gc.ca/daily-quo tidien/151209/dq151209c-eng.htm, accessed 28 February 2017) Sumner, D., and H. Boriss.",OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://www.urbanbeesupplies.ca/pack agedbeesandnucs.html, accessed 28 February 2017) (VBS 2017) Valley Beekeeping Supply 2017 .",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
(http://www.valleybeekeeping.,Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"(http://maarec.cas.psu.edu/pressReleases/FallDwindleUpdate0107.pdf, accessed 28 February 2017) vanEngelsdorp, D., J. Hayes, R. Underwood, and J. Pettis.",Non-OADS,/arxiv_data1/oa_pdf/86/60/tox077.PMC5444677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tox067.PMC5444682.pdf
Itis freely available at the website of CIP https://research.cip.cgiar.org/confluence/display/ilcym/Downloads (Sporleder et al.,OADS,/arxiv_data1/oa_pdf/bd/44/tox067.PMC5444682.pdf
(http://wbd.etibioinformatics.nl/bis/agromyzidae.php?menuen try¼inleiding) (accessed 23 February 2014).,OADS,/arxiv_data1/oa_pdf/bd/44/tox067.PMC5444682.pdf
"MeSH Keywords:  Child • Mycophenolic Acid • Purpura, Schoenlein-Henoch • ROC Curve  Abbreviations:  ACEI  – angiotensin-converting enzyme inhibitors; AUC – area under curve; GC – glucocorticoid;   HSP – Henoch-Schönlein purpura; HSPN  – Henoch-Schönlein purpura nephritis; MMF  – mycophenolate  mofetil  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904206Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Nephrology, The Children’s Hospital of Zhejiang University School  of Medicine, Hangzhou, Zhejiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/51/6e/medscimonit-23-2333.PMC5444683.pdf
"This is a n Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/l icenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/18/0e/S2059866116000327a.PMC5444804.pdf
"Supplementary Material To view supplementary material f or this article, please visit https://doi.org/10.1017/cts.2016.32 References 1.",Non-OADS,/arxiv_data1/oa_pdf/18/0e/S2059866116000327a.PMC5444804.pdf
"MeSH Keywords:  China • Drug-Related Side Effects and Adverse Reactions • Tuberculosis, Avian  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904682Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Epidemiology and Biostatistics, School of Public Health, Peking  University Health Science Center, Beijing, P.R.",Non-OADS,/arxiv_data1/oa_pdf/87/d9/medscimonit-23-2348.PMC5444822.pdf
"Lancet, 2004; 363: 474–81  6. WHO: Companion handbook to the WHO guidelines for the programmatic  management of drug-resistant tuberculosis [EB/OL]: http://www.who.int/ tb/publications/pmdt_companionhandbook/en/ , [2016/11/7]  7.",Non-OADS,/arxiv_data1/oa_pdf/87/d9/medscimonit-23-2348.PMC5444822.pdf
"Regulations on the Prevention and Control of MDR-TB in China [EB/OL]:  http://www.chinacdc.cn/zxdt/201110/t20111012_54235.html , [2015/12/13]  19.",Non-OADS,/arxiv_data1/oa_pdf/87/d9/medscimonit-23-2348.PMC5444822.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4b/77/tom9.PMC5444878.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2017.00112 TOMOGRAPHY.ORG |VOLUME 3 NUMBER 1 |MARCH 2017 9,Non-OADS,/arxiv_data1/oa_pdf/4b/77/tom9.PMC5444878.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/8c/main.PMC5444879.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDERTHE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.07.006,Non-OADS,/arxiv_data1/oa_pdf/55/8c/main.PMC5444879.pdf
"Available at: http://globocan.iarc.fr/Default.aspx; accessed March 27, 2017.1.",Non-OADS,/arxiv_data1/oa_pdf/dc/65/cbm-14-2-162.PMC5444928.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.3.,Non-OADS,/arxiv_data1/oa_pdf/3d/09/cbm-14-2-176.PMC5444929.pdf
Available from: http://emedicine.medscape.com/article/846797- overview#aw2aab6b6.,Non-OADS,/arxiv_data1/oa_pdf/3d/09/cbm-14-2-176.PMC5444929.pdf
Available from: http://www.cancerresearchuk.org/cancerhelp/aboutcancer/treatme nt/chemotherapy/chemotherapy-side-effects.18.,Non-OADS,/arxiv_data1/oa_pdf/3d/09/cbm-14-2-176.PMC5444929.pdf
Available from: http://www.cancerresearchuk.org/cancer-help/type/mouth- cancer/treatment/chemoradiation.19.,Non-OADS,/arxiv_data1/oa_pdf/3d/09/cbm-14-2-176.PMC5444929.pdf
BMC Cancer 2011; http://www.biomedicalcentral.com/ 1471-2407/11/19 .A c c e s s e d2 3J u l y2 0 1 5 25.,Non-OADS,/arxiv_data1/oa_pdf/a1/0e/520_2017_Article_3595.PMC5445145.pdf
Adult Survivorship from con- cept to innovation http://www.ncsi.org.uk/wp-content/uploads/ Concept_to_Innovation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a1/0e/520_2017_Article_3595.PMC5445145.pdf
http://cmd.cochrane.org/ search-strategies-identification-studies .,OADS,/arxiv_data1/oa_pdf/67/80/520_2017_Article_3688.PMC5445146.pdf
http://pathways.nice.org.uk/pathways/early-and-locally-advanced-breast-cancer/early-and-locally-advanced-breast-cancer-overview#content=view-node:nodes-follow-up-care .,Non-OADS,/arxiv_data1/oa_pdf/67/80/520_2017_Article_3688.PMC5445146.pdf
http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulat oryInformation/Guidances/ UCM193282.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f2/70/520_2017_Article_3625.PMC5445148.pdf
"Regional Cancer Centrum:National Guideline for Prostate Cancer 2015– 04-29, http://www.cancercentrum.se/samverkan/ cancerdiagnoser/prostata/vardprogram/gallande-vardprogram/Retrieved 2016 –12-23 19.",Non-OADS,/arxiv_data1/oa_pdf/f2/70/520_2017_Article_3625.PMC5445148.pdf
Available from https://uploads.staticjw.com/ha/halsolitteracitet/manual-scchl-skala-version-2-1-januari-2017.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/f2/70/520_2017_Article_3625.PMC5445148.pdf
Available at: http://groups.eortc.be/qol/manuals .,Non-OADS,/arxiv_data1/oa_pdf/d4/49/520_2017_Article_3598.PMC5445166.pdf
Available at: http://ec.europa.eu/health/ ehealth .,Non-OADS,/arxiv_data1/oa_pdf/d4/49/520_2017_Article_3598.PMC5445166.pdf
"329© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Human Papillomavirus Infection–Associated Adenoid Cystic Carcinoma  of the Hard Palate Arthur Minwoo Chung · Dong Il Sun1 · Eun Sun Jung · Youn Soo Lee Departments of Hospital Pathology and 1Otorhinolaryngology, College of Medicine, The Catholic University of Korea, Seoul, KoreaJournal of Pathology and Translational Medicine 2017; 51: 329-331 https://doi.org/10.4132/jptm.2016.07.07▒ BRIEF CASE REPORT ▒ Adenoid cystic carcinoma (ACC) is a rare tumor of the head  and neck region.",Non-OADS,/arxiv_data1/oa_pdf/de/58/jptm-2016-07-07.PMC5445195.pdf
"http://jpatholtm.org/330     •  Chung AM, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/58/jptm-2016-07-07.PMC5445195.pdf
"https://doi.org/10.4132/jptm.2016.07.07an HPV DNA chip, we report the first case of ACC of the hard  palate associated with HPV infection.",Non-OADS,/arxiv_data1/oa_pdf/de/58/jptm-2016-07-07.PMC5445195.pdf
"http://jpatholtm.org/HPV-Associated Adenoid Cystic Carcinoma   •     331 https://doi.org/10.4132/jptm.2016.07.07like basaloid squamous cell carcinoma, ACC usually lacks squa - mous differentiation.",Non-OADS,/arxiv_data1/oa_pdf/de/58/jptm-2016-07-07.PMC5445195.pdf
"335© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Cerebellar Liponeurocytoma: Relevant Clinical Cytogenetic Findings Alexander Tucker · Kritsanapol Boon-Unge1 · Nancy McLaughlin · Hassana Ibrahim2  Nagesh Rao3 · Neil Martin · Richard Everson · Négar Khanlou1 Department of Neurosurgery, 1Division of Neuropathology, Department of Pathology and Laboratory Medicine, 2Division of Neuroradiology, Department of Radiological  Sciences, 3Division of Clinical and Molecular Cytogenetics, Department of Pathology and Laboratory Medicine, University of California-Los Angeles, Los Angeles, CA, USAJournal of Pathology and Translational Medicine 2017; 51: 335-340 https://doi.org/10.4132/jptm.2016.07.24▒ BRIEF CASE REPORT ▒ Cerebellar liponeurocytoma (cLNC) is a glioneuronal tumor  first described in 1978.1 Histologically, the lesion is similar to  medulloblastoma and many pathologists incorrectly describe  cLNC as “lipomatous medulloblastoma.” Various other nomen - clatures have been used to describe cLNC, such as lipomatous  glioneurocytoma and lipidized mature neuroectodermal tumor  of the cerebellum.2 To date, over 40 cases have been reported in  the literature, including supratentorial variants.",Non-OADS,/arxiv_data1/oa_pdf/1e/2a/jptm-2016-07-24.PMC5445196.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.24336     •  Tucker A, et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/2a/jptm-2016-07-24.PMC5445196.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.24Cerebellar Liponeurocytoma   •     337 tor receptor ( EGFR ) amplification, MYC  or EWSR1  rearrange - ments, or PTEN  deletion.",Non-OADS,/arxiv_data1/oa_pdf/1e/2a/jptm-2016-07-24.PMC5445196.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.24338     •  Tucker A, et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/2a/jptm-2016-07-24.PMC5445196.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.24Cerebellar Liponeurocytoma   •     339 cerebellum should be approached cautiously and cLNC should  always be in included in its differential diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/1e/2a/jptm-2016-07-24.PMC5445196.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.24340     •  Tucker A, et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/2a/jptm-2016-07-24.PMC5445196.pdf
"332pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Rare Case of Nodular Mucinosis of the Breast Hyun Min Koh · Young Hee Maeng1 · Bo Geun Jang1 · Jae Hyuk Choi2 · Chang Lim Hyun1 Department of Pathology, Jeju National University Hospital, Jeju; Departments of 1Pathology and 2Surgery, Jeju National University Hospital, Jeju National University College of Medicine and Graduate School of Medicine, Jeju, KoreaJournal of Pathology and Translational Medicine 2017; 51: 332-334 https://doi.org/10.4132/jptm.2016.07.26▒ BRIEF CASE REPORT ▒ Nodular mucinosis of the breast is an extremely rare stromal  lesion described as a nerve sheath myxoma by Wee et al.1 in 1989,  which was the first report of its kind.",Non-OADS,/arxiv_data1/oa_pdf/f2/1f/jptm-2016-07-26.PMC5445197.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.26Nodular Mucinosis of the Breast   •     333 nous, hypoechoic mass and mammography shows a round- lobular, radiopaque mass without microcalcifications or spicula  formation.2-5 Fine needle aspiration typically reveals mucin  without epithelial elements or malignant evidence.2,4,5 The  treatment of choice is surgical excision, which usually leads to a  successful outcome without residual disease.",Non-OADS,/arxiv_data1/oa_pdf/f2/1f/jptm-2016-07-26.PMC5445197.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.26334     •  Koh HM, et al.",OADS,/arxiv_data1/oa_pdf/f2/1f/jptm-2016-07-26.PMC5445197.pdf
"320pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Unusual Histology of Eosinophilic Myenteric Ganglionitis: A Case Report Hyekyung Lee · Dongwook Kang   Heejin Kim1 · Byungsun Cho2  Jeho Jang2 Departments of Pathology, 1Radiology, and   2Surgery, Eulji University School of Medicine,  Daejeon, KoreaEosinophilic myenteric ganglionitis is a disorder characterized by infiltration of the Auerbach my - enteric plexus by eosinophils.",Non-OADS,/arxiv_data1/oa_pdf/57/80/jptm-2016-09-07.PMC5445198.pdf
"Key Words:  Eosinophils; Ganglionitis; Pseudo-obstructionReceived:  June 2, 2016 Revised:  August 5, 2016 Accepted:  September 7, 2016 Corresponding Author Jeho Jang, MD Department of Surgery, Eulji University School of  Medicine, 77 Gyeryong-ro 771beon-gil, Jung-gu,  Daejeon 34824, Korea Tel: +82-42-259-1272 Fax: +82-42-259-1111 E-mail: jhjang@eulji.ac.krJournal of Pathology and Translational Medicine 2017; 51: 320-324 https://doi.org/10.4132/jptm.2016.09.07▒ CASE STUDY ▒ Chronic intestinal pseudo-obstruction (CIPO) represents a  rare and highly morbid syndrome characterized by impaired  gastrointestinal propulsion together with symptoms of bowel  obstruction in the absence of any lesions occluding the gut  lumen.1,2 The diagnosis of CIPO is mainly clinical and confirmed  by endoscopic or radiologic findings.",Non-OADS,/arxiv_data1/oa_pdf/57/80/jptm-2016-09-07.PMC5445198.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.07Eosinophilic Myenteric Ganglionitis   •     321 tion showed luminal narrowing in the descending colon without  definite luminal obstructive lesions.,Non-OADS,/arxiv_data1/oa_pdf/57/80/jptm-2016-09-07.PMC5445198.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.07322     •  Lee HK, et al.",OADS,/arxiv_data1/oa_pdf/57/80/jptm-2016-09-07.PMC5445198.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.07Eosinophilic Myenteric Ganglionitis   •     323 the absence of an identifiable inflammatory response.,Non-OADS,/arxiv_data1/oa_pdf/57/80/jptm-2016-09-07.PMC5445198.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.07324     •  Lee HK, et al.",OADS,/arxiv_data1/oa_pdf/57/80/jptm-2016-09-07.PMC5445198.pdf
"325© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Clear Cell Renal Cell Carcinoma with Intratumoral Granulomatous   Reaction: A Case Report and Review of the Literature Hayeon Kim · Jong Wook Kim1  Aeree Kim · Hyeyoon Chang Departments of Pathology and 1Urology,   Korea University Guro Hospital, Seoul, KoreaGranulomatous reaction associated with clear cell renal cell carcinoma (CCRCC) is a rare finding,  and only a few cases have been described in the literature.",Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jptm-2016-09-08.PMC5445199.pdf
"Key Words:  Carcinoma, renal cell; Granulomatous reaction; Kidney neoplasmsReceived:  July 4, 2016 Revised:  August 26, 2016 Accepted:  September 7, 2016 Corresponding Author Hyeyoon Chang, MD Department of Pathology, Korea University Guro  Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308,  Korea  Tel: +82-2-2626-1470  Fax: +82-2-2626-1481  E-mail: breakfree83@hanmail.netJournal of Pathology and Translational Medicine 2017; 51: 325-328 https://doi.org/10.4132/jptm.2016.09.08▒ CASE STUDY ▒ Granulomatous inflammation is a distinctive pattern of chronic  inflammation composed of activated macrophages and T lym - phocytes.1 Central necrosis is often accompanied.",Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jptm-2016-09-08.PMC5445199.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.08326     •  Kim H, et al.",OADS,/arxiv_data1/oa_pdf/b2/4f/jptm-2016-09-08.PMC5445199.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.08CCRCC with Granulomatous Reaction   •     327 tumor-related SLRs, three cases had documented the absence of  sarcomatoid component.8,10 There was no mention of sarcoma - toid differentiation in the rest of the cases.",Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jptm-2016-09-08.PMC5445199.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.08328     •  Kim H, et al.",OADS,/arxiv_data1/oa_pdf/b2/4f/jptm-2016-09-08.PMC5445199.pdf
"264pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Characteristic Changes in Decidual Gene Expression Signature   in Spontaneous Term Parturition Haidy El-Azzamy1,* · Andrea Balogh1,2,*  Roberto Romero1,3,4,5 · Yi Xu1  Christopher LaJeunesse1 · Olesya Plazyo1  Zhonghui Xu1 · Theodore G. Price1  Zhong Dong1 · Adi L. Tarca1,6  Zoltan Papp7 · Sonia S. Hassan1,6  Tinnakorn Chaiworapongsa1,6  Chong Jai Kim1,8,9   Nardhy Gomez-Lopez1,6  Nandor Gabor Than1,6,7,10,11 1Perinatology Research Branch, NICHD/NIH/DHHS,  Bethesda, MD, and Detroit, MI, USA; 2Department of  Immunology, Eotvos Lorand University, Budapest,  Hungary; 3Department of Obstetrics and Gynecology,  University of Michigan, Ann Arbor, MI; 4Department of  Epidemiology and Biostatistics, Michigan State  University, East Lansing, MI; 5Center for Molecular  Medicine and Genetics, Wayne State University, Detroit,  MI; 6Department of Obstetrics and Gynecology, Wayne  State University, School of Medicine, Detroit, MI, USA;  7Maternity Private Department, Kutvolgyi Clinical Block,  Semmelweis University, Budapest, Hungary;   8Department of Pathology, Wayne State University,  School of Medicine, Detroit, MI, USA; 9Department of  Pathology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea; 10Systems Biology  of Reproduction Lendulet Research Group, Institute of  Enzymology, Research Centre for Natural Sciences,  Hungarian Academy of Sciences, Budapest; 11First  Department of Pathology and Experimental Cancer  Research, Semmelweis University, Budapest, HungaryBackground:  The decidua has been implicated in the “terminal pathway” of human term parturi - tion, which is characterized by the activation of pro-inflammatory pathways in gestational tissues.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"Key Words:  Chemokines; Cytokines; Estrogens; Galectins; Leukocytes; Progesterone Received:  October 2, 2016 Revised:  December 3, 2016 Accepted:  December 20, 2016 Corresponding Author Nandor Gabor Than, MD, PhD Systems Biology of Reproduction Lendulet Research  Group, Institute of Enzymology, Research Centre for  Natural Sciences, Hungarian Academy of Sciences,   2 Magyar Tudosok korutja, H-1117 Budapest, Hungary  Tel: +36-1-382-6788 E-mail: than.gabor@ttk.mta.hu Roberto Romero, MD, DMedSci  Perinatology Research Branch, NICHD/NIH/DHHS,  Hutzel Women’s Hospital, 3990 John R Street, 4 Brush,  Detroit, MI 48201, USA  Tel: +1-313-993-2700 Fax: +1-313-993-2694 E-mail: prbchiefstaff@med.wayne.edu *Haidy El-Azzamy and Andrea Balogh contributed  equally to this work.Journal of Pathology and Translational Medicine 2017; 51: 264-283 https://doi.org/10.4132/jptm.2016.12.20▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     265 Parturition is a complex process tightly regulated by the coop - eration of the neuroendocrine and immune systems.1,2 Among  the numerous hormonal factors implicated in the regulation of  uterine quiescence and parturition (e.g., corticotropin-releasing  hormone, cortisol, oxytocin), the changes in the bioavailability  of estrogen and progesterone seem to be key in parturition.2,3  While estrogen promotes labor by stimulating biochemical and  physiological changes in myometrial cells that augment uterine  contractility and excitability,4 the actions of progesterone support  pregnancy maintenance and prevent parturition by promoting  myometrial quiescence.5,6 In humans, the changes in the relative  expression of various progesterone receptors (elevation in the pro - gesterone receptor A [PR-A ]/PR-B ratio) in uterine tissues and  fetal membranes are responsible for decreasing progesterone  actions (functional progesterone withdrawal).7-9 A strong positive  association between the PR-A/PR-B ratio and estrogen receptor  α (ERα) expression in the myometrium of term pregnant women  has been demonstrated,7 suggesting that functional progesterone  withdrawal generates “functional estrogen activation.”3 All of  these changes can then lead to the stimulation of pro-inflamma - tory pathways in the cervix, decidua, and fetal membranes.10-12  The pro-inflammatory microenvironment in various gesta - tional tissues,10,13,14 generated by the influx and local activation  of maternal leukocytes15,16 and the increased production of soluble  immune mediators, is essential for the onset of labor.17,18 The  selective influx of leukocytes into gestational tissues19-21 and vari - ous layers of the fetal membranes22,23 is driven by chemokines,24,25  a subset of cytokines with chemotactic properties.26 The infiltrat - ing monocytes and differentiated macrophages, neutrophils, and  T cells as well as decidual stromal cells27,28 are rich sources of pro- inflammatory cytokines, including interleukin 1 (IL-1), IL-6,  and tumor necrosis factor α (TNFα).29-32 These cytokines have  been shown to regulate inflammatory processes leading to labor33  by promoting myometrial contractility, cervical ripening, and  membrane rupture.34,35 For example, pro-inflammatory cytokines  induce the expression of prostaglandin-endoperoxide synthase 2  (PTGS2) in the chorioamniotic membranes and decidua, leading  to the increase in local and amniotic fluid concentrations of pros - taglandins36-40 that contribute to the transition from myometrial  quiescence to labor initiation.41 These data suggest that cytokines  and chemokines orchestrate the activation of decidual tissue  during labor.20 To promote labor-associated inflammation, the actions of anti- inflammatory mechanisms, at least in part, need to be attenuated  in gestational tissues.5 Among anti-inflammatory molecules, sol - uble tumor necrosis factor receptors (TNF-R), IL-1 receptor antagonist (IL-1RA), IL-4, and IL-10 have been previously ex - amined in the amniotic fluid in relation to labor.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20266     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     267 systems, Wetzlar, Germany), and then mounted on polyethylene  membrane glass slides (Leica) and stored at –80°C until use.",OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20268     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     269 washed three times, and then 2 × Read Buffer T (Meso Scale  Discovery) was added to each well; the signals were read by the  SECTOR 2400 Imager (Meso Scale Discovery).",OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20270     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     271 pared to TNL cases (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20272     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     273 the most important roles in these processes mediated by estrogen  and progesterone receptors,6 while HOX genes are essential for  endometrial development, growth, and differentiation under  the regulation of estrogen and progesterone.85,86 Therefore, we  studied the most relevant estrogen and progesterone receptors  as well as HOX genes to gain insights into their decidual expres - sion changes during term parturition.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20274     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     275 TIL and TNL cases.,Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20276     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     277 study.,Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
Electronic Supplementary Material  Supplementary materials are available at the Journal of Pathology  and Translational Medicine (http://jpatholtm.org).,Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20278     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     279 paB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene  expression in ED27 trophoblast-like cells.,Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20280     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     281 94.,Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"http://jpatholtm.org/ https://ddoi.org/10.4132/jptm.2016.12.20282     •  El-Azzamy H, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.20Decidual Gene Signature in Term Delivery   •     283 gy 2008; 149: 6272-9.,OADS,/arxiv_data1/oa_pdf/d9/88/jptm-2016-12-20.PMC5445200.pdf
"255© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic  Tumors with Reference to ALK-1 Expression:   5-Year Experience in a Tertiary Care Center Ramesh Babu Telugu   Anne Jennifer Prabhu   Nobin Babu Kalappurayil   John Mathai1  Birla Roy Gnanamuthu2  Marie Therese Manipadam Departments of General Pathology, 1Paediatric  Surgery, and 2Thoracic Surgery, Christian   Medical College and Hospital, Vellore, IndiaBackground:  Inflammatory myofibroblastic tumor is a histopathologically distinctive neoplasm of  children and young adults.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"Key Words:  ALK protein; Atypia; Prognostic marker; Recurrence; NeoplasmsReceived:  September 5, 2016 Revised:  January 2, 2017 Accepted:  January 12, 2017 Corresponding Author Ramesh Babu Telugu, MD Department of General Pathology, Christian Medical  College and Hospital, Vellore, Tamilnadu 632004,  India  Tel: +91-9566434081 Fax: +91-416-2232054 E-mail: dr.rameshtelugu@gmail.comJournal of Pathology and Translational Medicine 2017; 51: 255-263 https://doi.org/10.4132/jptm.2017.01.12▒ ORIGINAL ARTICLE ▒ Inflammatory myofibroblastic tumor is a histopathologically  distinctive neoplasm that has been described in various anatomic  sites of children and young adults.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12256     •  Telugu RB, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12Inflammatory Myofibroblastic Tumors   •     257 had died of disease.,Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12258     •  Telugu RB, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12Inflammatory Myofibroblastic Tumors   •     259 Immunohistochemical findings Spindled tumor cells of inflammatory myofibroblastic tumors  showed cytoplasmic or membrane positivity for smooth muscle  actin (12/16 cases), muscle-specific actin (3/6 cases), vimentin  (8/8 cases), desmin (5/11 cases), and epithelial membrane antigen  (2/4 cases).",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12260     •  Telugu RB, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12Inflammatory Myofibroblastic Tumors   •     261 33.3% each of intrapulmonary and intra-abdominal locations  followed by other locations.,Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12262     •  Telugu RB, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.12Inflammatory Myofibroblastic Tumors   •     263 matory myofibroblastic tumor with RANBP2  and ALK gene rear - rangement: a report of two cases and literature review.,Non-OADS,/arxiv_data1/oa_pdf/3f/63/jptm-2017-01-12.PMC5445201.pdf
"306pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic   Indicator of Colorectal Cancer Hyeon Jeong Oh1,2 · Jeong Mo Bae2,3  Xian-Yu Wen2 · Nam-Yun Cho2  Jung Ho Kim1,2 · Gyeong Hoon Kang1,2 1Department of Pathology, Seoul National   University College of Medicine, Seoul;   2Laboratory of Epigenetics, Cancer Research  Institute, Seoul National University College of  Medicine, Seoul; 3Department of Pathology,  SMG-SNU Boramae Medical Center, Seoul,  KoreaBackground:  Tumor microenvironment has recently drawn attention in that it is related with tumor  prognosis.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"Key Words:  Colorectal neoplasms; POSTN; Immunohistochemistry; Stromal overexpression; Clini - copathological characters; PrognosisReceived:  October 11, 2016 Revised:  November 30, 2016 Accepted:  January 19, 2017 Corresponding Author Gyeong Hoon Kang, MD Department of Pathology, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 03080, Korea  Tel: +82-2-740-8263 Fax: +82-2-765-5600 E-mail: ghkang@snu.ac.krJournal of Pathology and Translational Medicine 2017; 51: 306-313 https://doi.org/10.4132/jptm.2017.01.19▒ ORIGINAL ARTICLE ▒ Colorectal cancer (CRC) is the third most common cancer in  the world, with nearly 1.4 million new cases diagnosed in  2012, and South Korea is one of the countries with the highest  incidence of CRC.1 Although TNM staging of American Joint  Committee on Cancer (AJCC) is the most powerful and reliable  tool for prediction of prognosis and therapeutic decision making  in CRC patients, the clinical outcome of CRC patients may vary  even within the same cancer stage.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19Stromal POSTN Overexpression in CRC   •     307 several malignancies.15-17  In the present study, we analyzed 1,125 CRC cases for their  expression status of POSTN using immunohistochemistry and  correlated POSTN expression with molecular features of CRCs,  including CpG island methylator phenotype (CIMP), microsat - ellite instability (MSI), and clinicopathological features of CRC,  including survival of patients.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19308     •  Oh HJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19Stromal POSTN Overexpression in CRC   •     309 62 (5.5%) patients, respectively.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19310     •  Oh HJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19Stromal POSTN Overexpression in CRC   •     311 DISCUSSION Recent studies show POSTN is overexpressed in cancer stroma  of various malignancies, including colorectal, breast, lung, pan - creatic, ovarian, gastric, head and neck, thyroid and prostate  cancer as well as in glioblastoma.19 POSTN is thought to play  important roles in tumorigenesis, such as invasiveness, metastasis,  angiogenesis, lymphangiogenesis, and chemoresistance.8,15,20-24  In this study, we found that POSTN is overexpressed in 304  (27.0%) out of 1,125 cases, which is consistent with the results  of other studies in several malignancies.19 Our study demon - strated that high POSTN expression is correlated with several  aggressive clinicopathological features of CRCs.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19312     •  Oh HJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.19Stromal POSTN Overexpression in CRC   •     313 via creating a cancer-supportive niche.,Non-OADS,/arxiv_data1/oa_pdf/2b/d3/jptm-2017-01-19.PMC5445202.pdf
"284pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Small Case Series of Intravascular Large B-Cell Lymphoma   with Unexpected Findings: Subset of Cases with Concomitant   Extravascular Central Nervous System (CNS) Involvement   Mimicking Primary CNS Lymphoma Kate Poropatich · Dave Dittmann   Yi-Hua Chen · Kirtee Raparia   Kristy Wolniak · Juehua Gao Department of Pathology, Northwestern   University Feinberg School of Medicine,   Chicago, IL, USABackground:  Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal lymphoma  with growth mainly in the lumina of vessels.",Non-OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
"Key Words:  Intravascular large B-cell lymphoma Received:  January 19, 2017 Revised:  February 13, 2017 Accepted:  February 15, 2017 Corresponding Author Kate Poropatich, MHS, MD Department of Pathology, Northwestern University  Feinberg School of Medicine, Feinberg Pavilion  7-330, 251 E. Huron St., Chicago, IL 60611, USA  Tel: +1-301-233-3533 Fax: +1-312-503-0189 E-mail: kate.poropatich@northwestern.eduJournal of Pathology and Translational Medicine 2017; 51: 284-291 https://doi.org/10.4132/jptm.2017.02.16▒ ORIGINAL ARTICLE ▒ Intravascular large B-cell lymphoma (IVLBCL) is a rare type of  extranodal large B-cell lymphoma characterized by the selective  growth of large lymphoma cells within smaller vessel lumina.1  Classified as a “Mature B cell” neoplasm in the 2008 World  Health Organization (WHO) classification,1 IVLBCL is consid - ered phenotypically and morphologically similar to diffuse large  B cell lymphoma (DLBCL).",Non-OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16Intravascular Large B-Cell Lymphoma   •     285 with mass-like lesions on magnetic resonance imaging (MRI).6,9,19-21  Most striking about these cases is that they mimic patterns seen  in primary CNS B-cell lymphoma based on angiocentric growth  of large, atypical B cells that have a predilection for the lepto - meninges.22 It remains unclear what the incidence of this mor - phologic pattern is in the CNS of patients presenting with IV - LBCL.",Non-OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16286     •  Poropatich K, et al.",OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16Intravascular Large B-Cell Lymphoma   •     287 prominent nucleoli.,Non-OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16288     •  Poropatich K, et al.",OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16Intravascular Large B-Cell Lymphoma   •     289 in all five cases.,Non-OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16290     •  Poropatich K, et al.",OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.16Intravascular Large B-Cell Lymphoma   •     291 management of intravascular large B-cell lymphoma: proposals  and perspectives from an international consensus meeting.,Non-OADS,/arxiv_data1/oa_pdf/c6/c1/jptm-2017-02-16.PMC5445203.pdf
"292pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.An Experimental Infarct Targeting the Internal Capsule:  Histopathological and Ultrastructural Changes Chang-Woo Han · Kyung-Hwa Lee  Myung Giun Noh · Jin-Myung Kim Hyung-Seok Kim 1 · Hyung-Sun Kim2  Ra Gyung Kim2 · Jongwook Cho2  Hyoung-Ihl Kim2 · Min-Cheol Lee Departments of Pathology and 1Forensic  Medicine, Chonnam National University Medical  School and Research Institute of Medical  Sciences, Gwangju; 2Department of Medical  System Engineering and School of Mechatronics,   Gwangju Institute of Science and Technology,   Gwangju, KoreaBackground:  Stroke involving the cerebral white matter (WM) has increased in prevalence, but  most experimental studies have focused on ischemic injury of the gray matter.",Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"Key Words:  Stroke; White matter; Models, animal; Pathology; Ultrastructure Received: September 24, 2016 Revised: February 3, 2017Accepted: February 16, 2017 Corresponding Author Min-Cheol Lee, MD, PhDDepartment of Pathology, Chonnam National University Medical School and Research Institute of Medical Sciences, 160 Baekseo-ro, Dong-gu, Gwangju 61469, KoreaTel: +82-62-220-4303 Fax: +82-62-220-5697 E-mail: mclee@jnu.ac.krJournal of Pathology and Translational Medicine 2017; 51: 292-305 https://doi.org/10.4132/jptm.2017.02.17▒ ORIGINAL ARTICLE ▒ As the human life span has continued to increase, stroke  patterns have changed.",Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     293 structure.12 A literature search through publications spanning the last 10  years revealed several experimental methods used to develop  WM stroke models, including occlusion of the common carotid  artery, proximal middle cerebral artery13 and anterior choroidal  artery (AchA)14 and administration of the vasoconstrictive agent  endothelin-1 (ET-1) into the subcortical WM, IC, and stria- tum.15-19 However, infarcts selectively targeting the IC and result - ing in chronic motor impairment cannot be induced consistently.",Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17294     •  Han C-W, et al.",OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     295 quently kept in processed paraffin-embedded tissue blocks.,Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17296     •  Han C-W, et al.",OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     297 E  F Fig.,Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17298     •  Han C-W, et al.",OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     299 central geographic necrosis surrounded by a wall of macro- phages, in which each macrophage had a central nucleus with  prominent nucleoli and abundant cytoplasm phagocytized with  light-blue or reddish granular debris (Fig.",Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17300     •  Han C-W, et al.",OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     301 covered with wrinkled axons (Fig.,Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17302     •  Han C-W, et al.",OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     303 emic injury and phagocytized axon-myelin debris and fat glob- ules.,Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17304     •  Han C-W, et al.",OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.02.17White Matter Infarct Neuropathology   •     305 expression of apoptosis regulatory proteins in a photochemically- induced focal cerebral ischemic rat brain.,Non-OADS,/arxiv_data1/oa_pdf/17/d0/jptm-2017-02-17.PMC5445204.pdf
"205© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Molecular Testing of Brain Tumor Sung-Hye Park1,2 · Jaekyung Won1  Seong-Ik Kim1 · Yujin Lee1  Chul-Kee Park3 · Seung-Ki Kim3  Seung-Hong Choi4 1Department of Pathology, 2Neurosicence  Institute, Departments of 3Neurosurgery and  4Radiology, Seoul National University, College of  Medicine, Seoul, KoreaThe World Health Organization (WHO) classification of central nervous system (CNS) tumors was  revised in 2016 with a basis on the integrated diagnosis of molecular genetics.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"Key Words:  Brain neoplasms; Molecular biology; Next generation sequencing; Pathological diag- nosisReceived: February 19, 2017 Accepted: March 8, 2017 Corresponding Author Sung-Hye Park, MD, PhDDepartment of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-3090Fax: +82-2-743-5530E-mail: shparknp@snu.ac.krJournal of Pathology and Translational Medicine 2017; 51: 205-223 https://doi.org/10.4132/jptm.2017.03.08▒ REVIEW ▒ The central nervous system (CNS) tumors are those of the  brain and spinal cord including the meninges, pituitary gland,  pineal gland, and nerves according to the 3rd edition of the  International Classification of Diseases for Oncology (ICD-O-3) (http://codes.iarc.fr/).",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"The incidence rate of all primary malig-nant and nonmalignant CNS tumors in the United States was 22.36 cases per 100,000 (5.67/100,000 for 0–14 years, 5.71/  100,000 for 0–19 years) according to the U.S. Central Brain  Tumor Registry (CBTRUS; http://www.cbtrus.org/factsheet/factsheet.html).",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"According  to the nationwide cancer registration (hospital based Korean  Central Cancer Registry [ KCCR] , http://www.iacr.com.fr/index.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"php?option=com_comprofiler&task=userprofile&user=973&Itemid=498, http://ncc.re.kr/cancerStatsView.ncc?bbsnum=358&searchKey=total&searchValue=&pageNum=1), 10,004  patients were diagnosed with primary CNS tumors in Korea in  2010, which means that the incidence of brain tumors in Korea is lower than that of United States.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08206     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"Through high-throughput studies such as the Cancer Genome Atlas (TCGA) project (https://cancergenome.nih.gov/) or the cBio- Portal project (http://www.cbioportal.org/), a large number of  brain tumors have been sequenced and major genetic alterations in brain tumors have been identified, 3 thus allowing for the  classification of gliomas.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     207 These findings demonstrate that tumors are genetic disorders  and that certain mutations can represent different biological be- haviors and result in different prognoses.,Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08208     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     209 ATRX is an X-linked gene of α-thalassemia and mental  retardation syndrome  ATRX is located in Xq21.1, encodes a 280-kDa nuclear pro- tein, and has been shown to be involved in a wide range of cellu - lar functions such as DNA recombination, repair, and tran- scription regulation.82 It binds strongly within the promyelocytic  leukemia body of the nucleus.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08210     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     211 acts as an RNA binding protein and alterations of its normal  function can lead to tumorigenesis, which has been suggested  to act either as a protooncogene or a tumor suppressor gene  depending on the tumor type.36,87 Through the c-Myc pathway,  FUBP1 promotes cell migration and protects cells from apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08212     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     213 BRAF mutations and BRAF-KIAA1549 fusions BRAF V600E mutations and fusions of BRAF with KIAA1549   or FAM131B are characteristics of pilocytic astrocytomas.,Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08214     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     215 METHODS OF MOLECULAR TESTING The molecular testing methods commonly used in pathology  laboratories include immunohistochemical staining, direct se- quencing, FISH, chromosomal genomic hybridization, and NGS.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08216     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     217 (SIOP) guidelines for neuroblastoma study.80 For each hybrid- ization, the number of green and orange signals is assessed for a  minimum of 100 nonoverlapping nuclei.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08218     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     219 CONCLUSION We are now in the era of precision medicine, and have slowly  caught up with the rapid development of precision medicine.",Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08220     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     221 tary fibrous tumor/hemangiopericytoma with dedifferentiated  component.,Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08222     •  Park S-H, et al.",OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.08Molecular Testing of Brain Tumors   •     223 into pediatric brain tumors have the potential to transform thera- py.,Non-OADS,/arxiv_data1/oa_pdf/55/17/jptm-2017-03-08.PMC5445205.pdf
"191© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 about the reliability of NGS cancer panels.",Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"Key Words:  High-throughput nucleotide sequencing; Molecular pathology; Neoplasms; Quality  control; Practice guidelines as topicReceived: February 20, 2017 Accepted: March 14, 2017 Corresponding Author Jihun Kim, MD, PhDDepartment of Pathology, Asan Medical Center,   University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-4556Fax: +82-2-472-7898E-mail: jihunkim@amc.seoul.kr *Jihun Kim and Woong-Yang Park contributed  equally to this work as co-first authors.Journal of Pathology and Translational Medicine 2017; 51: 191-204 https://doi.org/10.4132/jptm.2017.03.14▒ REVIEW ▒",Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14192     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14Guidelines for NGS-Based Clinical Tests   •     193 pathologists should be aware of the fact that the relative number  of tumor cell nuclei reflects tumor purity rather than occupied  tumor area.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14194     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14Guidelines for NGS-Based Clinical Tests   •     195 have the suspected insertions or deletions may be necessary in  such cases.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14196     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"Useful online resources for variant interpretation Subject Database/Algorithm URL Germline polymorphism dbSNP , dbVar 1000 Genomes ProjectExAChttps://www.ncbi.nlm.nih.gov/projects/SNP/http://browser.1000genomes.org/http://exac.broadinstitute.org Cancer-specific somatic variants COSMICcBioPortalMy Cancer GenomeCIViCPersonalized Cancer Therapy, MD Anderson Cancer Centerhttp://cancer.sanger.ac.uk/cosmichttp://www.cbioportal.org/https://www.mycancergenome.org/https://civic.genome.wustl.edu/#/homehttps://pct.mdanderson.org/#/ Genotype-phenotype association,  not limited to cancerClinVarHuman Gene Mutation DatabaseLeiden Open Variation Databasehttps://www.ncbi.nlm.nih.gov/clinvar/http://www.hgmd.cf.ac.uk/ac/index.phphttp://www.lovd.nl/3.0/home In silico functional prediction dbNSFP (pre-computed in silico functional prediction and  annotation of non-synonymous SNVs)Ensembl Variant Effector Predictorhttp://sites.google.com/site/jpopgen/dbNSFP  http://www.ensembl.org/info/docs/tools/vep/index.html This list is not comprehensive and only provides some examples.",Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14Guidelines for NGS-Based Clinical Tests   •     197 included in the report.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14198     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14Guidelines for NGS-Based Clinical Tests   •     199 regions.23 During this type of validation, an adequate depth of  coverage threshold35 necessary to accurately call all expected  variants can be empirically established by plotting false-posi- tives and false-negatives as a function of coverage.",Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14200     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14Guidelines for NGS-Based Clinical Tests   •     201 different laboratories until formal PT programs are set.24 A  Korean guideline published by the MFDS follows the same  principle and requires documentation of all procedures related  to PT or AA.43 There is no general agreement upon the number  of reference materials per one round of PT or AA but analysis of  two samples has been recommended.36 Policies: confirmatory testing, laboratory records, upgrades As NGS cancer panel tests with appropriate quality controls  are reported to meet a clinical grade performance,23,44-47 routine  confirmatory testing is not recommended.",Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14202     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14Guidelines for NGS-Based Clinical Tests   •     203 clinical practice.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from:  https://www.iso.org/obp/ui/#iso:std:iso:15189:ed-3:v2:en.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from: http://www.hgvs.org/mutnomen/.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from: http://www.fda.gov/down-loads/MedicalDevices/DeviceRegulationandGuidance/Guid-anceDocuments/UCM509838.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.14204     •  Kim J, et al.",OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from: https://www.ncbi.nlm.nih.gov/variation/tools/get-rm/.,OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from: https://www.amp.org/ committees/clinical_practice/AMPclinicalpracticeguidelines.cfm.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from: http://www.esmo.org/Guidelines.,Non-OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
Available from: http://www.mfds.go.kr/index.do?mid=1161&seq=11001&cmd=v.,OADS,/arxiv_data1/oa_pdf/69/11/jptm-2017-03-14.PMC5445206.pdf
"314pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Comparison of Unsatisfactory Samples from Conventional Smear versus  Liquid-Based Cytology in Uterine Cervical Cancer Screening Test Hoiseon Jeong · Sung Ran Hong1  Seoung-Wan Chae2 · So-Young Jin3  Hye Kyoung Yoon4 · Juhie Lee5  Eun Kyung Kim6 · Sook Tai Ha7  Sung Nam Kim8 · Eun-Jung Park9  Jong Jae Jung9 · Sun Hee Sung10  Sung-Chul Lim11 Department of Pathology, Korea University Ansan  Hospital, Korea University College of Medicine,  Seoul; 1Department of Pathology, Cheil General  Hospital and Women’s Health Care Center,  Dankook University College of Medicine, Seoul;  2Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, Seoul; 3Department of Pathology,  Soonchunhyang University Hospital,   Soonchunhyang University College of Medicine,  Seoul; 4Department of Pathology, Inje University  Busan Paik Hospital, Inje University College  of Medicine, Busan; 5Department of Pathology,  Kyung Hee University School of Medicine, Seoul;  6Department of Pathology, Eulji General Hospital,  Seoul; 7T&C Diagnostic Pathology Clinic, Seoul;  8Samkwang Medical Laboratories, Seoul;  9Foryou Pathology Laboratories, Gwangju;   10Department of Pathology, Ewha Womans  University Mokdong Hospital, Ewha Womans  University School of Medicine, Seoul;   11Department of Pathology, Chosun University  School of Medicine, Gwangju, KoreaBackground:  Cervical cytology for uterine cervical cancer screening has transitioned from con - ventional smear (CS) to liquid-based cytology (LBC), which has many advantages.",Non-OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
"Key Words:  Papanicolaou test; Cervical cytology; Unsatisfactory; Liquid-based cytology; Conven - tional smearReceived:  December 22, 2016 Revised:  March 9, 2017 Accepted:  March 14, 2017 Corresponding Author Sung-Chul Lim, MD, PhD  Department of Pathology, Chosun University School  of Medicine, 309 Pilmun-daero, Dong-gu, Gwangju  61452, Korea  Tel: +82-62-230-6343 Fax: +82-62-226-5860 E-mail: sclim@chosun.ac.kr *This study was presented at the 29th Annual  Spring Meeting of the Korean Society for   Cytopathologists, 2015 and the International  Academy of Cytology 2016 at Yokohama.Journal of Pathology and Translational Medicine 2017; 51: 314-319 https://doi.org/10.4132/jptm.2017.03.17▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.17Unsatisfactory Pap Tests in CS vs LBC   •     315 Cervical cytology, known as Papaniolaou (Pap) test, was first  introduced in Korea in the late 1950s and has since played an  important role in the early detection of uterine cervical cancer.1  Conventional smear (CS) is widely used for uterine cancer screen - ing owing to its low cost and easy application.",Non-OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.17316     •  Jeong H, et al.",OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.17Unsatisfactory Pap Tests in CS vs LBC   •     317 egory of technical problems, unsatisfactory cases due to a thick  preparation had the largest proportion (24 cases).",Non-OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.17318     •  Jeong H, et al.",OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.03.17Unsatisfactory Pap Tests in CS vs LBC   •     319 Acknowledgments This research was supported by The Korean Society for Cyto - pathologists Grant No.,Non-OADS,/arxiv_data1/oa_pdf/b3/8f/jptm-2017-03-17.PMC5445207.pdf
"224pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Molecular Testing of Lymphoproliferative Disorders :  Current Status and Perspectives Yoon Kyung Jeon · Sun Och Yoon1  Jin Ho Paik2 · Young A Kim3  Bong Kyung Shin4 · Hyun-Jung Kim5  Hee Jeong Cha6 · Ji Eun Kim3  Jooryung Huh7 · Young-Hyeh Ko8  The Hematopathology Study Group  of the Korean Society of Pathologists · The Molecular  Pathology Study Group of Korean Society of Pathologists Department of Pathology, Seoul National  University Hospital, Seoul National University  College of Medicine, Seoul; 1Department of  Pathology, Yonsei University College of Medicine,  Seoul; 2Department of Pathology, Seoul National  University Bundang Hospital, Seoul National University College of Medicine, Seongnam;  3Department of Pathology, SMG-SNU Boramae  Medical Center, Seoul National University College of Medicine, Seoul;  4Department of Pathology,  Korea University Guro Hospital, Korea University   School of Medicine, Seoul; 5Department of   Pathology, Inje University Sanggye Paik Hospital,   Seoul; 6Department of Pathology, Ulsan University   Hospital, University of Ulsan College of Medicine,   Ulsan; 7Department of Pathology, Asan Medical  Center, University of Ulsan College of Medicine,   Seoul; 8Department of Pathology, Samsung   Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaMolecular pathologic testing plays an important role for the diagnosis, prognostication and deci- sion of treatment strategy in lymphoproliferative disease.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"Key Words:  Lymphoproliferative disorders; Malignant lymphoma; Pathology, molecular; Molecular  diagnostics; Clonality test; Gene translocation; In situ hybridization, fluorescence; Next-generation sequencingReceived: March 17, 2017 Accepted: April 9, 2017 Corresponding Author Yoon Kyung Jeon, MD, PhDDepartment of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-1347Fax: +82-2-743-5530E-mail: ykjeon@snu.ac.kr Young-Hyeh Ko, MD, PhD Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: +82-2-3410-2762Fax: +82-2-3410-0025E-mail: yhko310@skku.eduJournal of Pathology and Translational Medicine 2017; 51: 224-241 https://doi.org/10.4132/jptm.2017.04.09▒ REVIEW ▒",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     225 Molecular pathologic testing plays an important role for the  diagnosis, prognostication and decision of treatment in lympho - proliferative disease.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09226     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     227 Fig.,Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09228     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     229 Moreover, it would be difficult to determine the presence of  unequivocal clonality when weak peaks or bands are observed.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09230     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     231 20%–35% of the cases; these “double-expressor lymphoma” cases  are four to five times higher in incidence than those with MYC  and BCL2 double-hit (i.e., translocation).29-31,34 Although a cut- off for MYC and BCL2 expression for double-expressor has varied among studies, a cutoff of 30% or 40% for MYC and a cutoff of  50% or 70% for BCL2 are usually used to define these cases.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09232     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     233 Cytocell, Dako, Kreatech, and Poseidon (Stretton), are generally  easy to use and validated.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09234     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     235 have been reported in almost half of HCL-v and in the majority  of HCL that use IGHV4-34 and which, like HCL-v, lack  BRAF V600E mutations.53,54 MYD88 mutation is important  in the differential diagnosis between nodal marginal zone lym-phoma and lymphoplasmacytic lymphoma (LPL).",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09236     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09Molecular Testing of Lymphoproliferative Disease   •     237 Fig.,Non-OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.04.09238     •  Jeon YK, et al.",OADS,/arxiv_data1/oa_pdf/5a/eb/jptm-2017-04-09.PMC5445208.pdf
